Element Solutions (ESI) 10-Q 7 Nov 16 2016 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2016	Nov. 01, 2016
Document and Entity Information [Abstract]
Entity Registrant Name	Platform Specialty Products Corp
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding (in shares)		278,470,487
Amendment Flag	false
Entity Central Index Key	1,590,714
Entity Filer Category	Large Accelerated Filer
Document Period End Date	Sep. 30, 2016
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q3

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Income Statement [Abstract]
Net sales	$ 890.5	$ 597.3	$ 2,635.9	$ 1,807.3
Cost of sales	515.4	354.6	1,524.1	1,088.8
Gross profit	375.1	242.7	1,111.8	718.5
Operating expenses:
Selling, technical, general and administrative	274.3	194.8	823.5	593.2
Research and development	20.9	16.6	61.3	47.8
Total operating expenses	295.2	211.4	884.8	641
Operating profit	79.9	31.3	227	77.5
Other (expense) income:
Interest expense, net	(98.5)	(52.7)	(289.7)	(143.2)
Loss on derivative contracts	(1.4)	(47.3)	(12.1)	(49.9)
Foreign exchange loss	(10.3)	(36.9)	(56.5)	(19.3)
Other income, net	116.6	1.4	120.4	19.8
Total other income (expense)	6.4	(135.5)	(237.9)	(192.6)
Income (loss) before income taxes and non-controlling interests	86.3	(104.2)	(10.9)	(115.1)
Income tax expense	(20.4)	(35.4)	(65.7)	(59.8)
Net income (loss)	65.9	(139.6)	(76.6)	(174.9)
Net loss (income) attributable to the non-controlling interests	5.9	(0.5)	4.7	(4)
Net income (loss) attributable to stockholders	71.8	(140.1)	(71.9)	(178.9)
Gain on amendment of Series B Convertible Preferred Stock	32.9	0	32.9	0
Net income (loss) attributable to common stockholders	$ 104.7	$ (140.1)	$ (39)	$ (178.9)
Income (loss) per share
Basic (in dollars per share)	$ 0.45	$ (0.66)	$ (0.17)	$ (0.89)
Diluted (in dollars per share)	$ (0.15)	$ (0.66)	$ (0.71)	$ (0.89)
Weighted average shares outstanding
Basic (in shares)	234.4	210.9	231.2	198.6
Diluted (in shares)	264.5	210.9	253.3	198.6

CONDENSED CONSOLIDATED STATEME3

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 65.9	$ (139.6)	$ (76.6)	$ (174.9)
Other comprehensive (loss) income
Foreign currency translation adjustments	(0.7)	(350.2)	451.8	(614)
Pension and post-retirement plans:
Tax expense	0	0	0	(0.5)
Pension and post-retirement plan, net of tax	0	0	0	(0.5)
Unrealized (loss) gain on available for sale securities:
Unrealized holding (loss) gain on available for sale securities	(0.2)	1	(2.5)	1.2
Tax benefit	0.1	0	0.8	0
Unrealized (loss) gain on available for sale securities, net of tax	(0.1)	1	(1.7)	1.2
Derivative financial instruments revaluation:
Unrealized hedging gain (loss), net	1.4	(18.1)	(15.4)	(18.1)
Tax benefit	0	6.3	0	6.3
Derivative financial instruments revaluation, net of tax	1.4	(11.8)	(15.4)	(11.8)
Total other comprehensive income (loss), net of tax	0.6	(361)	434.7	(625.1)
Other comprehensive loss (income) attributable to the non-controlling interests	9	7.2	(12.7)	14.3
Other comprehensive income (loss) attributable to common stockholders	9.6	(353.8)	422	(610.8)
Comprehensive income (loss) attributable to common stockholders:
Comprehensive income (loss)	75.5	(493.4)	345.4	(785.7)
Comprehensive income attributable to the non-controlling interests	5.9	(0.5)	4.7	(4)
Comprehensive income (loss) attributable to stockholders	$ 81.4	$ (493.9)	$ 350.1	$ (789.7)

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Assets
Cash and cash equivalents	$ 714.1	$ 432.2
Restricted cash	0.9	0.3
Accounts receivable, net of allowance for doubtful accounts of $28.7 and $14.4 at September 30, 2016 and December 31, 2015, respectively	1,141	1,023
Inventories	564.3	517.5
Note receivable	0	125
Prepaid expenses and other current assets	180.3	172.5
Total current assets	2,600.6	2,270.5
Property, plant and equipment, net	472.7	491.6
Goodwill	4,366.3	4,021.9
Intangible assets, net	3,393.2	3,314.3
Other assets	93.9	91.9
Total assets	10,926.7	10,190.2
Liabilities and Stockholders' Equity
Accounts payable	394.8	450.3
Current installments of long-term debt and revolving credit facilities	81.4	54.7
Accrued salaries, wages and employee benefits	78	78.1
Accrued income taxes payable	100.6	65.1
Preferred stock redemption liability	504	0
Accrued expenses and other current liabilities	409.4	414.2
Total current liabilities	1,568.2	1,062.4
Long-term debt and capital lease obligations	5,196.9	5,173.6
Long-term retirement benefits, less current portion	75.8	80.5
Long-term deferred income taxes	696.7	678.8
Long-term contingent consideration	75	70.7
Other long-term liabilities	253.8	205
Total liabilities	7,866.4	7,271
Commitments and contingencies
Redeemable preferred stock - Series B	0	645.9
Stockholders' Equity
Preferred stock - Series A	0	0
Common stock 400,000,000 shares authorized, 278,420,786 and 229,464,157 shares issued and outstanding at September 30, 2016 and December 31, 2015, respectively	2.8	2.3
Additional paid-in capital	3,921.1	3,520.4
Accumulated deficit	(571.6)	(532.7)
Accumulated other comprehensive loss	(464.1)	(886.1)
Total stockholders' equity	2,888.2	2,103.9
Non-controlling interests	172.1	169.4
Total equity	3,060.3	2,273.3
Total liabilities, redeemable preferred shares and stockholders' equity	$ 10,926.7	$ 10,190.2

CONDENSED CONSOLIDATED BALANCE5

CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Statement of Financial Position [Abstract]
Accounts receivable, allowance for doubtful accounts	$ 28.7	$ 14.4
Common shares authorized (in shares)	400,000,000	400,000,000
Common shares issued (in shares)	278,420,786	229,464,157
Common shares outstanding (in shares)	278,420,786	229,464,157

CONDENSED CONSOLIDATED STATEME6

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Cash flows from operating activities:
Net (loss) income	$ (76.6)	$ (174.9)
Reconciliation of net loss to net cash flows (used in) provided by operating activities:
Depreciation and amortization	254.9	176.3
Deferred income taxes	(57.8)	(52.3)
Manufacturer's profit in inventory adjustment	11.7	58
Foreign exchange loss	47.8	57.5
Other, net	(53.9)	26.4
Changes in assets & liabilities, net of acquisitions:
Accounts receivable	(61.9)	(68.5)
Inventories	(34.1)	(63.2)
Accounts payable and accrued expenses	(56.8)	195.6
Other changes in assets and liabilities, net	2.7	(23.8)
Net cash flows (used in) provided by operating activities	(24)	131.1
Cash flows from investing activities:
Change in restricted cash	(0.5)	599.7
Capital expenditures	(32.8)	(32.1)
Investment in registrations of products	(22.4)	(26.2)
Proceeds from disposal of property, plant and equipment	12.5	12.1
Acquisition of businesses, net of acquired cash	1.3	(2,857.9)
Other, net	4.4	(1.4)
Net cash flows used in investing activities	(37.5)	(2,305.8)
Cash flows from financing activities:
Debt proceeds, net of discount and premium	0	2,085.6
Change in revolving credit facilities, net	18.9	4.7
Repayments of borrowings	(26)	(15.5)
Proceeds from issuance of common stock, net	391.5	469.5
Payment of debt financing fees	(0.7)	(45.5)
Change in factored liabilities	(45.5)	(16.8)
Other, net	(0.8)	(1)
Net cash flows provided by financing activities	337.4	2,481
Effect of exchange rate changes on cash and cash equivalents	6	(21.6)
Net increase in cash and cash equivalents	281.9	284.7
Cash and cash equivalents at beginning of period	432.2	397.3
Cash and cash equivalents at end of period	714.1	682
Non-cash Investing Activities
Settlement of Note Receivable in exchange for OMG Malaysia	125	0
OMG Malaysia Acquisition through the settlement of Note Receivable	$ (125)	$ 0

CONDENSED CONSOLIDATED STATEME7

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Millions	Total	Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive (Loss) Income	Total Stockholders' Equity	Non-Controlling Interests
Balance (in shares) at Dec. 31, 2014		2,000,000	182,066,980
Balance at Dec. 31, 2014	$ 2,552.6	$ 0	$ 1.9	$ 2,812.4	$ (224.1)	$ (130.6)	$ 2,459.6	$ 93
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(26.3)				(26.7)		(26.7)	0.4
Other comprehensive income, net of taxes	(353.1)					(344.4)	(344.4)	(8.7)
Issuance of common stock to Founder Entities as stock dividend on Series A Preferred Stock declared on 12/31/14 (in shares)			10,050,290
Issuance of common stock to former non-founder director for exercise of stock options (in shares)			75,000
Issuance of common stock to former non-founder director for exercise of stock options	0.9			0.9			0.9
Conversion of PDH Common Stock into common stock (in shares)			21,316
Conversion of PDH Common Stock into common stock	0			0.2			0.2	(0.2)
Issuance of common stock under ESPP (in shares)			7,986
Issuance of common stock under ESPP	0.1			0.1			0.1
Acquisition of non-controlling interest with Arysta Acquisition	24.6							24.6
Equity compensation expense	0.7			0.7			0.7
Balance (in shares) at Mar. 31, 2015		2,000,000	192,221,572
Balance at Mar. 31, 2015	2,199.5	$ 0	$ 1.9	2,814.3	(250.8)	(475)	2,090.4	109.1
Balance (in shares) at Dec. 31, 2014		2,000,000	182,066,980
Balance at Dec. 31, 2014	2,552.6	$ 0	$ 1.9	2,812.4	(224.1)	(130.6)	2,459.6	93
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(9.1)				(12.2)		(12.2)	3.1
Other comprehensive income, net of taxes	89					87.4	87.4	1.6
Issuance of common stock in equity offering (in shares)			18,226,414
Issuance of common stock in equity offering	483		$ 0.2	482.8			483
Issuance costs in connection with the Equity Offering	(14.8)			(14.8)			(14.8)
Conversion of PDH Common Stock into common stock (in shares)			406,217
Conversion of PDH Common Stock into common stock	0			4.7			4.7	(4.7)
Issuance of common stock under ESPP (in shares)			6,841
Issuance of common stock under ESPP	0.3			0.3			0.3
Equity compensation expense	0.6			0.6			0.6
Balance (in shares) at Jun. 30, 2015		2,000,000	210,861,044
Balance at Jun. 30, 2015	2,748.5	$ 0	$ 2.1	3,287.9	(263)	(387.6)	2,639.4	109.1
Balance (in shares) at Dec. 31, 2014		2,000,000	182,066,980
Balance at Dec. 31, 2014	2,552.6	$ 0	$ 1.9	2,812.4	(224.1)	(130.6)	2,459.6	93
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(174.9)
Other comprehensive income, net of taxes	(625.1)
Balance (in shares) at Sep. 30, 2015		2,000,000	210,879,597
Balance at Sep. 30, 2015	2,250.4	$ 0	$ 2.1	3,287.3	(403.1)	(741.4)	2,144.9	105.5
Balance (in shares) at Jun. 30, 2015		2,000,000	210,861,044
Balance at Jun. 30, 2015	2,748.5	$ 0	$ 2.1	3,287.9	(263)	(387.6)	2,639.4	109.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(139.6)				(140.1)		(140.1)	0.5
Other comprehensive income, net of taxes	(361)					(353.8)	(353.8)	(7.2)
Issuance of common stock to former non-founder director for exercise of stock options (in shares)			2,500
Issuance of common stock in equity offering (in shares)			6,343
Issuance of common stock under ESPP (in shares)			9,710
Issuance of common stock under ESPP	0.1			0.1			0.1
Acquisition of non-controlling interest with Arysta Acquisition	6.4							6.4
Acquisition of remaining interest in Arysta Colombia	(3.3)							(3.3)
Equity compensation expense	(0.7)			(0.7)			(0.7)
Balance (in shares) at Sep. 30, 2015		2,000,000	210,879,597
Balance at Sep. 30, 2015	2,250.4	$ 0	$ 2.1	3,287.3	(403.1)	(741.4)	2,144.9	105.5
Balance (in shares) at Dec. 31, 2015		2,000,000	229,464,157
Balance at Dec. 31, 2015	2,273.3	$ 0	$ 2.3	3,520.4	(532.7)	(886.1)	2,103.9	169.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(134.4)				(134.8)		(134.8)	0.4
Other comprehensive income, net of taxes	310.1					298.4	298.4	11.7
Issuance of common stock to former non-founder director for exercise of stock options (in shares)			7,642
Conversion of PDH Common Stock into common stock (in shares)			16,499
Conversion of PDH Common Stock into common stock	0			0.2			0.2	(0.2)
Issuance of common stock under ESPP (in shares)			35,399
Issuance of common stock under ESPP	0.2			0.2			0.2
Equity compensation expense	0.9			0.9			0.9
Balance (in shares) at Mar. 31, 2016		2,000,000	229,523,697
Balance at Mar. 31, 2016	2,450.1	$ 0	$ 2.3	3,521.7	(667.5)	(587.7)	2,268.8	181.3
Balance (in shares) at Dec. 31, 2015		2,000,000	229,464,157
Balance at Dec. 31, 2015	2,273.3	$ 0	$ 2.3	3,520.4	(532.7)	(886.1)	2,103.9	169.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(76.6)
Other comprehensive income, net of taxes	$ 434.7
Issuance of common stock to former non-founder director for exercise of stock options (in shares)	0
Balance (in shares) at Sep. 30, 2016		2,000,000	278,420,786
Balance at Sep. 30, 2016	$ 3,060.3	$ 0	$ 2.8	3,921.1	(571.6)	(464.1)	2,888.2	172.1
Balance (in shares) at Mar. 31, 2016		2,000,000	229,523,697
Balance at Mar. 31, 2016	2,450.1	$ 0	$ 2.3	3,521.7	(667.5)	(587.7)	2,268.8	181.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(8.1)				(8.8)		(8.8)	0.7
Other comprehensive income, net of taxes	124					114	114	10
Conversion of PDH Common Stock into common stock (in shares)			37,445
Conversion of PDH Common Stock into common stock	0			0.4			0.4	(0.4)
Issuance of common stock under ESPP (in shares)			36,104
Issuance of common stock under ESPP	0.2			0.2			0.2
Equity compensation expense	1.9			1.9			1.9
Changes in non-controlling interests	(0.2)							(0.2)
Balance (in shares) at Jun. 30, 2016		2,000,000	229,597,246
Balance at Jun. 30, 2016	2,567.9	$ 0	$ 2.3	3,524.2	(676.3)	(473.7)	2,376.5	191.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	65.9				71.8		71.8	(5.9)
Other comprehensive income, net of taxes	0.6					9.6	9.6	(9)
Issuance of common stock in equity offering (in shares)			48,787,878
Issuance of common stock in equity offering	402.5		$ 0.5	402			402.5
Issuance costs in connection with the Equity Offering	(11.6)			(11.6)			(11.6)
Conversion of PDH Common Stock into common stock (in shares)			10,000
Conversion of PDH Common Stock into common stock	0			0.1			0.1	(0.1)
Issuance of common stock under ESPP (in shares)			25,662
Issuance of common stock under ESPP	0.2			0.2			0.2
Gain on amendment of Series B Convertible Preferred Stock	32.9				32.9		32.9
Equity compensation expense	2.5			2.5			2.5
Changes in non-controlling interests	(0.6)			3.7			3.7	(4.3)
Balance (in shares) at Sep. 30, 2016		2,000,000	278,420,786
Balance at Sep. 30, 2016	$ 3,060.3	$ 0	$ 2.8	$ 3,921.1	$ (571.6)	$ (464.1)	$ 2,888.2	$ 172.1

CONDENSED CONSOLIDATED STATEME8

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parentheticals) - $ / shares	Sep. 30, 2016	Jun. 30, 2015
Common Stock
Share price (in dollars per share)	$ 8.25	$ 26.50

Basis of Presentation and Signi

Basis of Presentation and Significant Accounting Policies	9 Months Ended
	Sep. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES	BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES Description of the Company and Business Platform Specialty Products Corporation is a global, diversified producer of high-technology specialty chemical products and provider of technical services. The Company's business involves the formulation of a broad range of solutions-oriented specialty chemicals which are sold into multiple industries, including agricultural, animal health, electronics, graphic arts, plating, offshore oil and gas production and drilling. The Company refers to its products as “dynamic chemistries” due to their intricate chemical compositions which are used in a wide variety of niche markets. As further described in Note 19, Segment Information , the Company operates in two segments: Performance Solutions and Agricultural Solutions. Until the MacDermid Acquisition on October 31, 2013, the Company had neither engaged in any operations nor generated any income. Following the MacDermid Acquisition, on January 22, 2014, the Company was domesticated in Delaware and on January 23, 2014, its common stock, par value $0.01 per share, began trading on the NYSE under the ticker symbol “PAH.” Basis of Presentation These unaudited interim Condensed Consolidated Financial Statements and related information have been prepared in accordance with GAAP for interim financial information and in accordance with the applicable rules and regulations of the SEC. Accordingly, they do not include all of the disclosures required in connection with annual financial statements. These unaudited interim Condensed Consolidated Financial Statements reflect all adjustments that are, in the opinion of management, normal, recurring and necessary for a fair statement of the Company's results of operations. These unaudited interim Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and the related notes thereto included in the Company’s Annual Report. The year-end Condensed Consolidated Balance Sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP. Principles of Consolidation The accompanying unaudited interim Condensed Consolidated Financial Statements include Platform's accounts and all of its controlled subsidiaries. All subsidiaries are included in the unaudited interim Condensed Consolidated Financial Statements for the entire period or, if acquired, from the date on which the Company obtains control. The Company fully consolidates the income, expenses, assets, liabilities and cash flows of subsidiaries from the date it acquires control or becomes the primary beneficiary up to the date control ceases. All intercompany accounts and transactions have been eliminated in consolidation. Recently Adopted Accounting Pronouncements Compensation - Stock Compensation (Topic 718) - In March 2016, the FASB issued ASU No. 2016-09, “ Improvements to Employee Share-Based Payment Accounting.” This update changes the accounting treatment related to tax windfall and shortfalls associated with share-based awards. It also eliminates the requirement for entities to estimate future forfeiture rates associated with share-based awards and stipulates the requirement that cash payments made by employers when directly withholding shares for tax-withholdings purposes should be classified as a financing activity in the statement of cash flows. The guidance is effective for fiscal years and interim periods beginning after December 15, 2016 with early adoption permitted. The Company adopted this ASU as of April 1, 2016. This ASU did not have a material impact on the Company's financial statements. Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40 ) - In April 2015, the FASB issued ASU No. 2015-05, “ Customer's Accounting for Fees Paid in a Cloud Computing Arrangement.” This update provides explicit guidance to customers utilizing a cloud computing solution to help determine whether such an arrangement includes a software license, in which case the accounting applied would be similar to that of other software license arrangements. Otherwise, the arrangement would be accounted for as a service contract. The Company adopted this ASU as of January 1, 2016. This ASU did not have a material impact on the Company's financial statements. Income Statement – Extraordinary and Unusual Items (Subtopic 225-20) - In January 2015, the FASB issued ASU No. 2015-1, “ Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items.” This update eliminates the requirement for entities to identify extraordinary events and transactions, those being both unusual in nature and infrequent in occurrence, and separately classify, present and disclose such items. The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2015. The Company adopted this ASU as of January 1, 2016. The Company did not have any extraordinary or unusual income statement items recorded for any periods presented and therefore, this ASU did not have a material impact on the Company's financial statements. Compensation – Stock Compensation (Topic 718) - In June 2014, the FASB issued ASU No. 2014-12, “ Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period (a consensus of the FASB Emerging Issues Task Force).” Under the provisions of this update, a performance target that affects vesting and that could be achieved after the requisite service period are treated as a performance condition. The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2015. The Company adopted this ASU as of January 1, 2016. This ASU did not have a material impact on the Company's financial statements as it had no share-based compensation awards that were effected by this pronouncement. Recently Issued Accounting Pronouncements Not Yet Adopted Consolidation (Topic 810) - In October 2016, the FASB issued ASU No. 2016-17, "Interests Held through Related Parties that are Under Common Control." This update clarifies how a reporting entity that is the single decision maker of a variable interest entity (VIE) should treat indirect interests in the entity held through related parties that are under common control with the reporting entity when determining whether it is the primary beneficiary of that VIE. The guidance is effective for fiscal years and interim periods beginning after December 15, 2016, with early adoption permitted. The Company is evaluating the impact of this ASU. Income Taxes (Topic 740) - In October 2016, the FASB issued ASU No. 2016-16, " Intra-Entity Transfers of Assets Other than Inventory. " This update stipulates that entities recognize the income tax consequences of intra-entity transfers of assets other than inventory when the transfer occurs. The amendments in this guidance apply to assets other than inventory, for example, intellectual property and property, plant and equipment. The guidance is effective for fiscal years beginning after December 15, 2017 and interim periods within those fiscal years, with early adoption permitted in the first quarter of an annual reporting period for which financial statements have not been issued or made available for issuance. The Company is evaluating the impact of this ASU. Statement of Cash Flows (Topic 230) - In August 2016, the FASB issued ASU No. 2016-15, " Classification of Certain Cash Receipts and Cash Payments. " This update was issued to reduce the differences in the classification of certain transactions in the statement of cash flows. The update addresses eight specific cash flow issues, including debt prepayment and extinguishment costs, zero coupon bond settlement, contingent consideration payments, insurance claim settlements, company-owned life insurance receipts/payments, distributions from equity method investments, beneficial interests in securitization transactions, and separately identifiable cash flows. The guidance is effective for fiscal years beginning after December 15, 2017 and interim periods within those fiscal years, with early adoption permitted. The Company does not expect this ASU to have a material impact on its financial statements. Financial Instruments - Credit Losses (Topic 326) - In June 2016, the FASB issued ASU No. 2016-13, " Measurement of Credit Losses on Financial Instruments. " This update introduces new guidance for the accounting for credit losses on certain types of financial instruments, which are to be estimated based on the expected losses. It also modifies the impairment model for available-for-sale debt securities and provides for a simplified accounting model for purchased financial assets with credit deterioration since their origination. The guidance is effective on a modified retrospective basis for fiscal years and interim periods beginning after December 15, 2019 with early adoption permitted for fiscal years and interim periods beginning after December 15, 2018. The Company is evaluating the impact of this ASU. Investments - Equity Method and Joint Ventures (Topic 323) - In March 2016, the FASB issued ASU No. 2016-07, " Simplifying the Transition to the Equity Method of Accounting. " This update simplifies transition accounting when the ownership level or degree of influence held in an investment qualifies that investment for equity method accounting. The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2016, with early adoption permitted. The Company does not expect this ASU to have a material impact on its financial statements. Derivatives and Hedging (Topic 815) - In March 2016, the FASB issued ASU No. 2016-06, " Contingent Put and Call Options in Debt Instruments (a consensus of the FASB Emerging Issues Task Force) ." The ASU clarifies guidance around determining whether call or put options that can accelerate the repayment of principal on a debt or hybrid instrument that are considered embedded derivatives meet the "clearly and closely related" criterion for determining whether the embedded derivative is required to be separated from the host contract and accounted for separately as a derivative. The guidance is effective for fiscal years and interim periods beginning after December 15, 2016 with early adoption permitted. Adoption is required on a modified retrospective basis. The Company does not expect this ASU to have a material impact on its financial statements. Derivatives and Hedging (Topic 815) - In March 2016, the FASB issued ASU No. 2016-05, " Effect of Derivative Contract Novations on Existing Hedge Accounting Relationships (a consensus of the FASB Emerging Issues Task Force). " This update stipulates that a change in the counterparty of a derivative instrument that has been designated as a hedging instrument under Topic 815 does not, in and of itself, require de-designation of that hedging relationship, provided that all other hedge accounting criteria continue to be met. The guidance is effective for fiscal years and interim periods beginning after December 15, 2016 and provides entities with the option to apply either a prospective or a modified retrospective approach. The Company does not expect this ASU to have a material impact on its financial statements. Leases (Topic 842) - In February 2016, the FASB issued ASU No. 2016-02, “Leases.” The updated guidance applies to capital (or finance) and operating leases, and requires the lessee to recognize a lease liability for the obligation to make lease payments and a right-of-use asset for the right to use the underlying asset for the lease term. The lessee can make an accounting policy choice to not recognize right of use assets and lease liabilities for short-term leases (leases with a lease term of 12 months or less). The guidance is effective for fiscal years and interim periods beginning after December 15, 2018, with early adoption permitted. The Company continues to evaluate the impact of this ASU. Financial Instruments - Overall (Subtopic 825.10) - In January 2016, the FASB issued ASU No. 2016-1, “Recognition and Measurement of Financial Assets and Financial Liabilities.” This update addresses certain aspects of recognition, measurement, presentation, and disclosure of financial assets and liabilities. Provisions of this ASU include, among others, requiring the measurement of certain equity investments at fair value, with changes in value recognized in net income, and simplifying the impairment assessment of certain equity investments. The guidance is effective for fiscal years and interim periods beginning after December 15, 2017. The guidance is effective on a modified retrospective basis, except as it relates to equity securities without a readily determinable fair value, for which it is effective on a prospective basis. Early adoption is only permitted for provisions related to the recognition of changes in fair value of financial liabilities. The Company does not expect this ASU to have a material impact on its financial statements. Revenue from Contracts with Customers (Topic 606) - In August 2015, the FASB issued ASU No. 2015-14, “Deferral of the Effective Date,” which defers the effective date of ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606)," for all entities by one year. As a result, the provisions of ASU No. 2014-09 will be effective prospectively for fiscal years and interim periods beginning after December 15, 2017. ASU No. 2014-09 (1) removes inconsistencies and weaknesses in revenue requirements, (2) provides a more robust framework for addressing revenue issues, (3) improves comparability of revenue recognition practices across entities, industries, jurisdictions, and capital markets, (4) provides more useful information to users of financial statements through improved disclosure requirements, and (5) simplifies the preparation of financial statements by reducing the number of requirements to which an entity must refer. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The FASB has issued the following amendments and supplements to the guidance of ASU Nos. 2014-09 and 2015-14, all of which become effective for fiscal years and interim periods beginning after December 15, 2017: • ASU No. 2016-08, " Principal versus Agent Considerations, " issued in March 2016. This update improves the operability and understandability of the implementation guidance on principal versus agent considerations. • ASU No. 2016-10, " Identifying Performance Obligations and Licensing, " issued in April 2016. This update provides clarification on the implementation guidance defining when a good or service is separately identifiable from other promises in the contract and on contracts with licenses of intellectual property. • ASU No. 2016-12, " Narrow-Scope Improvements and Practical Expedients, " issued in May 2016. This update provides clarification on the collectability criterion, presentation of taxes, non-cash consideration and contract modification guidance espoused in ASU No. 2014-09. This update also clarifies the accounting treatment for completed contracts and retrospective application of the standard to prior reporting periods. The Company continues to evaluate the impact of ASU Nos. 2014-09, 2015-14 and their subsequent amendments. Presentation of Financial Statements - Going Concern (Subtopic 205-40) - In August 2014, the FASB issued ASU No. 2014-15, " Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern ." This update provides clarification on conditions and events that should be considered by management at each annual and interim reporting period in determining whether there exists substantial doubt as to an entity’s ability to continue as a going concern. The guidance is effective for fiscal years and interim periods ending after December 15, 2016 with early adoption permitted. The Company does not expect this ASU to have a material impact on its financial statements. Out of Period Adjustment In connection with the preparation of the Company's unaudited interim Condensed Consolidated Financial Statements for the period ended September 30, 2016, the Company identified an error that effected prior periods related to the allocation of expenses to non-controlling interests. On a cumulative basis since the first quarter of 2015, the Company determined $6.1 million of expenses were not allocated to its non-controlling interests resulting in an overstatement of “Non-controlling Interests” and “Accumulated Deficit” in the Company’s Condensed Consolidated Balance Sheets and an understatement of “Net loss attributable to non-controlling interests” and overstatement of “Net loss attributable to stockholders” in the Company's Condensed Consolidated Statements of Operations. Based on an analysis of qualitative and quantitative factors, management has concluded that this error was not material to the Company's unaudited interim Condensed Consolidated Financial Statements for 2015 and 2016 as well as the Company's Annual Report for the year ended December 31, 2015. As a result, the effects of the adjustment were corrected in the unaudited interim Condensed Consolidated Financial Statements for the period ended September 30, 2016. Restatement As previously disclosed in the Company's Annual Report, the Company restated its unaudited Condensed Consolidated Statement of Operations for the three and nine months ended September 30, 2015 and its unaudited Condensed Consolidated Balance Sheet as of September 30, 2015 that were previously included in the Company's quarterly report on Form 10-Q for the quarter ended September 30, 2015 to correct an error as a result of improperly recording a benefit on an unrealized loss associated with a foreign currency hedge entered into in connection with the Alent Acquisition for income tax accounting purposes, which resulted in an understatement of income tax expense of $17.8 million . As a result of the error, "Loss per share" was understated by $0.08 for the three and nine month periods ended September 30, 2015. In addition, "Prepaid expenses and other current assets" were overstated by $19.6 million , "Other assets" were understated by $2.8 million , and "Accrued income taxes payable" was understated by $1.0 million .

Acquisitions of Businesses

Acquisitions of Businesses	9 Months Ended
	Sep. 30, 2016
Business Combinations [Abstract]
ACQUISITIONS OF BUSINESSES	ACQUISITIONS OF BUSINESSES OMG Malaysia Acquisition On January 31, 2016, the Company completed the OMG Malaysia Acquisition for approximately $124 million , net of acquired cash and closing working capital adjustments. The Company acquired OMG Malaysia to further enhance its Performance Solutions segment. OMG Malaysia, which is highly-synergistic with the OMG Businesses, is included in the Company's Performance Solutions business segment. Alent Acquisition On December 1, 2015, Platform completed the Alent Acquisition by acquiring all of the issued shares of Alent for approximately $1.74 billion in cash, net of acquired cash, and 18,419,738 shares of the Company's common stock at $12.56 per share, issued to Alent shareholders, including Cevian Capital II Master Fund LP, the then largest shareholder of Alent. The Company acquired Alent to expand its product capabilities and offerings and improve its geographic outreach in surface treatments. Alent is a global supplier of specialty chemicals and engineered materials used primarily in electronics, automotive, industrial applications, and high performance consumable products and services. Alent is included in the Company's Performance Solutions business segment. OMG Acquisition On October 28, 2015, Platform completed the OMG Acquisition for approximately $239 million in cash, net of acquired cash, and purchase price adjustments. The Company acquired the highly-synergistic OMG Businesses to bolster its Performance Solutions business segment. OMG’s Electronic Chemicals business develops, produces and supplies chemicals for electronic and industrial applications. OMG’s Photomasks products are used by customers to produce semiconductors and related products. These businesses are included in the Company's Performance Solutions business segment. Arysta Acquisition On February 13, 2015, Platform completed the Arysta Acquisition for approximately $3.50 billion , consisting of $2.86 billion in cash, net of acquired cash and closing working capital adjustments, and including Arysta Seller transaction expenses paid by Platform, and the issuance to the Arysta Seller of $600 million of Platform’s Series B Convertible Preferred Stock with a fair value of $646 million . On September 9, 2016, the Company entered into a settlement agreement with the Arysta Seller with respect to certain of its obligations relating to the Company's shares of Series B Convertible Preferred Stock. See Note 11, Stockholders' Equity, under the heading " Series B Convertible Preferred Stock." The Company acquired Arysta to expand its presence in the agrochemical business, complementing the Agriphar and CAS Acquisitions. Arysta provides products and solutions utilizing globally managed patented and proprietary off-patent agrochemical AIs and biological solutions, or biosolutions, and off-patent agrochemical offerings. Biosolutions includes stimulants, or biostimulants, innovative nutrition and biological control, or biocontrol, products. Arysta is included in the Company's Agricultural Solutions business segment. Acquisition Net Sales and Net Income (Loss) Since the dates of their respective acquisitions, net sales contributed by the OMG Malaysia, Alent, OMG and Arysta Acquisitions for the three and nine months ended September 30, 2016 and 2015 were as follows: Three Months Ended September 30, Nine Months Ended September 30, (amounts in millions) 2016 2015 2016 2015 OMG Malaysia $ 8.5 $ — $ 21.4 $ — Alent 243.9 — 693.0 — OMG 27.8 — 80.9 — Arysta 363.7 318.2 1,013.4 837.6 Total $ 643.9 $ 318.2 $ 1,808.7 $ 837.6 Net income (loss) generated by the OMG Malaysia, Alent, OMG and Arysta Acquisitions, excluding corporate allocations, for the three and nine months ended September 30, 2016 and 2015 was as follows: Three Months Ended September 30, Nine Months Ended September 30, (amounts in millions) 2016 2015 2016 2015 OMG Malaysia $ 1.2 $ — $ 2.3 $ — Alent 23.7 — 38.8 — OMG 4.2 — 4.5 — Arysta (8.9 ) (34.8 ) (174.1 ) (100.6 ) Total $ 20.2 $ (34.8 ) $ (128.5 ) $ (100.6 ) As the integration continues for (1) the OMG Malaysia, Alent and OMG Acquisitions within the Company's Performance Solutions business segment and (2) the Arysta Acquisition within the Agricultural Solutions segment, discrete results reported by these existing businesses are being effected by the integration process and are becoming less comparable to prior periods. Purchase Price Allocation The following table summarizes the consideration transferred and transaction costs incurred to acquire OMG Malaysia, Alent and the OMG Businesses, as well as the applicable amounts of identified assets acquired and liabilities assumed at the applicable acquisition date: (amounts in millions) OMG Malaysia Alent OMG Consideration Cash, net $ (1.3 ) $ 1,507.0 $ 239.1 Equity instruments — 231.4 — Note receivable settlement 125.0 — — Total consideration $ 123.7 $ 1,738.4 $ 239.1 Acquisition costs $ 0.5 $ 29.2 $ 7.4 Identifiable assets acquired and liabilities assumed Accounts receivable $ 4.3 $ 177.4 $ 33.1 - less uncollectible — (1.8 ) (1.6 ) Accounts receivable - fair value 4.3 175.6 31.5 Inventories 6.4 116.1 13.2 Other current assets 0.2 29.3 1.6 Property, plant and equipment 4.7 192.2 35.1 Identifiable intangible assets 38.3 682.9 77.9 Other assets — 38.3 0.2 Current liabilities (3.5 ) (181.8 ) (21.5 ) Non-current deferred tax liability (10.0 ) (139.6 ) (13.6 ) Other long term liabilities — (345.2 ) (2.9 ) Total identifiable net assets 40.4 567.8 121.5 Goodwill 83.3 1,170.6 117.6 Total purchase price $ 123.7 $ 1,738.4 $ 239.1 The purchase accounting and purchase price allocation is complete for the OMG Acquisition. During the nine months ended September 30, 2016, the Company increased the environmental reserves by $1.5 million and reduced non-current accrued tax liability by $2.6 million . The collective impact of these adjustments resulted in a decrease of $1.1 million in goodwill. The purchase accounting and purchase price allocation is substantially complete for the Alent Acquisition with the exception of intangible assets, income taxes, environmental reserves and AROs. The Company is still gathering information to finalize purchase accounting for the Alent Acquisition. During the nine months ended September 30, 2016, the Company updated the environmental reserves, non-current other liabilities and non-current deferred tax assets. The updates resulted in increases in environmental reserves of $25.6 million and non-current other liabilities of $2.8 million . The collective impact of these adjustments resulted in an increase of $0.7 million in non-current deferred tax asset along with corresponding adjustments reflected in goodwill. The purchase accounting and purchase price allocation is substantially complete for the OMG Malaysia Acquisition with the exception of intangible assets. Subsequent to this acquisition, the Company updated the valuation of inventories, identifiable intangible assets and non-current deferred tax liability. The updated valuations resulted in decreases in inventories of $0.8 million and identifiable intangible assets of $20.7 million . The collective impact of the adjustments noted above resulted in a decrease of $5.1 million in non-current deferred tax liability, with corresponding adjustments reflected in goodwill. All the measurement period adjustments noted above had an immaterial impact on Condensed Consolidated Statement of Operations for the nine months ended September 30, 2016. There were no measurement period adjustments made for the three months ended September 30, 2016 . The excess of the respective cost of the OMG Malaysia, Alent and OMG Acquisitions over the net of amounts assigned to the fair values of the assets acquired and the liabilities assumed in connection with these acquisitions is recorded as goodwill and represents the value of estimated synergies and the assembled workforces resulting from these acquisitions. Of the $1.37 billion of goodwill recorded in connection with the OMG Malaysia, Alent and OMG Acquisitions, $113 million is expected to be deductible for tax purposes as a result of the OMG Malaysia and OMG Acquisitions. Identifiable intangible assets recorded in conjunction with the OMG Malaysia, Alent and OMG Acquisitions were as follows: OMG Malaysia Alent OMG Total (amounts in millions) Fair Value Weighted average useful life (years) Fair Value Weighted average useful life (years) Fair Value Weighted average useful life (years) Fair Value Weighted average useful life (years) Customer lists $ 35.0 25.0 $ 391.4 14.7 $ 49.0 24.3 $ 475.4 16.5 Developed technology 3.3 5.0 203.3 10.0 28.0 10.0 234.6 9.9 Tradenames — — 85.8 (1) 20.0 0.9 10.0 86.7 18.3 In process - R&D — — 2.4 (2) — — — 2.4 — Total $ 38.3 23.3 $ 682.9 13.2 $ 77.9 19.0 $ 799.1 14.3 (1) Includes $81.4 million of indefinite-lived tradenames which have been excluded from the calculation of weighted average useful life. (2) Excluded from the calculation of weighted average useful life. Pro Forma Revenue and Earnings The following unaudited pro forma summary presents consolidated information of the Company for the three and nine months ended September 30, 2016 and 2015 as if the OMG Malaysia, Alent and OMG Acquisitions had each occurred on January 1, 2015, and as if the Arysta Acquisition had occurred on January 1, 2014: Three Months Ended September 30, Nine Months Ended September 30, (amounts in millions) 2016 2015 2016 2015 Pro forma revenue $ 890.5 $ 865.5 $ 2,638.8 $ 2,713.9 Pro forma net income (loss) attributable to stockholders 105.5 (151.8 ) (21.8 ) (198.5 ) For the three and nine months ended September 30, 2016 , the Company incurred $1.3 million and $14.3 million of acquisition and integration expenses, respectively, related to the OMG Malaysia, Alent, OMG and Arysta Acquisitions, which have been reflected in the pro forma earnings above as if each of these Acquisitions had occurred in 2015. In addition, for the three and nine months ended September 30, 2015 , the Company incurred acquisition and integration expenses of $4.4 million and $32.2 million , respectively, related to the Arysta Acquisition, which have been excluded from the September 30, 2015 pro forma earnings above. These pro forma amounts have been prepared to reflect fair value adjustments to intangible assets and the related amortization expense, net of tax, from January 1, 2015, as well as the effect of the debt instruments used to fund the Arysta and Alent Acquisitions.

Inventories

Inventories	9 Months Ended
	Sep. 30, 2016
Inventory Disclosure [Abstract]
INVENTORIES	INVENTORIES The major components of inventory were as follows: (amounts in millions) September 30, December 31, 2015 Finished goods $ 355.9 $ 340.1 Work in process 44.2 28.5 Raw materials and supplies 164.2 148.9 Total inventory, net $ 564.3 $ 517.5 In connection with Platform's various business acquisitions, the value of inventory was increased at the respective dates of acquisition to reflect fair value. For the three months ended September 30, 2016 and 2015 , zero and $1.3 million , respectively, was recorded to "Cost of sales" in the Condensed Consolidated Statements of Operations based on inventory turnover of such acquisitions and purchase price adjustments. For the nine months ended September 30, 2016 and 2015 , $11.7 million and $58.0 million , respectively, was charged to "Cost of sales" in the Condensed Consolidated Statements of Operations based on inventory turnover of such acquisitions and purchase price adjustments.

Property, Plant and Equipment

Property, Plant and Equipment	9 Months Ended
	Sep. 30, 2016
Property, Plant and Equipment [Abstract]
PROPERTY, PLANT AND EQUIPMENT	PROPERTY, PLANT AND EQUIPMENT The major components of property, plant and equipment, including equipment under capital leases, were as follows: (amounts in millions) September 30, December 31, 2015 Land and leasehold improvements $ 109.2 $ 107.9 Buildings and improvements 138.1 143.8 Machinery, equipment, fixtures and software 302.4 276.8 Construction in process 27.4 21.4 Assets under capital lease: Land and buildings 8.2 6.4 Machinery and equipment 5.3 5.1 Total property, plant and equipment 590.6 561.4 Accumulated depreciation (111.1 ) (64.3 ) Accumulated amortization of capital leases (6.8 ) (5.5 ) Property, plant and equipment, net $ 472.7 $ 491.6 For the three months ended September 30, 2016 and 2015 , the Company recorded depreciation expense of $18.9 million and $11.6 million , respectively. For the nine months ended September 30, 2016 and 2015 , the Company recorded depreciation expense of $55.8 million and $33.7 million , respectively. In March 2016, the Company entered into a sale agreement for a long-lived asset with a net book value of $12.1 million in exchange for a cash payment of $9.3 million , net of estimated selling costs of $0.2 million . As a result, the Company reduced the net book value of the asset by $2.8 million , which was recorded in "Selling, technical, general and administrative expense" in the Condensed Consolidated Statements of Operations during the first quarter of 2016. The asset was subsequently sold during the second quarter of 2016.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	9 Months Ended
	Sep. 30, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL AND INTANGIBLE ASSETS	GOODWILL AND INTANGIBLE ASSETS The changes in the carrying amount of goodwill by segment were as follows: (amounts in millions) Performance Solutions Agricultural Solutions Total December 31, 2015 $ 2,147.2 $ 1,874.7 $ 4,021.9 Addition from acquisitions 66.9 — 66.9 Purchase accounting adjustments 46.3 — 46.3 Foreign currency translation and other 4.6 226.6 231.2 September 30, 2016 $ 2,265.0 $ 2,101.3 $ 4,366.3 The carrying value of indefinite-lived intangible assets other than goodwill, which consist solely of tradenames, was $391 million and $360 million at September 30, 2016 and December 31, 2015 , respectively. During the nine months ended September 30, 2016 , the Company found no indications of impairment related to its goodwill and indefinite-lived intangible assets. Intangible assets subject to amortization were as follows: September 30, 2016 December 31, 2015 (amounts in millions) Weighted Average Useful Life (years) Gross Carrying Amount and Foreign Exchange Accumulated Amortization and Foreign Exchange Net Book Value Gross Carrying Amount and Foreign Exchange Accumulated Amortization and Foreign Exchange Net Book Value Customer lists 18.3 $ 1,240.5 $ (117.9 ) $ 1,122.6 $ 1,297.2 $ (184.0 ) $ 1,113.2 Developed technology 11.7 2,009.4 (146.7 ) 1,862.7 2,260.9 (440.4 ) 1,820.5 Tradenames 8.0 22.2 (5.9 ) 16.3 24.2 (5.4 ) 18.8 Non-compete agreements 5.0 1.9 (0.9 ) 1.0 1.9 (0.5 ) 1.4 Total 14.1 $ 3,274.0 $ (271.4 ) $ 3,002.6 $ 3,584.2 $ (630.3 ) $ 2,953.9 For the three months ended September 30, 2016 and 2015 , the Company recorded amortization expense on intangible assets of $68.0 million and $50.4 million , respectively. For the nine months ended September 30, 2016 and 2015 , the Company recorded amortization expense on intangible assets of $199 million and $143 million , respectively.

Long-term Compensation Plans

Long-term Compensation Plans	9 Months Ended
	Sep. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
LONG-TERM COMPENSATION PLANS	LONG-TERM COMPENSATION PLANS In June 2014, the Company’s stockholders approved the 2013 Plan, which is administered by the compensation committee of the Board, except as otherwise expressly provided in the 2013 Plan. The Board approved a maximum of 15,500,000 shares of common stock (subject to increase in accordance with the terms of the 2013 Plan), which were reserved and made available for issuance under the 2013 Plan. As of September 30, 2016 , a total of 373,434 shares of common stock had been issued and 2,824,164 awarded RSUs and stock options were outstanding under the 2013 Plan. Nine Months Ended September 30, 2016 Total RSUs Stock Options Equity Classified Liability Classified Outstanding at December 31, 2015 1,006,436 501,634 329,802 175,000 Granted 2,110,173 1,719,975 — 390,198 Exercised/Issued (7,642 ) (7,642 ) — — Forfeited (109,803 ) (100,313 ) (9,490 ) — Outstanding at September 30, 2016 2,999,164 2,113,654 320,312 565,198 Equity Classified RSUs During the nine months ended September 30, 2016 , the Company issued the following RSU grants following their approval by the Board: RSUs Weighted average grant date fair value Weighted average vesting period (months) RSUs issued 1,719,975 $ 10.86 34.1 In addition to RSUs containing only service vesting conditions, the Company has issued RSUs for which vesting is also tied to performance or market conditions. Certain of these RSUs with performance or market vesting conditions also contain provisions for additional share awards in the event certain performance or market conditions are met at the end of certain applicable measurement periods. These conditions are generally based on ROIC or TSR targets. As of September 30, 2016 , the following equity classified RSUs were outstanding: September 30, 2016 Vesting Conditions: Outstanding Weighted average service period (years) Potential additional awards Service-based 772,835 2.8 — Performance-based 713,830 3.3 433,780 Market-based 626,989 3.5 1,202,067 Total 2,113,654 3.2 1,635,847 In addition, the Board had approved 166,667 RSUs under the 2013 Plan subject to EBITDA performance conditions that must be achieved in the applicable vesting year which have yet to be set. These awards also include a multiplier of zero to 100% based upon adjusted EBITDA target benchmarks. As the target adjusted EBITDA benchmarks have not yet been established, these RSUs have been excluded from the above grant activity. The adjusted EBITDA target benchmarks are expected to be established in 2017 and 2018. For the three months ended September 30, 2016 and 2015 , total compensation expense associated with RSUs classified as equity totaled $2.0 million and $0.2 , respectively. For the nine months ended September 30, 2016 and 2015 , total compensation expense associated with RSUs classified as equity totaled $4.6 million and $0.6 million , respectively. Liability Classified RSUs In March 2014, the Company granted to certain employees 329,823 RSUs that cliff vest on December 31, 2020. These RSUs are subject to an adjusted EBITDA performance condition and a share price market condition. Additionally, the number of shares of common stock to be issued is limited to a maximum cash value, requiring these awards to be classified as liabilities. There were 320,312 RSUs associated with these grants outstanding as of September 30, 2016 . The combined undiscounted maximum cash value of all liability-classified RSUs issued is approximately $6.9 million , which is being recognized as compensation expense over the period from grant to the vesting date. For the three months ended September 30, 2016 and 2015 , compensation expense (income) associated with these awards totaled zero and $(0.6) million , respectively. For the nine months ended September 30, 2016 and 2015 , compensation expense associated with these awards totaled zero and $0.8 million , respectively. Stock Options During the nine months ended September 30, 2016 , the Company granted non-qualified stock options under the 2013 Plan as follows: Stock Options Weighted average strike price per share Weighted average grant date fair value per share Stock options granted 390,198 $ 8.05 $ 4.35 All options granted during 2016 are subject to graded vesting over a three -year period and have contractual lives of ten years from the grant date. Fair value of the grants is calculated using the Black-Scholes option pricing model at the grant date. The following table provides the range of assumptions used in valuing the option grants using the Black-Scholes option pricing method: Black-Scholes Input Assumptions Weighted average expected term (years) 6.0 Expected volatility 53.0% Risk-free rate 1.52% to 1.56% Expected dividend rate —% Fair value price per share $4.32 to $4.81 Weighted average expected term is calculated based on the simplified method for plain vanilla options as the Company has concluded that its historical share option exercise experience does not provide a reasonable basis upon which to estimate expected term and certain alternative information to assist with estimating it is not easily obtainable. Expected volatility is calculated based on a blend of the implied and historical equity volatility of an index of comparable companies. Risk-free rate of return is based on an interpolation of U.S. Treasury rates to reflect an expected term of six years at the date of grant. For the three and nine months ended September 30, 2016, the Company recognized compensation expense associated with stock options of $0.1 million and $0.3 million , respectively. Long Term Cash Bonus Plan The Company established the LTCB during the first quarter of 2015. As of September 30, 2016 , the LTCB provides participants with the right to receive long-term cash bonuses totaling in the aggregate $10.5 million , a decrease of $4.8 million from December 31, 2015 due to forfeitures. Benefits under the plan vest over periods ranging from 36 to 62.5 months and include adjusted EBITDA performance targets, which are subject to appropriate and equitable adjustments by the compensation committee of the Board in order to reflect any subsequent acquisition, divestiture or other corporate reorganizations, as necessary. For the three months ended September 30, 2016 and 2015 , compensation expense (income) associated with the LTCB totaled $0.1 million and $(0.6) million , respectively. For the nine months ended September 30, 2016 and 2015 , compensation expense associated with the LTCB totaled $0.2 million and $0.2 million , respectively. Employee Stock Purchase Plan The Company adopted the ESPP in 2014. The Board approved a maximum of 5,178,815 shares of common stock, which were reserved and made available for issuance under the plan. As of September 30, 2016 , a total of 152,665 shares had been issued under the ESPP, and approximately 1,200 persons were eligible to participate in the ESPP. For the three months ended September 30, 2016 and 2015 , compensation expense associated with the ESPP totaled $0.2 million and zero , respectively. For the nine months ended September 30, 2016 and 2015 , compensation expense associated with the ESPP totaled $0.3 million and $0.1 million , respectively.

Pension and Post-Retirement Pla

Pension and Post-Retirement Plans	9 Months Ended
	Sep. 30, 2016
Compensation and Retirement Disclosure [Abstract]
PENSION AND POST-RETIREMENT PLANS	PENSION AND POST-RETIREMENT PLANS The components of net periodic pension and post-retirement benefit costs for the three and nine months ended September 30, 2016 and 2015 were as follows: Three Months Ended September 30, Nine Months Ended September 30, (amounts in millions) 2016 2015 2016 2015 Pension & SERP Benefits Domestic Foreign Domestic Foreign Domestic Foreign Domestic Foreign Net periodic (benefit) cost Service cost $ — $ 0.4 $ — $ 0.2 $ — $ 1.3 $ — $ 0.6 Interest cost on the projected benefit obligation 2.5 0.8 1.6 0.5 7.6 2.3 4.8 1.5 Expected return on plan assets (2.9 ) (0.6 ) (2.4 ) (0.5 ) (8.7 ) (1.9 ) (7.2 ) (1.5 ) Amortization of prior service cost — 0.1 — — — 0.4 — — Net periodic (benefit) cost $ (0.4 ) $ 0.7 $ (0.8 ) $ 0.2 $ (1.1 ) $ 2.1 $ (2.4 ) $ 0.6 Three Months Ended September 30, Nine Months Ended September 30, (amounts in millions) 2016 2015 2016 2015 Post-retirement Benefits Domestic Foreign Domestic Foreign Domestic Foreign Domestic Foreign Net periodic cost Interest cost on the projected benefit obligation $ 0.1 $ 0.1 $ 0.1 $ — $ 0.3 $ 0.2 $ 0.3 $ — Net periodic cost $ 0.1 $ 0.1 $ 0.1 $ — $ 0.3 $ 0.2 $ 0.3 $ — No pension service costs were recognized during the three and nine months ended September 30, 2016 and 2015 under the domestic pension plans, nor will there be in future periods, as benefits in the plans were frozen. The Company expects to make contributions totaling $6.9 million to its pension and other post-retirement benefit plans during 2016, of which $6.6 million was contributed as of September 30, 2016 .

Debt, Capital Leases, Financial

Debt, Capital Leases, Financial Guarantees and Factoring Arrangements	9 Months Ended
	Sep. 30, 2016
Debt Disclosure [Abstract]
DEBT, CAPITAL LEASES, FINANCIAL GUARANTEES AND FACTORING ARRANGEMENTS	DEBT, CAPITAL LEASES, FINANCIAL GUARANTEES AND FACTORING ARRANGEMENTS Excluding the "Preferred stock redemption liability," the Company’s debt and capital lease obligations consisted of the following: (amounts in millions) September 30, December 31, 2015 Debt and Capital Lease Obligations USD Senior Notes due 2022, $ 1,082.5 $ 1,081.1 EUR Senior Notes due 2023, 387.6 374.0 USD Senior Notes due 2021, 488.5 487.5 First Lien Credit Facility - U.S. Dollar Term Loans due 2020, 2,620.0 2,631.3 First Lien Credit Facility - Euro Term Loans due 2020, 638.0 619.2 Borrowings under the Revolving Credit Facility, — — Borrowings under lines of credit, 42.8 16.7 Other 18.9 18.5 Total debt and capital lease obligations 5,278.3 5,228.3 Less: current portion debt and capital lease obligations (81.4 ) (54.7 ) Total long-term debt and capital lease obligations $ 5,196.9 $ 5,173.6 The weighted average effective interest rate associated with debt outstanding at September 30, 2016 , based on currently applicable interest rates, was 6.99% . This rate includes the effects of interest rate swaps, as well as the impact of deferred financing fees and original issue discount and premium amortization calculated using the effective interest method. In August 2015, the Company entered into a series of pay fixed, receive floating interest rate swaps with respect to a portion of its indebtedness. The swaps effectively fix the floating base rate portion of the interest payments on approximately $1.15 billion of the Company's USD denominated debt and €282 million of its Euro denominated debt at 1.96% and 1.20% , respectively, from September 2015 through June 2020. On September 9, 2016, the Company entered into a settlement agreement with the Arysta Seller with respect to certain obligations relating to the Company's shares of Series B Convertible Preferred Stock. As a result of the settlement agreement, for accounting purposes, the Series B Convertible Preferred Stock was deemed extinguished in exchange for the issuance of another financial instrument that is recognized as a "Preferred stock redemption liability" in the current liability section of the Condensed Consolidated Balance Sheet, which totaled $504 million as of September 30, 2016. See Note 11, Stockholders' Equity, under the heading "Preferred Stock - Series B Convertible Preferred Stock" for further information . Minimum principal payments on long-term debt and capital leases were as follows: (amounts in millions) Principal Payments Year ending December 31, 2016 - remaining $ 8.9 2017 34.9 2018 34.8 2019 34.6 2020 3,218.8 2021 500.7 Thereafter 1,494.4 Total $ 5,327.1 In order to fund its acquisition activity, the Company has $5.28 billion of debt as of September 30, 2016 , with expected interest payments in excess of $300 million per year. The first significant principal debt payments, totaling $3.22 billion , are due in 2020 and represent maturities of outstanding term loans under the Amended and Restated Credit Agreement. On October 14, 2016, the Company created new tranches of term loans, the proceeds of which were used to prepay, in full, more than half of the Company's previously existing term loans, having the effect of reducing future interest payments and extending maturity dates. See " Amended and Restated Agreement - Subsequent Events" below. In addition, to the extent the Company does not settle its preferred stock redemption liability as described below, on April 20, 2017, it will be required to repurchase, in consideration and exchange for shares of its common stock, each share of Series B Convertible Preferred Stock that has not been previously converted into shares of the Company's common stock or automatically redeemed for cash. Upon such repurchase, the Company would also pay to holders of Series B Convertible Preferred Stock in cash a make whole payment, which corresponds to any deficit between (i) the 10 -day volume weighted price of Platform’s common stock prior to such repurchase and (ii) $27.14 per share. Based on Platform's common stock price of $8.11 as of September 30, 2016 , the maximum potential make whole payment would total approximately $421 million . Under the terms of a recent settlement agreement with the Arysta Seller, from October 20, 2016 until the close of business on December 15, 2016, the Company may however settle (i) all of its obligations with respect to the Series B Convertible Preferred Stock in exchange for a cash payment of $1.00 and the issuance of 5,500,000 shares of its common stock upon simultaneous conversion of the Series B Convertible Preferred Stock by the Arysta Seller, and (ii) for a payment of $460 million , its obligation to pay the make whole payment mentioned above to the Arysta Seller. The Company anticipates sufficient cash from operations to fund interest, working capital and other capital expenditures for the foreseeable future and has access to a $500 million line of credit under the Revolving Credit Facility, with current availability of $500 million , as well as availability under various lines of credit and overdraft facilities of $118 million . In addition, during the third quarter of 2016, the Company completed the September 2016 Equity Offering of 48,787,878 shares of common stock. This offering resulted in gross proceeds of approximately $402.5 million . Despite the above, a combination of the settlement of the preferred stock redemption liability, working capital shortfalls and future acquisitions may require utilization of the Revolving Credit Facility as well as proceeds from future debt and/or equity offerings. The Company's long-term liquidity may also be impacted by its ability to borrow additional funds, renegotiate existing debt and/or raise equity or debt under favorable terms. Amended and Restated Credit Agreement The Company is party to the Amended and Restated Credit Agreement, which governs the First Lien Credit Facility and the Revolving Credit Facility (in U.S. Dollar or multicurrency). A portion of the Revolving Credit Facility not in excess of $30.0 million is available for the issuance of letters of credit. As of September 30, 2016 , the maximum borrowing capacity under the Amended and Restated Credit Agreement consisted (i) an aggregate principal amount of up to $250 million under the Revolving Credit Facility to be denominated in U.S. Dollars, and (ii) an aggregate principal amount of up to $250 million under the Revolving Credit Facility to be denominated in multicurrency. Pursuant to the terms of the Amended and Restated Credit Agreement, each of the First Lien Credit Facility term loans bear interest at a rate per annum equal to the greater of 5.50% or LIBOR plus an adjusted eurocurrency rate, or 4.50% plus an adjusted base rate, calculated as set forth in the Amended and Restated Credit Agreement. Each tranche of term loans will mature on June 7, 2020. Pursuant to the terms of the Amended and Restated Credit Agreement, loans under the Revolving Credit Facility bear interest at a rate per annum equal to 3.00% plus an adjusted eurocurrency rate, or 2.00% plus an adjusted base rate, each as calculated as set forth in the Amended and Restated Credit Agreement. The Revolving Credit Facility will mature on June 7, 2019. Revolving loans and commitments held by revolving facility lenders who did not consent to any extension, will mature on June 7, 2018. Certain domestic and foreign subsidiaries of the Company, including certain subsidiaries acquired in the Alent, Arysta and OMG Acquisitions, are guarantors under the Amended and Restated Credit Agreement, with certain of these subsidiaries having pledged collateral to secure the obligations incurred thereunder. Covenants and Events of Default The Amended and Restated Credit Agreement contains customary covenants including limitations on additional indebtedness, dividends and other distributions, entry into new lines of business, use of loan proceeds, capital expenditures, restricted payments, restrictions on liens, transactions with affiliates, amendments to organizational documents, accounting changes, sale and leaseback transactions and dispositions. The Revolving Credit Facility also imposes a financial covenant to maintain a first lien net leverage ratio of 6.25 to 1.0 of (x) consolidated indebtedness secured by a first lien minus unrestricted cash and cash equivalents of the borrowers and guarantors under the Amended and Restated Credit Agreement to (y) consolidated EBITDA for the four most recent fiscal quarters, subject to a right to cure. A violation of this financial covenant can become an event of default under the Credit Facilities and result in the acceleration of all of the Company's indebtedness. As of September 30, 2016 , the Company was in compliance with the debt covenants contained in the Credit Facilities and, in accordance with such debt covenants, had full availability of its unused borrowing capacity of $500 million under the Revolving Credit Facility. The Amended and Restated Credit Agreement also contains customary events of default that include, among others, non-payment of principal, interest or fees, violation of certain covenants, inaccuracy of representations and warranties, failure to make payment on certain other material indebtedness, bankruptcy and insolvency events, material judgments and change of control provisions. Upon the occurrence of an event of default, payment of any outstanding loans under the Amended and Restated Credit Agreement may be accelerated. Borrowings under the Amended and Restated Credit Agreement are also subject to mandatory prepayment from the proceeds of certain dispositions of assets and from certain insurance and condemnation proceeds, excess cash flow and debt incurrences, in each case, subject to customary carve-outs and exceptions. The Amended and Restated Credit Agreement also contains a yield protection provision wherein the yield on any current indebtedness issued under the Amended and Restated Credit Agreement would be increased to within 50 basis points of the yield on any additional incremental term loan(s), in the event the incremental term loan(s) provided an initial yield, including original issue discount (OID), subject to the yield calculation provisions, as defined, is in excess of 50 basis points of the yield on existing term loan indebtedness. Subsequent Event On October 14, 2016, the Company entered into and closed the transactions contemplated by Amendment No. 5 to the Second Amended and Restated Credit Agreement. Amendment No. 5, among other things, provided for the prepayment in full of previously existing tranche B and tranche B-2 term loans denominated in U.S. dollars and tranche C-1 term loans denominated in Euros with the aggregate proceeds of newly created tranche B-4 term loans denominated in U.S. dollars in an aggregate principal amount of $1.48 billion (less original issue discount of 0.5% ) and tranche C-3 term loans denominated in Euros in an aggregate principal amount of €433 million (or $487 million based on the Euro/USD exchange rate of 1.124 on September 30, 2016)(less original issue discount of 0.25% ). The amendment effectively reduced interest rates by 50 basis points for the new U.S. Dollar denominated term loans and by 75 basis points for the new Euro denominated term loans. The new tranche B-4 term loans bear interest at 4.0% per annum, plus an applicable eurocurrency rate and the new Euro tranche C-3 term loans bear interest at 3.75% per annum, plus an applicable eurocurrency rate, in each case as calculated in the Credit Agreement. The maturity date of the new term loans is June 7, 2023; provided that if, on or prior to November 2, 2021, the Company has not prepaid, redeemed or otherwise retired and/or refinanced in full its 6.50% USD Notes due 2022, as permitted under the Amended and Restated Credit Agreement, the maturity date of the new term loans will be November 2, 2021. Amendment No. 5 also (i) amended the Restricted Payments basket, as defined in the Amended and Restated Credit Agreement, to limit select forms of restricted payments if such payments would cause the total net leverage ratio, calculated as set forth in the Amended and Restated Credit Agreement, to exceed 6.00 to 1.00 , and (ii) requires a prepayment percentage in the case of excess cash flow, both calculated as set forth in the Amended and Restated Credit Agreement, of 75% with step-downs to 50% , 25% and 0% based on the applicable first lien net leverage ratio on the prepayment date. Except as set forth in Amendment No. 5 and above, the new USD tranche B-4 term loans have identical terms as the existing U.S. dollar denominated tranche B-3 term loans and the new Euro tranche C-3 term loans have identical terms as the existing Euro denominated tranche C-2 term loans and, in each case, are otherwise subject to the provisions of the Amended and Restated Credit Agreement. Guarantees The obligations of Platform and MacDermid, as borrowers, under the Amended and Restated Credit Agreement are guaranteed by current and future direct and indirect domestic subsidiaries. Certain of Platform's foreign subsidiaries also guarantee the obligations of MAS Holdings, NAIP, MacDermid Europe and MacDermid Funding with respect to the Euro tranche C term loans. Pursuant to the Security Agreement, the Company's obligations under the Amended and Restated Credit Agreement are secured by a security interest in substantially all of the personal property, whether owned on the date of the Security Agreement, or entered into or acquired in the future, of Platform and MacDermid, as borrowers, and the guarantors listed in the Security Agreement, including the pledge by Platform, MacDermid and guarantors generally of 100% of the voting common stock and other equity interests in all of their respective domestic subsidiaries and 65% of the voting common stock and other equity interests in all of their respective directly owned non-domestic subsidiaries (in each case, whether existing on the date of the Security Agreement or entered into or acquired thereafter), subject to certain exceptions contained in the Amended and Restated Credit Agreement and the Security Agreement. Lines of Credit and Other Debt Facilities The Company carries a Revolving Credit Facility and various lines of credit, short-term debt facilities and overdraft facilities worldwide which are used to fund short-term cash needs. As of September 30, 2016 and December 31, 2015 , the aggregate principal amount outstanding under such facilities totaled $42.8 million and $16.7 million , respectively. The Company also had letters of credit outstanding of $32.9 million and $40.0 million as of September 30, 2016 and December 31, 2015 , respectively, of which $11.2 million and $11.0 million as of September 30, 2016 and December 31, 2015 , respectively, reduce the borrowings available under the Revolving Credit Facility. As of September 30, 2016 and December 31, 2015 , the availability under these facilities was approximately $618 million , net of outstanding letters of credit. Financial Guarantees and Factoring Arrangements The Company periodically enters into certain arrangements with vendors and customers under which it provides guarantees to financial institutions for loans entered into between its vendors and customers and the financial institutions, the proceeds of which are used to settle outstanding accounts receivables. The terms of the guarantees are equivalent to the terms of the customer loans. Liabilities for the guarantees are recorded at amounts that approximate fair value, based on the Company’s historical collection experience with vendors and customers that participate in the program and a current assessment of credit exposure. Such liabilities are included in "Accrued expenses and other current liabilities" in the Company's Condensed Consolidated Balance Sheets, and totaled $6.7 million and $46.3 million as of September 30, 2016 and December 31, 2015 , respectively. Program income and expenses are recorded in "Interest expense, net" in the Condensed Consolidated Statements of Operations. For the three months ended September 30, 2016 and 2015 , program income (expenses) totaled $0.1 million and $(0.5) million , respectively. For the nine months ended September 30, 2016 and 2015 , program income (expenses) totaled $0.3 million and $(1.5) million , respectively. The Company also utilizes accounts receivable factoring arrangements as a part of its working capital management strategies. Total current capacity under such programs is approximately $287 million as of September 30, 2016 . Under these arrangements, factored accounts receivable may be transferred with or without recourse. Factoring transactions qualifying for sales treatment, where the derecognition criteria have been met, totaled $33.1 million as of September 30, 2016 . As of December 31, 2015 , such transactions totaled $189 million . Accounts receivable balances related to arrangements not having met the derecognition criteria, where the risks and rewards of ownership have not been transferred, remain recorded in "Accounts receivable" and the related liabilities are included in "Accrued expenses and other current liabilities" in the Company's Condensed Consolidated Balance Sheets, and totaled $31.0 million and $24.8 million as of September 30, 2016 and December 31, 2015 , respectively. Factoring fees are recorded in "Interest expense, net" in the Condensed Consolidated Statements of Operations and totaled $0.7 million and $0.1 million for the three months ended September 30, 2016 and 2015 , respectively. For the nine months ended September 30, 2016 and 2015 , factoring fees totaled $1.4 million and $0.1 million , respectively. As of September 30, 2016 , the Company had additional capacity under its factoring arrangements of approximately $96.8 million , subject to the limitations outlined in its Credit Facilities and other agreements governing outstanding debt. Some of the Company’s subsidiaries in the United States and the Netherlands periodically enter into arrangements with financial institutions for consignment and/or purchase of precious metals. The present and future indebtedness and liability relating to such arrangements are guaranteed by the Company. The Company’s maximum guarantee liability under these arrangements is limited to an aggregate of $18.0 million .

Derivative Instruments

Derivative Instruments	9 Months Ended
	Sep. 30, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE INSTRUMENTS	DERIVATIVE INSTRUMENTS In the normal course of business, the Company is exposed to risks relating to changes in foreign currency exchange rates, interest rates and commodity prices. Derivative financial instruments, such as foreign currency exchange forward contracts, interest rate swaps and commodities futures contracts are used to manage the risks associated with changes in the conditions of those markets. All derivatives are recognized in the Condensed Consolidated Balance Sheets at fair value at the end of each period. The counterparties to the Company’s derivative agreements are primarily major international financial institutions. The Company continually monitors its positions and the credit ratings of its counterparties and does not anticipate nonperformance by the counterparties. Foreign Currency The Company conducts a significant portion of its business in currencies other than the U.S. Dollar and in currencies other than the functional currencies of its subsidiaries. As a result, the Company’s operating results are affected by foreign currency exchange rate volatility. As of September 30, 2016 , the Company held foreign currency forward contracts to purchase and sell various currencies primarily with U.S. Dollars and Euro, with less significant amounts traded with Japanese Yen. The Company has not designated any foreign currency exchange forward contracts as eligible for hedge accounting. The total U.S. Dollar equivalent of foreign currency exchange forward contracts held at September 30, 2016 was approximately $264 million , all of which have settlement dates within one year . The following table details the Company's significant outstanding foreign exchange derivative contracts as of September 30, 2016 : (in millions) Traded against USD Traded against EUR (USD equivalent) Currency Purchasing Selling Purchasing Selling Euro (EUR) $ 41.4 $ 36.9 $ — $ — Brazilian Real (BRL) 13.8 66.1 — — Japanese Yen (JPY) 12.3 18.7 9.5 1.6 South African Rand (ZAR) — 22.3 — 1.4 Taiwan Dollar (TWD) 10.6 — — — Other 15.4 2.9 9.1 0.3 Total $ 93.5 $ 146.9 $ 18.6 $ 3.3 The change in the net fair value of the foreign currency forward contracts is recorded in "Loss on derivative contracts" in the Condensed Consolidated Statements of Operations. Interest Rates In August 2015, the Company entered into a series of pay fixed, receive floating interest rate swaps with respect to a portion of its indebtedness. The swaps effectively fix the floating base rate portion of the interest payments on approximately $1.15 billion of the Company's USD denominated debt and €282 million of its Euro denominated debt at 1.96% and 1.20% , respectively, from September 2015 through June 2020. Changes in the fair value of a derivative that is designated as, and meets all the required criteria of, a cash flow hedge are recorded in "Accumulated other comprehensive income (loss)" and reclassified into earnings as the underlying hedged item affects earnings. Amounts reclassified into earnings related to the interest rate swaps are included in interest expense. Commodities As part of its risk management policy, the Company enters into commodities futures contracts on an ongoing basis for the purpose of mitigating its exposure to fluctuations in prices of certain metals it uses in the production of its finished goods. The Company held futures contracts to purchase and sell various metals, primarily silver and tin, for a notional amount of $38.7 million and $16.5 million as of September 30, 2016 and December 31, 2015 , respectively. All contracts outstanding at September 30, 2016 have delivery dates within the next twelve months . The change in the net fair value of the commodities futures contracts is recorded in "Loss on derivative contracts" in the Condensed Consolidated Statements of Operations. Certain subsidiaries of the Company have entered into supply agreements with a third party that have been deemed to constitute financing agreements with an embedded derivative feature whose fair value is determined by the change in the market value of the underlying metals between delivery date and measurement date. Amounts associated with these supply agreements, which serve as the notional value of the embedded derivative, have been recorded in "Inventory" and "Current installments of long-term debt and revolving credit facilities" in the Condensed Consolidated Balance Sheets and totaled $13.7 million and $13.0 million at September 30, 2016 and December 31, 2015 , respectively, and primarily relate to gold purchases. The fair value of these contracts has been bifurcated and recorded as a derivative liability in "Accrued expenses and other current liabilities" in the Condensed Consolidated Balance Sheets and totaled $0.4 million and zero at September 30, 2016 and December 31, 2015 , respectively. Fair Value of Derivative Instruments The following table summarizes the fair value of derivative instruments reported in the Condensed Consolidated Balance Sheets: (amounts in millions) September 30, December 31, 2015 Derivatives designated as hedging instruments Liabilities Balance Sheet location Interest rate swaps Accrued expenses and other current liabilities $ (10.5 ) $ — Interest rate swaps Other long-term liabilities (17.5 ) (12.5 ) Derivatives not designated as hedging instruments: Assets Balance Sheet location Foreign exchange and metals contracts Prepaid expenses and other current assets 2.6 1.1 Foreign exchange contracts Other assets — 1.0 Liabilities Balance Sheet location Foreign exchange and metals contracts Accrued expenses and other current liabilities (5.5 ) (1.0 ) Net derivative contract liability $ (30.9 ) $ (11.4 ) The Company recorded unrealized losses of $1.6 million and $24.3 million for the three and nine months ended September 30, 2016 , respectively, in "Other comprehensive income (loss)" related to interest rate swaps. For the three and nine months ended September 30, 2015 , such losses totaled $18.1 million . The interest rate swaps were deemed highly effective with no ineffective portions for cash flow hedge accounting purposes during the nine months ended September 30, 2016 . For the three and nine months ended September 30, 2016 , the Company reclassified $3.0 million and $8.9 million , respectively, of unrealized losses associated with the interest rate swaps from "Accumulated other comprehensive income" to "Interest expense, net." During the next twelve months, the Company expects to reclassify $10.5 million from "Accumulated other comprehensive income" to "Interest expense, net" in the Condensed Consolidated Statements of Operations. For the three months ended September 30, 2016 and 2015 , the Company recorded realized and unrealized losses of $1.4 million and $47.3 million in "Loss on derivative contracts" in the Condensed Consolidated Statements of Operations related to foreign exchange and metals derivative contracts. For the nine months ended September 30, 2016 and 2015 , such losses totaled $12.1 million and $49.9 million , respectively. Master Netting Arrangements In the normal course of business, the Company enters into contracts with certain counterparties to purchase and sell foreign currency exchange forwards and metal futures that contain master netting arrangements, typically in the form of an International Swaps and Derivatives Association (ISDA) or similar agreements. The right to set-off within these agreements is limited to certain termination events, such as bankruptcy or default of either party to the agreement. The Company has made an accounting policy decision not to offset and reports gross derivative asset and liability balances in the Condensed Consolidated Balance Sheets. The following table presents recognized foreign currency exchange forward and metal future derivative contracts that are subject to master netting arrangements but not offset, as of September 30, 2016 and December 31, 2015 , and shows in the "Net" column what the net impact would be on the Company's Condensed Consolidated Balance Sheets if all set-off rights were exercised: September 30, 2016 (amounts in millions) Amounts offset Amounts not offset Net Financial assets Gross assets Gross liabilities offset Net amounts presented Financial instruments Cash collateral paid Derivative assets $ 2.1 $ — $ 2.1 $ (0.4 ) $ — $ 1.7 September 30, 2016 Amounts offset Amounts not offset Net Financial liabilities Gross liabilities Gross assets offset Net amounts presented Financial instruments Cash collateral paid Derivative liabilities $ 4.8 $ — $ 4.8 $ (1.0 ) $ (1.0 ) $ 2.8 December 31, 2015 (amounts in millions) Amounts offset Amounts not offset Net Financial assets Gross assets Gross liabilities offset Net amounts presented Financial instruments Cash collateral paid Derivative assets $ 3.1 $ — $ 3.1 $ (0.3 ) $ — $ 2.8 December 31, 2015 Amounts offset Amounts not offset Net Financial liabilities Gross liabilities Gross assets offset Net amounts presented Financial instruments Cash collateral paid Derivative liabilities $ 1.7 $ — $ 1.7 $ (1.2 ) $ (0.9 ) $ (0.4 ) Collateral paid to counterparties is recorded in "Prepaid expenses and other current assets" in the Condensed Consolidated Balance Sheets.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2016
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	FAIR VALUE MEASUREMENTS The Company determines fair value measurements used in its unaudited interim Condensed Consolidated Financial Statements based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants exclusive of any transaction costs, as determined by either the principal market or the most advantageous market. The principal market is the market with the greatest level of activity and volume for the asset or liability. Absent a principal market to measure fair value, the Company uses the most advantageous market, which is the market in which the Company would receive the highest selling price for the asset or pay the lowest price to settle the liability, after considering transaction costs. However, when using the most advantageous market, transaction costs are only considered to determine which market is the most advantageous and these costs are then excluded when applying a fair value measurement. Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy. The basis for fair value measurements for each level within the hierarchy is described below, with Level 1 having the highest priority, and Level 3 having the lowest. The three levels of the fair value hierarchy are as follows: • Level 1 – quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. • Level 2 – quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in non-active markets; and model-derived valuations whose inputs are observable or whose significant valuation drivers are observable. • Level 3 – significant inputs to the valuation model are unobservable and/or reflect the Company’s market assumptions. Recurring Fair Value Measurements The following tables present the Company’s financial instruments, assets and liabilities that are measured at fair value on a recurring basis: Fair Value Measurement Using (amounts in millions) September 30, Quoted prices in active markets (Level 1) Significant other observable inputs (Level 2) Significant unobservable inputs (Level 3) Asset Category Cash equivalents $ 23.2 $ — $ 23.2 $ — Available for sale equity securities 2.5 1.9 0.6 — Derivatives 2.6 — 2.6 — Total $ 28.3 $ 1.9 $ 26.4 $ — Liability Category Derivatives $ 33.5 $ — $ 33.5 $ — Long-term contingent consideration 75.0 — — 75.0 Preferred stock redemption liability 504.0 — — 504.0 Total $ 612.5 $ — $ 33.5 $ 579.0 Fair Value Measurement Using (amounts in millions) December 31, 2015 Quoted prices in active markets (Level 1) Significant other observable inputs (Level 2) Significant unobservable inputs (Level 3) Asset Category Cash equivalents $ 59.4 $ 2.9 $ 56.5 $ — Available for sale equity securities 6.6 5.8 0.8 — Derivatives 2.1 — 2.1 — Total $ 68.1 $ 8.7 $ 59.4 $ — Liability Category Derivatives $ 13.5 $ — $ 13.5 $ — Long-term contingent consideration 70.7 — — 70.7 Total $ 84.2 $ — $ 13.5 $ 70.7 The following methods and assumptions were used to estimate the fair value of each class of the Company’s financial instruments, assets and liabilities: Cash equivalents - Cash equivalents primarily comprise certificates of deposits issued by financial institutions. These funds are not publicly traded, but historically have been highly liquid. The Company records certificates of deposit at amortized cost in the Condensed Consolidated Balance Sheets. Given the relatively short maturities of these instruments, the Company believes amortized cost approximates fair value. The Company classifies these instruments as Level 2. Available for sale equity securities - Equity securities classified as available for sale are measured using quoted market prices at the reporting date multiplied by the quantity held and, accordingly, are classified as Level 1 assets. Level 2 equity securities are measured using quoted prices for similar instruments in active markets. Available for sale securities are included in "Other assets" in the Condensed Consolidated Balance Sheets. Derivatives - Derivative assets and liabilities include foreign currency, metals and interest rate derivatives. The values were determined using pricing models based upon observable market inputs, such as market spot and futures prices on over-the-counter derivative instruments, market interest rates and consideration of counterparty credit risk. Long-term contingent consideration - The long-term contingent consideration represents a potential liability of up to $100 million tied to achievement of EBITDA and common stock trading price performance metrics over a seven -year period ending December 2020 in connection with the MacDermid Acquisition. The common stock performance metric has been satisfied. The fair value of the EBITDA performance metric is derived using the income approach with unobservable inputs, based on future forecasts and present value assumptions which include a discount rate of approximately 1.06% and expected future value of payments of $60.0 million calculated using a probability weighted EBITDA assessment with higher probability associated with the Company achieving the maximum EBITDA targets. Changes in the fair value of the long-term contingent consideration are recorded in "Selling, technical, general and administrative expenses" in the Condensed Consolidated Statements of Operations. Relative to the share price metric, an increase or decrease in the discount rate of 1% changes the fair value measure of the metric by approximately $1.7 million . Relative to the EBITDA metric, an increase or a decrease in the discount rate of 1% , within a range of probability between 80% and 100% , changes the fair value measure of the metric by approximately $3.0 million . Preferred stock redemption liability - The preferred stock redemption liability represents a potential liability of up to $600 million related to the issuance of 600,000 shares of Series B Convertible Preferred Stock in connection with the Arysta Acquisition. The Company and the Arysta Seller entered into a settlement agreement in September 2016 with respect to certain obligations related to the Company's shares of Series B Convertible Preferred Stock. See Note 11, Stockholders' Equity, under the heading " Series B Convertible Preferred Stock." The fair value of the preferred stock redemption liability is computed as the sum of the $460 million cash consideration, which is discounted at an interpolated, risk-free rate, the September 30, 2016 market value of the 5,500,000 shares of common stock of the Company and accounts for settlement option assumptions. Accordingly, this liability is measured using Level 3 inputs. For the three and nine months ended September 30, 2016, the Company recorded a $6.0 million gain associated with the change in fair value of the preferred stock redemption liability, which was recorded to "Other income, net" in the Condensed Consolidated Statement of Operations. The following table provides a reconciliation of the beginning and ending balances for the nine months ended September 30, 2016 for instruments measured at fair value on a recurring basis using significant unobservable inputs (Level 3): (amounts in millions) September 30, 2016 Fair value measurements using significant unobservable inputs (Level 3) Balance at December 31, 2015 $ 70.7 Changes in fair value (1.7 ) Purchases, sales and settlements (1) — Additions 510.0 Transfers into Level 3 — Transfers out of Level 3 — Balance at September 30, 2016 $ 579.0 (1) There were no purchases, sales or settlements during the nine months ended September 30, 2016 . The Company consistently applies its policy for transfers between fair value hierarchy levels as disclosed in the Company's Annual Report. There were no significant transfers between the fair value hierarchy levels for the nine months ended September 30, 2016 . Nonrecurring Fair Value Measurements The following table presents the carrying value and estimated fair value of the Company’s long-term debt and capital lease obligations: (amounts in millions) September 30, 2016 December 31, 2015 Carrying Value Fair Value Carrying Value Fair Value USD Senior Notes due 2022 $ 1,082.5 $ 1,071.6 $ 1,081.1 $ 946.3 EUR Senior Notes due 2023 387.6 371.6 374.0 326.7 USD Senior Notes due 2021 488.5 539.9 487.5 500.0 First Lien Credit Facility - U.S. Dollar Term Loans 2,620.0 2,685.7 2,631.3 2,603.6 First Lien Credit Facility - Euro Term Loans 638.0 657.8 619.2 624.3 Capital lease obligations 5.1 5.2 5.5 5.3 Total $ 5,221.7 $ 5,331.8 $ 5,198.6 $ 5,006.2 Carrying values presented above include unamortized premiums, discounts and debt issuance costs. The following methods and assumptions were used to estimate the fair value of the Company’s liabilities: Long-term Debt and Capital Lease Instruments - These financial instruments are measured using quoted market prices at the reporting date multiplied by the gross carrying amount of the related debt, which excludes unamortized premiums, discounts and debt issuance costs. Such instruments are valued using Level 2 inputs.

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Sep. 30, 2016
Stockholders' Equity Note [Abstract]
STOCKHOLDERS’ EQUITY	STOCKHOLDERS’ EQUITY Underwritten Public Offering On September 21, 2016, the Company completed the September 2016 Equity Offering of 48,787,878 shares of its common stock at a public offering price of $8.25 per share. This number of shares includes 6,363,636 shares sold to the underwriters upon exercise in full of their option to purchase additional shares. The September 2016 Equity Offering was registered with the SEC pursuant to Platform's shelf registration statement on Form S-3 declared effective by the SEC on July 26, 2016. The September 2016 Equity Offering resulted in gross proceeds to Platform of approximately $402.5 million , before underwriting discounts and commissions and offering expenses of $11.6 million . Preferred Stock The Company is authorized to issue 5,000,000 shares of preferred stock. The Board has designated 2,000,000 of those shares as "Series A Preferred Stock." As of September 30, 2016 and December 31, 2015 , a total of 2,000,000 shares of Series A Preferred Stock were issued and outstanding. The Board has also designated 600,000 of the authorized shares as "Series B Convertible Preferred Stock," which are redeemable and were presented in the mezzanine section of the Company's Condensed Consolidated Balance Sheet as of December 31, 2015. As further described below under the heading " Series B Convertible Preferred Stock", the Series B Convertible Preferred Stock was, for accounting purposes, deemed extinguished. As of September 30, 2016 and December 31, 2015 , a total of 600,000 shares of Series B Convertible Preferred Stock were issued and outstanding. Shares of preferred stock have no voting rights, except in respect of any amendment to the Company's Certificate of Incorporation, as amended, that would alter or change their rights or privileges. Series A Preferred Stock The Founder Entities are the current holders of Platform's outstanding 2,000,000 shares of Series A Preferred Stock. Each share of Series A Preferred Stock is convertible into one share of common stock at the option of the holders until December 31, 2020. All outstanding shares of Series A Preferred Stock will be automatically converted into shares of common stock on a one for one basis (i) in the event of a change of control of the Company following an acquisition or (ii) upon the last day of the seventh full financial year following the MacDermid Acquisition, being December 31, 2020 (which may be extended by the Board for three additional years). Holders of Series A Preferred Stock are entitled to receive dividends in the form of shares of common stock. The dividend amount is calculated based on the appreciated stock price compared to the highest dividend price previously used in calculating the Series A Preferred Stock dividends, which is currently $22.85 . Series B Convertible Preferred Stock In connection with the Arysta Acquisition, the Company issued to the Arysta Seller 600,000 shares of Series B Convertible Preferred Stock, which have a $1,000 per share liquidation preference. The fair value of these shares at the time of the Arysta Acquisition of $646 million was recognized as "Redeemable preferred stock – Series B" in the Condensed Consolidated Balance Sheets. To the extent the Company does not settle all of its obligations pursuant to the settlement agreement mentioned below, at any time after December 15, 2016, the Arysta Seller has the ability to convert these shares into common stock of Platform at a conversion price of $27.14 per share. Additionally, any shares that have not previously been converted will be automatically redeemed at a $1,000 redemption price in the event of certain mergers or consolidations, the sale of all or substantially all of the Company’s assets or subsidiaries, the sale of certain subsidiaries of the Company or the approval of any plan for the dissolution, liquidation or termination of the Company by its stockholders. Under the terms of a settlement agreement with the Arysta Seller, from October 20, 2016 until the close of business on December 15, 2016, the Company may settle (i) all of its obligations with respect to the Series B Convertible Preferred Stock in exchange for a cash payment of $1.00 and the issuance of 5,500,000 shares of its common stock upon simultaneous conversion of the Series B Convertible Preferred Stock by the Arysta Seller, and (ii) for a payment of $460 million , its obligation to pay the make whole payment mentioned below to the Arysta Seller. To the extent the Company does not settle all of its obligations by December 15, 2016, it will be required, on April 20, 2017, pursuant to a share purchase agreement among the Company, the Arysta Seller and certain other parties thereto, dated as of October 20, 2014, as amended, to repurchase each share of Series B Convertible Preferred Stock that has not been converted into shares of common stock of Platform, or automatically redeemed as described above at the $1,000 redemption price payable in shares of the Company's common stock ( 22,107,590 shares of common stock valued at $27.14 per share). Upon such repurchase, the Company shall also pay to holders of Series B Convertible Preferred Stock in cash a make whole payment, which corresponds to any deficit between (i) the 10 -day volume weighted price of Platform’s common stock prior to such repurchase and (ii) $27.14 per share. Based on Platform's common stock price of $8.11 as of September 30, 2016 , the maximum potential make whole payment would total approximately $421 million . To the extent the Company does not settle all of its obligations by December 15, 2016, the holders of Series B Convertible Preferred Stock are also entitled to an incremental payment equal to $4.0 million per month from October 20, 2016 to April 20, 2017, or such earlier date after October 20, 2016 that the then outstanding shares of Series B Convertible Preferred Stock are converted into shares of common stock of Platform or automatically redeemed for cash by Platform. As a result of the settlement agreement, for accounting purposes, the Series B Convertible Preferred Stock was deemed an extinguishment in exchange for the issuance of another financial instrument that is recognized as a "Preferred stock redemption liability" in the Condensed Consolidated Balance Sheets. The Company recognized a gain of $103 million in "Other income, net" in the accompanying Condensed Consolidated Statement of Operations and a gain of $32.9 million in "Net income (loss) attributable to common stockholders." The Company also elected the fair value option to measure the liability as it most accurately reflects the economics of the transaction and the value of the liability. For the three and nine months ended September 30, 2016, the Company recorded a $6.0 million gain associated with the remeasurement of the liability, which was recorded to "Other income, net" in the Condensed Consolidated Statement of Operations. Non-Controlling Interest In connection with the MacDermid Acquisition, approximately $97.5 million was raised in new equity consisting of shares of PDH Common Stock. Since October 31, 2014, all shares of PDH common stock are convertible, at the option of the holder, into a like number of shares of the Company's common stock, the sale of which is subject to a contractual lock-up of 25% per year over a four -year period, which started on October 31, 2013. The PDH Common Stock is classified as a non-controlling interest on the Condensed Consolidated Balance Sheets at September 30, 2016 and December 31, 2015 and will continue to be until such time as it is fully converted into shares of the Company's common stock. The total number of shares of common stock originally issuable upon the exchange of PDH Common Stock pursuant to the RHSA was approximately 8.8 million , against which 776,862 shares have been issued as of September 30, 2016 . For the three months ended September 30, 2016 and 2015 , approximately $1.5 million and $1.1 million , respectively, of net loss has been allocated to the Retaining Holders, as included in the Condensed Consolidated Statements of Operations, representing non-controlling interest of 6.20% and 6.35% at September 30, 2016 and 2015 , respectively. For the nine months ended September 30, 2016 and 2015 , approximately $(4.2) million and $0.1 million , respectively, of net (loss) income has been allocated to the Retaining Holders, as included in the Condensed Consolidated Statements of Operations.

Accumulated Other Comprehensive

Accumulated Other Comprehensive (Loss) Income	9 Months Ended
	Sep. 30, 2016
Equity [Abstract]
ACCUMULATED OTHER COMPREHENSIVE (LOSS) INCOME	ACCUMULATED OTHER COMPREHENSIVE (LOSS) INCOME Changes in each component of accumulated other comprehensive (loss) income, net of tax, for the three and nine months ended September 30, 2016 and 2015 were as follows: Three Months Ended September 30, 2016 (amounts in millions) Foreign Currency Translation Adjustments Pension and Post-retirement Plans Unrealized Loss on Available for Sale Securities Derivative Financial Instrument Revaluation Non-Controlling Interests Accumulated Other Comprehensive (Loss) Income Balance at June 30, 2016 $ (446.8 ) $ (26.3 ) $ (0.4 ) $ (24.9 ) $ 24.7 $ (473.7 ) Other comprehensive (loss) income before reclassifications, net (0.7 ) — (0.1 ) (1.6 ) 9.0 6.6 Reclassifications, pretax — — — 3.0 — 3.0 Balance at September 30, 2016 $ (447.5 ) $ (26.3 ) $ (0.5 ) $ (23.5 ) $ 33.7 $ (464.1 ) Nine Months Ended September 30, 2016 (amounts in millions) Foreign Currency Translation Adjustments Pension and Post-retirement Plans Unrealized Gain on Available for Sale Securities Derivative Financial Instrument Revaluation Non-Controlling Interests Accumulated Other Comprehensive (loss) Income Balance at December 31, 2015 $ (899.3 ) $ (26.3 ) $ 1.2 $ (8.1 ) $ 46.4 $ (886.1 ) Other comprehensive income (loss) before reclassifications, net 451.8 — (1.7 ) (24.3 ) (12.7 ) 413.1 Reclassifications, pretax — — — 8.9 — 8.9 Balance at September 30, 2016 $ (447.5 ) $ (26.3 ) $ (0.5 ) $ (23.5 ) $ 33.7 $ (464.1 ) Three Months Ended September 30, 2015 (amounts in millions) Foreign Currency Translation Adjustments Pension and Post-retirement Plans Unrealized Gain on Available for Sale Securities Derivative Financial Instrument Revaluation Non-Controlling Interests Accumulated Other Comprehensive Loss Balance at June 30, 2015 $ (386.0 ) $ (15.4 ) $ 0.3 $ — $ 13.5 $ (387.6 ) Other comprehensive (loss) income before reclassifications, net (350.2 ) — 1.0 (11.8 ) 7.2 (353.8 ) Balance at September 30, 2015 $ (736.2 ) $ (15.4 ) $ 1.3 $ (11.8 ) $ 20.7 $ (741.4 ) Nine Months Ended September 30, 2015 (amounts in millions) Foreign Currency Translation Adjustments Pension and Post-retirement Plans Unrealized Gain on Available for Sale Securities Derivative Financial Instrument Revaluation Non-Controlling Interests Accumulated Other Comprehensive Loss Balance at December 31, 2014 $ (122.2 ) $ (14.9 ) $ 0.1 $ — $ 6.4 $ (130.6 ) Other comprehensive (loss) income before reclassifications, net (614.0 ) — 1.2 (11.8 ) 14.3 (610.3 ) Tax expense reclassified — (0.5 ) — — — (0.5 ) Balance at September 30, 2015 $ (736.2 ) $ (15.4 ) $ 1.3 $ (11.8 ) $ 20.7 $ (741.4 )

Earnings (Loss) Per Share

Earnings (Loss) Per Share	9 Months Ended
	Sep. 30, 2016
Earnings Per Share [Abstract]
EARNINGS (LOSS) PER SHARE	EARNINGS (LOSS) PER SHARE A computation of earnings (loss) per share and weighted average shares of common stock outstanding for the three and nine months ended September 30, 2016 and 2015 follows: Three Months Ended September 30, Nine Months Ended September 30, (amounts in millions, except per share amounts) 2016 2015 2016 2015 (as restated) (as restated) Net income (loss) attributable to common stockholders for basic EPS $ 104.7 $ (140.1 ) $ (39.0 ) $ (178.9 ) Adjustments to the numerator for diluted earnings per share: Gain on settlement agreement related to Series B Convertible Preferred Stock (103.0 ) — (103.0 ) — Gain on amendment of Series B Convertible Preferred Stock (32.9 ) — (32.9 ) — Remeasurement adjustment associated with the Preferred Series B redemption liability (6.0 ) — (6.0 ) — Income allocated to PDH non-controlling interest (1.5 ) — — — Net loss attributable to common stockholders for diluted EPS $ (38.7 ) $ (140.1 ) $ (180.9 ) $ (178.9 ) Basic weighted average common stock outstanding 234.4 210.9 231.2 198.6 Assumed conversion related to the amendment of Series B preferred shares 17.1 — 20.4 — Assumed settlement of preferred stock redemption liability 5.0 — 1.7 — Issuable upon conversion of the PDH non-controlling interest 8.0 — — — Share adjustments (1) 30.1 — 22.1 — Dilutive weighted average common stock outstanding 264.5 210.9 253.3 198.6 Income (loss) per share attributable to common stockholders: Basic $ 0.45 $ (0.66 ) $ (0.17 ) $ (0.89 ) Diluted $ (0.15 ) $ (0.66 ) $ (0.71 ) $ (0.89 ) Dividends per share paid to common stockholders $ — $ — $ — $ — (1) For the three and nine months ended September 30, 2015, no share adjustments are included in the dilutive weighted average shares outstanding computation as their effect would have been anti-dilutive. For more information about such dilutive shares outstanding, refer to the table below. For the three and nine months ended September 30, 2016 and 2015 , the following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive or because performance targets were not yet achieved for awards contingent upon performance. These securities may become dilutive in future periods. Three Months Ended September 30, Nine Months Ended September 30, (amounts in thousands) 2016 2015 2016 2015 Shares contingently issuable to Founder Entities as stock dividend on Series A Preferred Stock — — — 1,652 Shares issuable upon conversion of PDH Common Stock — 8,207 8,023 8,207 Shares issuable upon conversion of Series A Preferred Stock 2,000 2,000 2,000 2,000 Shares issuable upon conversion of Series B Convertible Preferred Stock — 22,108 — 18,544 Shares contingently issuable for the contingent consideration 9,262 2,496 8,820 1,719 Stock options — 55 — 70 RSUs 186 60 110 94 Shares issuable under the ESPP 1 2 3 1 11,449 34,928 18,956 32,287

Operating Lease Commitments

Operating Lease Commitments	9 Months Ended
	Sep. 30, 2016
Leases [Abstract]
OPERATING LEASE COMMITMENTS	OPERATING LEASE COMMITMENTS The Company leases certain land, office space, warehouse space and equipment under agreements which are classified as operating leases for financial statement purposes. Certain of these leases provide for payment of real estate taxes, common area maintenance, insurance and certain other expenses. Lease terms may have escalating rent provisions and rent holidays which are recognized on a straight-line basis over the term of the lease. The leases expire at various dates through 2055. Total rent expense for operating leases was as follows: Three Months Ended September 30, Nine Months Ended September 30, (amounts in millions) 2016 2015 2016 2015 Rent expense $ 8.9 $ 6.0 $ 28.0 $ 16.4 Minimum non-cancelable operating lease commitments were as follows: (amounts in millions) Operating Lease Payment As of September 30, 2016 2016, remaining $ 10.2 2017 26.0 2018 17.7 2019 12.0 2020 9.8 2021 8.7 Thereafter 26.8 Total minimum non-cancelable operating lease commitments $ 111.2 The fixed operating lease commitments detailed above assume that the Company continues the leases through their initial lease terms.

Contingencies, Environmental an

Contingencies, Environmental and Legal Matters	9 Months Ended
	Sep. 30, 2016
Commitments and Contingencies Disclosure [Abstract]
CONTINGENCIES, ENVIRONMENTAL AND LEGAL MATTERS	CONTINGENCIES, ENVIRONMENTAL AND LEGAL MATTERS Asset Retirement Obligations The Company has recognized AROs for properties where it can make a reasonable estimate of the future expenditures necessary to satisfy the related obligations. The Company considers identified legally enforceable obligations, estimated settlement dates and appropriate discount and inflation rates in calculating the fair value of its AROs. As of September 30, 2016 and December 31, 2015 , the Company's ARO reserves, included in other short and long-term liabilities in the Condensed Consolidated Balance Sheets, totaled $21.2 million and $17.5 million , respectively. Changes in the Company’s AROs were as follows: Three Months Ended September 30, Nine Months Ended September 30, (amounts in millions) 2016 2015 2016 2015 AROs, beginning of period $ 20.9 $ 17.7 $ 17.5 $ 18.5 Acquisitions — — 2.8 0.4 Accretion expense 0.3 0.2 0.9 0.7 Remeasurements — 0.5 0.1 (0.2 ) Payments — (0.4 ) (0.5 ) (0.4 ) Foreign currency adjustments — (0.2 ) 0.4 (1.2 ) AROs, end of period $ 21.2 $ 17.8 $ 21.2 $ 17.8 Environmental The Company formulates and distributes specialty chemical products and is therefore subject to extensive domestic and foreign environmental protection laws and regulations, including those governing the management, discharge and disposal of hazardous materials and pollutants into the soil, air and water, as well as laws and regulations governing workers' health and safety. As a result, the Company is exposed to risks of liability or claims with respect to environmental clean-up of contaminated facilities or other matters, including those in connection with the disposal or releases of, or exposure to, hazardous materials. The Company has incurred, and will continue to incur, costs and capital expenditures in complying with these laws and regulations. Additional costs could be incurred, including clean-up costs, fines, sanctions, and third-party claims, as a result of violations of or liabilities under environmental laws. Among other environmental laws, the Company is subject to the Comprehensive Environmental Response, Compensation and Liability Act of 1980 (commonly known as Superfund), under which the Company may be designated as a “potentially responsible party,” or PRP, with respect to clean-up costs associated with sites on the U.S. Environmental Protection Agency National Priority List. The Company conducts studies, individually or jointly with other PRPs, to determine the feasibility of various remedial techniques. It is the Company's policy to record appropriate liabilities for environmental matters when remedial efforts or damage claim payments are probable and the costs can be reasonably estimated. Such liabilities are based on the Company's best estimate of the undiscounted future costs required to complete the remedial work. The recorded liabilities are adjusted periodically as remediation efforts are determined. Remediation activities vary substantially in duration and cost from site to site. These activities, and their associated costs, depend on the mix of unique site characteristics, evolving remediation technologies, diverse regulatory agencies and enforcement policies, as well as the presence or absence of PRPs. In particular, the Company has reserved approximately $44.7 million primarily related to potential liability in connection with environmental remediation, clean-up costs, and monitoring of sites that were either closed or disposed of in prior years by Alent, which the Company acquired in December 2015. These sites are in various stages of environmental management: at some sites, the work is in the early stages of assessment and investigation, while at others, the clean-up remedies have been implemented and the remaining work consists of monitoring the integrity of those remedies. These sites include, but are not limited to, federal or state Superfund sites. Because the laws pertaining to Superfund sites generally impose retroactive, strict, joint and several liability, a governmental plaintiff could seek to recover all remediation costs at any such site from any of the PRPs for such site, including the Company, despite the involvement of other PRPs. The Company is one of several identified PRPs in the aforementioned Superfund sites. The Company believes that the liability associated with these sites has been apportioned based on the type and amount of waste disposed by each PRP at such disposal site and the number of financially solvent PRPs. In many cases, the nature of future environmental expenditures cannot be quantified with accuracy. The Company does not currently anticipate any material losses in excess of the reserve amount recorded. However, it is possible that new information about these sites, such as results of investigations, could make it necessary for the Company to reassess its potential exposure related to these environmental matters. As the settlement of many of the obligations for which provision is made is subject to legal or other regulatory process, the timing of the associated cash outflows is subject to some uncertainty, but the majority of the amounts provided are expected to be utilized over the next five to ten years. As of September 30, 2016 and December 31, 2015 , the Company's environmental reserves totaled $47.9 million and $25.7 million , respectively. As of the date hereof, management does not believe it is possible to develop an estimate of the range of reasonably possible environmental loss in excess of the Company's recorded liabilities, and is unable to ascertain the ultimate aggregate amount of monetary liability or financial impact with respect to these matters. Legal Proceedings From time to time, the Company is involved in various legal proceedings in the normal course of its business. The Company believes that the resolution of these claims, to the extent not covered by insurance, will not, individually or in the aggregate, have a material adverse effect on the Company’s business, financial condition, results of operations or cash flows. As of September 30, 2016 and December 31, 2015 , the Company has reserved approximately $8.8 million and $6.5 million , respectively, for its outstanding legal proceedings. The following is a description of certain litigation matters. Product liability and/or personal injury claims for, or relating to, products the Company sells under its Agricultural Solutions segment are complex in nature and have outcomes that are difficult to predict. Since these products are used in the food chain on a global basis, any such product liability or personal injury claim could lead to litigation in multiple jurisdictions. In September 2014, Agricola Colonet, SA de CV filed a complaint with the 1st Civil Court in San Quintin (Baja California) where it alleged that certain Arysta products purchased from a retail distributor in Mexico were contaminated, requiring treated crops to be destroyed. Agricola Colonet, SA de CV is seeking compensation of approximately MXN 191 million ( $9.8 million , based on the MXN/ USD exchange rate of 0.0516 on September 30, 2016 ). A related complaint was filed in June 2016 in the U.S. District Court for the Southern District of California by Fresh Pac International, Inc., naming the Company as a defendant. In the complaint, Fresh Pac International Inc. claims to be a distributor of produce for Agricola Colonet, SA de CV and seeks in excess of $6.0 million in damages allegedly sustained in connection with the events that appear to form the basis of the claim by Agricola Colonet SA de CV. The Company believes that it has adequate defenses and intends to vigorously defend against these claims. Under its risk management policies, the Company maintains certain insurance policies under which such claims may be covered. In March 2013, a claim was filed against Arysta LifeScience Corporation, a subsidiary of the Company, relating to a purchasing optimization agreement entered into in 2011 between Arysta LifeScience Corporation and a consulting firm. The agreement provided for an incentive fee to be paid to the plaintiff based upon savings to Arysta resulting from the plaintiff's work. In addition to fees already received, the plaintiff claims damages, which the Company considered to be immaterial. The Company believes this claim was without merit and that the fees already paid under the agreement exceeded or were equal to the fees owed to the plaintiff. An arbitration hearing was conducted in May 2014, and in May 2015 the tribunal published a partial award, ruling on various issues of principle, but declining to calculate an award amount, rather asking the parties to attempt to agree upon a calculation reflecting the decisions of the tribunal set out in the award. In April 2016, the tribunal awarded the plaintiff $0.1 million pursuant to the agreement. In addition, the tribunal ordered the plaintiff to pay to Arysta LifeScience Corporation the amount of $0.6 million , which represents a portion of Arysta LifeScience Corporation's total legal costs, with each party bearing 50% of the arbitration costs. Finally, the tribunal dismissed any and all other claims in this arbitration. The time period available to the plaintiff under the arbitration rules to seek to "correct" the award has expired, with no such attempt by the plaintiff. The plaintiff may seek to vacate the award in a judicial proceeding, but the Company believes there are no grounds for any such action. The $600 million of Series B Convertible Preferred Stock issued in connection with the Arysta Acquisition may be converted into a maximum of 22,107,590 shares of Platform common stock. Under the terms of a settlement agreement with the Arysta Seller, from October 20, 2016 until the close of business on December 15, 2016, the Company may settle all of its obligations with respect to the Series B Convertible Preferred Stock as described in Note 11, Stockholders' Equity , to the Company's unaudited interim Condensed Consolidated Financial Statements included in this Quarterly Report. To the extent the Company does not settle all of its obligations by December 15, 2016, it will be required, on April 20, 2017, to repurchase each outstanding share of Series B Convertible Preferred Stock. To the extent that the aggregate value of the shares of common stock which the shares of Series B Convertible Preferred Stock are converted into is less than $600 million (based on a 10 -day volume weighted average price), then such shortfall would be payable in cash by Platform. As previously disclosed, such shortfall would be reduced by a portion, or all, of the amount for which the March 2013 arbitration matter described in the preceding paragraph may be resolved. In light of the resolution of this matter as described above, such shortfall reduction is expected to be immaterial. In June 2009, a lawsuit was filed in the District Court for the City of Ulianópolis in the State of Pará, Brazil by a private individual against Arysta LifeScience do Brasil Industria Química e Agropecuária Ltda, or Arysta Brazil, and 25 other defendants, and in November 2011, a claim was filed, also in the District Court for the City of Ulianópolis in the State of Pará, Brazil, against Arysta Brazil and five other defendants by the city of Ulianópolis, in each case in connection with materials sent by Arysta Brazil and others to an incineration site owned and operated by an unaffiliated third party in the state of Pará, Brazil. Arysta Brazil was summoned and has filed its answer in connection with both cases. Proceedings have been suspended indefinitely in order to allow the Pará State Attorney to conduct civil inquiries to determine the extent of contamination and the appropriate remediation, and to identify potentially responsible parties. Damages sought in the private lawsuit include a penalty of BRL 50.0 million ( $15.3 million , based on the BRL/USD exchange rate of 0.3065 on September 30, 2016 ), plus interest and the cost of remediation. The cost of remediation in the case brought by the city of Ulianopolis was previously estimated by the city to be BRL 70.9 million ( $21.7 million , based on the BRL/USD exchange rate of 0.3065 on September 30, 2016 ). In addition, 29 former employees of the incineration facility have brought actions in the Labor Court of Paragominas in the State of Pará, Brazil naming 80 defendants, including Arysta Brazil, seeking compensation in an aggregate amount of BRL 387 million ( $118 million , based on the BRL/USD exchange rate of 0.3065 on September 30, 2016 ) for health problems allegedly contracted as a result of their employment at the incineration site. From time to time, in the ordinary course of our business, we contest tax assessments received by our subsidiaries in various jurisdictions. Our contested tax assessments have been most prevalent in Brazil, where the tax regime is complex, and the administrative and judicial procedures for resolving disputed tax assessments are expensive and time-consuming. In addition, short of simply paying the entire amount demanded, including penalties, interest, and attorney’s fees, it is not possible to settle disputed tax assessments other than by submission for inclusion in formal tax amnesty programs announced by the Brazilian federal or state governments from time to time at irregular intervals. The terms of such amnesty programs vary, but generally offer the possibility of reduced interest and penalties. Historically, Arysta has submitted selected contested tax matters for inclusion in such amnesty programs in Brazil, when it appeared prudent to management to do so. The Company is currently contesting several tax assessments at various stages of the applicable administrative and judicial processes, with a combined amount at issue, including interest and penalties, of approximately BRL 81.1 million ( $24.9 million , based on the BRL/USD exchange rate of 0.3065 on September 30, 2016 ). Because tax matters in Brazil historically take many years to resolve, it is very difficult to estimate when these matters will be finally resolved. Based on management's judgments, the Company does not expect it will incur a material loss in excess of accrued liabilities. In July 2014, a federal court jury in the U.S. District Court for the District of Connecticut found in favor of MacDermid Printing Solutions LLC in litigation against Cortron, Inc. The court entered a judgment in the amount of approximately $64.7 million . Cortron, Inc. appealed the verdict, and in August 2016 the United States Court of Appeals for the Second Circuit issued a decision in which it reversed the District Court’s verdict with respect to certain claims, affirmed with respect to other claims, and remanded to the District Court to recalculate the damages payable to MacDermid Printing Solutions LLC. Accordingly, the amount of the ultimate judgment is subject to further proceedings in the District Court and is, therefore, uncertain. All proceeds from this litigation are subject to the pending litigation provisions of the Business Combination Agreement and Plan of Merger dated as of October 10, 2013. In September 2014, the U.S. District Court for the District of New Jersey rendered a summary judgment in favor of MacDermid related to a patent litigation with E.I. du Pont de Nemours and Company. The Court issued summary judgment rulings in favor of MacDermid finding certain E.I. du Pont de Nemours and Company’s patents invalid and not infringed. These rulings summarily found against E.I. du Pont de Nemours and Company on all of the patent claims asserted by E.I. du Pont de Nemours and Company in this lawsuit. The ruling, however, leaves the counterclaims made by MacDermid against E.I. du Pont de Nemours and Company in place. E.I. du Pont de Nemours and Company appealed the summary judgment, and in August 2016 the United States Court of Appeals for the Federal Circuit affirmed the District Court’s summary judgment rulings. E.I. du Pont de Nemours and Company petitioned the Court of Appeals for a review of the decision en banc , which petition was denied. A trial date for MacDermid’s counterclaims against E.I. du Pont de Nemours and Company has not yet been set. All proceeds from this litigation are subject to the pending litigation provisions of the Business Combination Agreement and Plan of Merger dated as of October 10, 2013. In February 2015, MacDermid, as plaintiff, settled a litigation with Cookson Group plc, Enthone Inc., Cookson Electronics and David North, as defendants, for $25.0 million . The litigation related to certain corporate activities that occurred between MacDermid and the defendants in 2006 and 2007. On April 3, 2015, the Company received part of the settlement in the amount of $16.0 million , and placed the remainder, net of legal costs, into escrow for future distribution in accordance with the pending litigation provisions of our Business Combination Agreement and Plan of Merger dated as of October 10, 2013. In March and April 2016, a class action lawsuit entitled Dillard v. Platform Specialty Products Corporation, et al. and a shareholder derivative action entitled Tuttelman v. Platform Specialty Products Corporation, et al. , respectively, were filed against Platform, certain of its former and current executive officers and, in the case of the derivative action, its directors in the U.S. District Court for the Southern District of Florida alleging that the defendants made material false and misleading statements relating to the Company's business, operational and compliance policies in light of certain matters discovered and reported by the Company itself in connection with a Company internal investigation into certain past business practices of the Company's Arysta West Africa business, as disclosed herein and in the Annual Report. In June 2016, the shareholder derivative action was dismissed by the Court. In June 2016, the Court appointed joint lead plaintiffs in the class action lawsuit, and in July 2016, the lead plaintiffs filed an amended complaint with an expanded class period but stating substantially similar claims to those contained in the original complaint. The amended complaint seeks unspecified damages. In September 2016, Platform filed a motion to dismiss this complaint, which is fully briefed and currently pending before the Court. The Company believes this proceeding is without merit and intends to defend it vigorously.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2016
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES For the three months ended September 30, 2016 and 2015 , income tax expense totaled $20.4 million and $35.4 million , respectively. The Company's effective tax rate in the third quarter of 2016 was 23.6% on pre-tax income of $86.3 million , compared to an effective tax rate of (34.0)% on pre-tax losses of $104 million in the third quarter of 2015 . The difference between the statutory and effective tax rates for the three months ended September 30, 2016 primarily relates to the recognition of a $38.2 million benefit for a nontaxable purchase price adjustment related to the Arysta Acquisition, a $25.6 million benefit for deductions associated with the Alent Acquisition, and a $15.3 million benefit related to the recognition of tax deductible goodwill. Partially offsetting these items was a $21.9 million valuation allowance on current quarter losses that may not be recoverable for U.S. and foreign companies, a $26.0 million increase in tax reserves primarily for deductions related to the Alent Acquisition, and a $14.7 million charge related to tax on foreign operations. For the nine months ended September 30, 2016 and 2015 , income tax expense totaled $65.7 million and $59.8 million , respectively. The Company's effective tax rate for the nine months ended September 30, 2016 was (602.8)% on pre-tax losses of $10.9 million , compared to an effective tax rate of (52.0)% on pre-tax losses of $115 million for the nine months ended September 30, 2015 . The difference between the statutory and effective tax rates for the nine months ended September 30, 2016 primarily relates to the recognition of a $ 103 million valuation allowance on current period losses that may not be recoverable for U.S. and foreign companies, a $27.9 million increase in tax reserves primarily for deductions related to the Alent Acquisition, and a $10.0 million charge related to tax on foreign operations. Partially offsetting these items was a $38.2 million benefit for a nontaxable purchase price adjustment related to the Arysta Acquisition, a $25.6 million benefit for deductions associated with the Alent Acquisition, and a $15.3 million benefit related to the recognition of tax deductible goodwill. The amount of unrecognized tax benefits was $188 million and $112 million at September 30, 2016 and December 31, 2015 , respectively, of which $94.0 million and $92.0 million , respectively, if recognized, would reduce the Company's effective tax rate. The increase of unrecognized tax benefits during the period is in part attributable to the Alent Acquisition. Based on an analysis of the information that existed as of the acquisition date, the Company recorded an unrecognized tax benefit of $44.5 million in purchase accounting related to certain acquired net operating losses. In addition, the Company also increased its unrecognized tax benefits by $25.6 million for deductions related to the Alent Acquisition. Accrued interest and penalties related to unrecognized tax benefits were $19.7 million and $17.5 million at September 30, 2016 and December 31, 2015 , respectively. The Company recognized interest and penalties of $3.5 million and $0.4 million related to unrecognized tax benefits in the income tax provision for the nine months ended September 30, 2016 and 2015 , respectively. The unrecognized tax benefits could be reduced by $7.8 million over the next 12 months as a result of the lapse of statutes of limitations in various jurisdictions.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2016
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	RELATED PARTY TRANSACTIONS Series B Convertible Preferred Stock On September 9, 2016, the Company entered into a settlement agreement with the Arysta Seller with respect to certain of its obligations relating to the Company's shares of Series B Convertible Preferred Stock. See Note 11, Stockholders' Equity, under the heading " Series B Convertible Preferred Stock." RHSA Immediately prior to the closing of the MacDermid Acquisition, each Retaining Holder entered into a RHSA pursuant to which they agreed to exchange their respective interests in MacDermid Holdings for shares of PDH Common Stock, at an exchange rate of $11.00 per share plus, with respect to the common, class A and class B unit equity interests of MacDermid Holdings held by the Retaining Holder, (i) a proportionate share of a contingent interest in certain pending litigation, and (ii) a proportionate share of up to $100 million of contingent purchase price payable upon the attainment of certain EBITDA and stock trading price performance metrics during the seven -year period following the closing of the MacDermid Acquisition. The resulting non-controlling interest percentage for the Retaining Holders was 6.20% at September 30, 2016 and 6.25% at December 31, 2015 . Advisory Services Agreement The Company is party to an Advisory Services Agreement with Mariposa Capital, LLC, an affiliate of one of our founder directors, whereby Mariposa Capital, LLC is entitled to receive an annual fee equal to $2.0 million , payable in quarterly installments. This agreement is automatically renewed for successive one -year terms unless either party notifies the other party in writing of its intention not to renew no later than 90 days prior to the expiration of the term. For each of the three month periods ended September 30, 2016 and 2015 , the Company incurred advisory fees under the agreement totaling $0.5 million . For each of the nine month periods ended September 30, 2016 and 2015 , the Company incurred advisory fees under the agreement totaling $1.5 million .

Restructuring

Restructuring	9 Months Ended
	Sep. 30, 2016
Restructuring and Related Activities [Abstract]
RESTRUCTURING	RESTRUCTURING The Company continuously evaluates all operations to identify opportunities to improve profitability by leveraging existing infrastructure to reduce operating costs and respond to overall economic conditions. Restructuring expenses were recorded as follows in each of the Company's segments: Three Months Ended September 30, Nine Months Ended September 30, (amounts in millions) 2016 2015 2016 2015 Performance Solutions $ 6.4 $ 2.9 $ 16.8 $ 5.8 Agricultural Solutions 0.9 1.6 2.7 12.4 Total restructuring $ 7.3 $ 4.5 $ 19.5 $ 18.2 The restructuring plans initiated within the Performance Solutions segment primarily relate to headcount reductions associated with the integration of the Alent, OMG and OMG Malaysia Acquisitions. The restructuring plans initiated within the Agricultural Solutions segment primarily relate to cost saving opportunities associated with the integration of the Arysta, CAS and Agriphar Acquisitions. There are no material additional costs expected to be incurred related to these discrete restructuring plans. As of September 30, 2016 and December 31, 2015 , restructuring liabilities totaled $0.4 million and $1.1 million , respectively, and were included in "Accrued expenses and other current liabilities" in the Condensed Consolidated Balance Sheets. Restructuring expenses were recorded as follows in the Condensed Consolidated Statements of Operations: Three Months Ended September 30, Nine Months Ended September 30, (amounts in millions) 2016 2015 2016 2015 Cost of sales $ — $ 2.4 $ (0.4 ) $ 3.6 Selling, technical, general and administrative 7.3 2.1 19.9 14.6 Total restructuring $ 7.3 $ 4.5 $ 19.5 $ 18.2

Segment Information

Segment Information	9 Months Ended
	Sep. 30, 2016
Segment Reporting [Abstract]
SEGMENT INFORMATION	SEGMENT INFORMATION The Company's operations are organized into two reportable segments: Performance Solutions and Agricultural Solutions. The reporting segments represent businesses for which separate financial information is utilized by the chief operating decision maker, or CODM, for purpose of allocating resources and evaluating performance. Each of the reportable segments has its own president, who reports to the CODM. Performance Solutions - The Performance Solutions segment formulates and markets dynamic chemistry solutions that are used in automotive production, commercial packaging and printing, electronics, and oil and gas production and drilling. Its products include surface and coating materials, functional conversion coatings, electronics assembly materials, water-based hydraulic control fluids and photopolymers. Performance Solutions products are sold worldwide. In conjunction with the sale of its products, extensive technical service and support is provided to ensure superior performance. Within this segment, the Company provides specialty chemicals to the following industries: Electronics, Electronics Assembly Materials, Commercial Packing and Printing, Industrial, and Offshore. For the Electronics industry, the segment designs and formulates a complete line of proprietary “wet” dynamic chemistries used by customers to process the surface of the printed circuit boards and other electronic components they manufacture. For the Electronics Assembly Materials industry, the segment develops, manufactures and sells innovative interconnected materials, primarily in the electronics market, used to assemble printed circuit boards and advanced semiconductor packaging. For the Commercial Packaging and Printing industries, the segment produces photopolymers, through an extensive line of flexographic plates, which are used to produce printing plates for transferring images onto commercial packaging, including packaging for consumer food products, pet food bags, corrugated boxes, labels and beverage containers. In addition, the segment also produces photopolymer printing plates for the flexographic and letterpress newspaper and publications markets. For the Industrials, the segment's dynamic chemistries are used for finishing, cleaning and providing surface coatings for a broad range of metal and non-metal surfaces which improve the performance or look of a component of an industrial part or process. For the Offshore industry, the segment produces water-based hydraulic control fluids for major oil and gas companies and drilling contractors for offshore deep water production and drilling applications. Agricultural Solutions - The Agricultural Solutions segment is based on a solutions-oriented business model that focuses on product innovation to address an ever-increasing need for higher crop yield and quality. It offers to growers diverse crop-protection solutions from weeds (herbicides), insects (insecticides) and diseases (fungicides), in foliar and seed treatment applications. The segment also offers a wide variety of proven biosolutions, including biostimulants, innovative nutrition and biocontrol products. It emphasizes farmer economics and food safety by combining, when possible, biosolutions with crop protection and seed treatment agrochemicals. Its Global Value Added Portfolio, or GVAP, consists of agrochemicals in the fungicides, herbicides, insecticides and seed treatment categories, based on patented or proprietary off-patent AIs. Its Global BioSolutions Portfolio, or GBP, includes biostimulants, innovative nutrition and biocontrol products. The segment considers its GVAP and GBP offerings to be key pillars for sustainable growth. In addition, the segment offers regional off-patent AIs and certain non-crop products, including animal health products, such as honey bee protective miticides and certain veterinary vaccines. The Company evaluates the performance of its operating segments based on net sales and adjusted EBITDA. Adjusted EBITDA for each segment is defined as earnings before interest, taxes, depreciation and amortization, as further adjusted for additional items included in earnings that are not representative or indicative of each segment's ongoing business. Adjusted EBITDA for each segment also includes an allocation of corporate costs such as corporate salaries, wages, equity compensation expenses and legal costs. The following table summarizes financial information regarding each reportable segment’s results of operations for the periods presented. Three Months Ended September 30, Nine Months Ended September 30, (amounts in millions) 2016 2015 2016 2015 Net Sales (from external customers): Performance Solutions $ 454.9 $ 179.7 $ 1,312.9 $ 541.6 Agricultural Solutions 435.6 417.6 1,323.0 1,265.7 Consolidated net sales $ 890.5 $ 597.3 $ 2,635.9 $ 1,807.3 Adjusted EBITDA: Performance Solutions $ 109.9 $ 54.1 $ 290.7 $ 156.9 Agricultural Solutions 80.2 59.5 260.7 256.5 Adjusted EBITDA $ 190.1 $ 113.6 $ 551.4 $ 413.4 The following table reconciles Net income (loss) attributable to common stockholders to Adjusted EBITDA: Three months ended September 30, Nine months ended September 30, (amounts in millions) 2016 2015 2016 2015 Net income (loss) attributable to common stockholders $ 104.7 $ (140.1 ) $ (39.0 ) $ (178.9 ) Gain on amendment of Series B Convertible Preferred Stock (32.9 ) — (32.9 ) — Net (loss) income attributable to the non-controlling interests (5.9 ) 0.5 (4.7 ) 4.0 Income tax expense 20.4 35.4 65.7 59.8 Income (loss) before income taxes and non-controlling interests 86.3 (104.2 ) (10.9 ) (115.1 ) Adjustments to reconcile to Adjusted EBITDA: Interest expense, net 98.5 52.7 289.7 143.2 Depreciation expense 18.9 11.6 55.8 33.7 Amortization expense 68.0 50.4 199.1 142.6 Long-term compensation issued in connection with acquisitions 0.2 (1.5 ) 0.6 0.2 Restructuring expenses 7.3 4.5 19.5 18.2 Manufacturer's profit in inventory purchase accounting adjustments — 1.3 11.7 58.0 Acquisition and integration costs 3.2 15.0 27.4 70.4 Non-cash change in fair value of contingent consideration 0.2 2.7 4.3 6.3 Legal settlements — — (2.8 ) (16.0 ) Foreign exchange loss on foreign denominated external and internal debt 12.0 33.0 58.7 26.8 Fair value loss on foreign exchange forward contract — 48.1 — 48.1 Gain on settlement agreement related to Series B Convertible Preferred Stock (103.0 ) — (103.0 ) — Non-cash change in fair value of preferred stock redemption liability (6.0 ) — (6.0 ) — Other income (expense), net 4.5 — 7.3 (3.0 ) Adjusted EBITDA $ 190.1 $ 113.6 $ 551.4 $ 413.4

Basis of Presentation and Sig28

Basis of Presentation and Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	These unaudited interim Condensed Consolidated Financial Statements and related information have been prepared in accordance with GAAP for interim financial information and in accordance with the applicable rules and regulations of the SEC. Accordingly, they do not include all of the disclosures required in connection with annual financial statements. These unaudited interim Condensed Consolidated Financial Statements reflect all adjustments that are, in the opinion of management, normal, recurring and necessary for a fair statement of the Company's results of operations. These unaudited interim Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and the related notes thereto included in the Company’s Annual Report. The year-end Condensed Consolidated Balance Sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP.
Principles of Consolidation	The accompanying unaudited interim Condensed Consolidated Financial Statements include Platform's accounts and all of its controlled subsidiaries. All subsidiaries are included in the unaudited interim Condensed Consolidated Financial Statements for the entire period or, if acquired, from the date on which the Company obtains control. The Company fully consolidates the income, expenses, assets, liabilities and cash flows of subsidiaries from the date it acquires control or becomes the primary beneficiary up to the date control ceases. All intercompany accounts and transactions have been eliminated in consolidation.
Recently Adopted and Recently Issued Accounting Pronouncements Not Yet Adopted	Recently Adopted Accounting Pronouncements Compensation - Stock Compensation (Topic 718) - In March 2016, the FASB issued ASU No. 2016-09, “ Improvements to Employee Share-Based Payment Accounting.” This update changes the accounting treatment related to tax windfall and shortfalls associated with share-based awards. It also eliminates the requirement for entities to estimate future forfeiture rates associated with share-based awards and stipulates the requirement that cash payments made by employers when directly withholding shares for tax-withholdings purposes should be classified as a financing activity in the statement of cash flows. The guidance is effective for fiscal years and interim periods beginning after December 15, 2016 with early adoption permitted. The Company adopted this ASU as of April 1, 2016. This ASU did not have a material impact on the Company's financial statements. Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40 ) - In April 2015, the FASB issued ASU No. 2015-05, “ Customer's Accounting for Fees Paid in a Cloud Computing Arrangement.” This update provides explicit guidance to customers utilizing a cloud computing solution to help determine whether such an arrangement includes a software license, in which case the accounting applied would be similar to that of other software license arrangements. Otherwise, the arrangement would be accounted for as a service contract. The Company adopted this ASU as of January 1, 2016. This ASU did not have a material impact on the Company's financial statements. Income Statement – Extraordinary and Unusual Items (Subtopic 225-20) - In January 2015, the FASB issued ASU No. 2015-1, “ Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items.” This update eliminates the requirement for entities to identify extraordinary events and transactions, those being both unusual in nature and infrequent in occurrence, and separately classify, present and disclose such items. The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2015. The Company adopted this ASU as of January 1, 2016. The Company did not have any extraordinary or unusual income statement items recorded for any periods presented and therefore, this ASU did not have a material impact on the Company's financial statements. Compensation – Stock Compensation (Topic 718) - In June 2014, the FASB issued ASU No. 2014-12, “ Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period (a consensus of the FASB Emerging Issues Task Force).” Under the provisions of this update, a performance target that affects vesting and that could be achieved after the requisite service period are treated as a performance condition. The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2015. The Company adopted this ASU as of January 1, 2016. This ASU did not have a material impact on the Company's financial statements as it had no share-based compensation awards that were effected by this pronouncement. Recently Issued Accounting Pronouncements Not Yet Adopted Consolidation (Topic 810) - In October 2016, the FASB issued ASU No. 2016-17, "Interests Held through Related Parties that are Under Common Control." This update clarifies how a reporting entity that is the single decision maker of a variable interest entity (VIE) should treat indirect interests in the entity held through related parties that are under common control with the reporting entity when determining whether it is the primary beneficiary of that VIE. The guidance is effective for fiscal years and interim periods beginning after December 15, 2016, with early adoption permitted. The Company is evaluating the impact of this ASU. Income Taxes (Topic 740) - In October 2016, the FASB issued ASU No. 2016-16, " Intra-Entity Transfers of Assets Other than Inventory. " This update stipulates that entities recognize the income tax consequences of intra-entity transfers of assets other than inventory when the transfer occurs. The amendments in this guidance apply to assets other than inventory, for example, intellectual property and property, plant and equipment. The guidance is effective for fiscal years beginning after December 15, 2017 and interim periods within those fiscal years, with early adoption permitted in the first quarter of an annual reporting period for which financial statements have not been issued or made available for issuance. The Company is evaluating the impact of this ASU. Statement of Cash Flows (Topic 230) - In August 2016, the FASB issued ASU No. 2016-15, " Classification of Certain Cash Receipts and Cash Payments. " This update was issued to reduce the differences in the classification of certain transactions in the statement of cash flows. The update addresses eight specific cash flow issues, including debt prepayment and extinguishment costs, zero coupon bond settlement, contingent consideration payments, insurance claim settlements, company-owned life insurance receipts/payments, distributions from equity method investments, beneficial interests in securitization transactions, and separately identifiable cash flows. The guidance is effective for fiscal years beginning after December 15, 2017 and interim periods within those fiscal years, with early adoption permitted. The Company does not expect this ASU to have a material impact on its financial statements. Financial Instruments - Credit Losses (Topic 326) - In June 2016, the FASB issued ASU No. 2016-13, " Measurement of Credit Losses on Financial Instruments. " This update introduces new guidance for the accounting for credit losses on certain types of financial instruments, which are to be estimated based on the expected losses. It also modifies the impairment model for available-for-sale debt securities and provides for a simplified accounting model for purchased financial assets with credit deterioration since their origination. The guidance is effective on a modified retrospective basis for fiscal years and interim periods beginning after December 15, 2019 with early adoption permitted for fiscal years and interim periods beginning after December 15, 2018. The Company is evaluating the impact of this ASU. Investments - Equity Method and Joint Ventures (Topic 323) - In March 2016, the FASB issued ASU No. 2016-07, " Simplifying the Transition to the Equity Method of Accounting. " This update simplifies transition accounting when the ownership level or degree of influence held in an investment qualifies that investment for equity method accounting. The guidance is effective prospectively for fiscal years and interim periods beginning after December 15, 2016, with early adoption permitted. The Company does not expect this ASU to have a material impact on its financial statements. Derivatives and Hedging (Topic 815) - In March 2016, the FASB issued ASU No. 2016-06, " Contingent Put and Call Options in Debt Instruments (a consensus of the FASB Emerging Issues Task Force) ." The ASU clarifies guidance around determining whether call or put options that can accelerate the repayment of principal on a debt or hybrid instrument that are considered embedded derivatives meet the "clearly and closely related" criterion for determining whether the embedded derivative is required to be separated from the host contract and accounted for separately as a derivative. The guidance is effective for fiscal years and interim periods beginning after December 15, 2016 with early adoption permitted. Adoption is required on a modified retrospective basis. The Company does not expect this ASU to have a material impact on its financial statements. Derivatives and Hedging (Topic 815) - In March 2016, the FASB issued ASU No. 2016-05, " Effect of Derivative Contract Novations on Existing Hedge Accounting Relationships (a consensus of the FASB Emerging Issues Task Force). " This update stipulates that a change in the counterparty of a derivative instrument that has been designated as a hedging instrument under Topic 815 does not, in and of itself, require de-designation of that hedging relationship, provided that all other hedge accounting criteria continue to be met. The guidance is effective for fiscal years and interim periods beginning after December 15, 2016 and provides entities with the option to apply either a prospective or a modified retrospective approach. The Company does not expect this ASU to have a material impact on its financial statements. Leases (Topic 842) - In February 2016, the FASB issued ASU No. 2016-02, “Leases.” The updated guidance applies to capital (or finance) and operating leases, and requires the lessee to recognize a lease liability for the obligation to make lease payments and a right-of-use asset for the right to use the underlying asset for the lease term. The lessee can make an accounting policy choice to not recognize right of use assets and lease liabilities for short-term leases (leases with a lease term of 12 months or less). The guidance is effective for fiscal years and interim periods beginning after December 15, 2018, with early adoption permitted. The Company continues to evaluate the impact of this ASU. Financial Instruments - Overall (Subtopic 825.10) - In January 2016, the FASB issued ASU No. 2016-1, “Recognition and Measurement of Financial Assets and Financial Liabilities.” This update addresses certain aspects of recognition, measurement, presentation, and disclosure of financial assets and liabilities. Provisions of this ASU include, among others, requiring the measurement of certain equity investments at fair value, with changes in value recognized in net income, and simplifying the impairment assessment of certain equity investments. The guidance is effective for fiscal years and interim periods beginning after December 15, 2017. The guidance is effective on a modified retrospective basis, except as it relates to equity securities without a readily determinable fair value, for which it is effective on a prospective basis. Early adoption is only permitted for provisions related to the recognition of changes in fair value of financial liabilities. The Company does not expect this ASU to have a material impact on its financial statements. Revenue from Contracts with Customers (Topic 606) - In August 2015, the FASB issued ASU No. 2015-14, “Deferral of the Effective Date,” which defers the effective date of ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606)," for all entities by one year. As a result, the provisions of ASU No. 2014-09 will be effective prospectively for fiscal years and interim periods beginning after December 15, 2017. ASU No. 2014-09 (1) removes inconsistencies and weaknesses in revenue requirements, (2) provides a more robust framework for addressing revenue issues, (3) improves comparability of revenue recognition practices across entities, industries, jurisdictions, and capital markets, (4) provides more useful information to users of financial statements through improved disclosure requirements, and (5) simplifies the preparation of financial statements by reducing the number of requirements to which an entity must refer. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The FASB has issued the following amendments and supplements to the guidance of ASU Nos. 2014-09 and 2015-14, all of which become effective for fiscal years and interim periods beginning after December 15, 2017: • ASU No. 2016-08, " Principal versus Agent Considerations, " issued in March 2016. This update improves the operability and understandability of the implementation guidance on principal versus agent considerations. • ASU No. 2016-10, " Identifying Performance Obligations and Licensing, " issued in April 2016. This update provides clarification on the implementation guidance defining when a good or service is separately identifiable from other promises in the contract and on contracts with licenses of intellectual property. • ASU No. 2016-12, " Narrow-Scope Improvements and Practical Expedients, " issued in May 2016. This update provides clarification on the collectability criterion, presentation of taxes, non-cash consideration and contract modification guidance espoused in ASU No. 2014-09. This update also clarifies the accounting treatment for completed contracts and retrospective application of the standard to prior reporting periods. The Company continues to evaluate the impact of ASU Nos. 2014-09, 2015-14 and their subsequent amendments. Presentation of Financial Statements - Going Concern (Subtopic 205-40) - In August 2014, the FASB issued ASU No. 2014-15, " Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern ." This update provides clarification on conditions and events that should be considered by management at each annual and interim reporting period in determining whether there exists substantial doubt as to an entity’s ability to continue as a going concern. The guidance is effective for fiscal years and interim periods ending after December 15, 2016 with early adoption permitted. The Company does not expect this ASU to have a material impact on its financial statements.
Restatement	As previously disclosed in the Company's Annual Report, the Company restated its unaudited Condensed Consolidated Statement of Operations for the three and nine months ended September 30, 2015 and its unaudited Condensed Consolidated Balance Sheet as of September 30, 2015 that were previously included in the Company's quarterly report on Form 10-Q for the quarter ended September 30, 2015 to correct an error as a result of improperly recording a benefit on an unrealized loss associated with a foreign currency hedge entered into in connection with the Alent Acquisition for income tax accounting purposes, which resulted in an understatement of income tax expense of $17.8 million . As a result of the error, "Loss per share" was understated by $0.08 for the three and nine month periods ended September 30, 2015. In addition, "Prepaid expenses and other current assets" were overstated by $19.6 million , "Other assets" were understated by $2.8 million , and "Accrued income taxes payable" was understated by $1.0 million .

Acquisitions of Businesses (Tab

Acquisitions of Businesses (Tables)	9 Months Ended
	Sep. 30, 2016
Business Combinations [Abstract]
Revenues and losses contributed by acquisitions	Since the dates of their respective acquisitions, net sales contributed by the OMG Malaysia, Alent, OMG and Arysta Acquisitions for the three and nine months ended September 30, 2016 and 2015 were as follows: Three Months Ended September 30, Nine Months Ended September 30, (amounts in millions) 2016 2015 2016 2015 OMG Malaysia $ 8.5 $ — $ 21.4 $ — Alent 243.9 — 693.0 — OMG 27.8 — 80.9 — Arysta 363.7 318.2 1,013.4 837.6 Total $ 643.9 $ 318.2 $ 1,808.7 $ 837.6 Net income (loss) generated by the OMG Malaysia, Alent, OMG and Arysta Acquisitions, excluding corporate allocations, for the three and nine months ended September 30, 2016 and 2015 was as follows: Three Months Ended September 30, Nine Months Ended September 30, (amounts in millions) 2016 2015 2016 2015 OMG Malaysia $ 1.2 $ — $ 2.3 $ — Alent 23.7 — 38.8 — OMG 4.2 — 4.5 — Arysta (8.9 ) (34.8 ) (174.1 ) (100.6 ) Total $ 20.2 $ (34.8 ) $ (128.5 ) $ (100.6 )
Purchase price allocation	The following table summarizes the consideration transferred and transaction costs incurred to acquire OMG Malaysia, Alent and the OMG Businesses, as well as the applicable amounts of identified assets acquired and liabilities assumed at the applicable acquisition date: (amounts in millions) OMG Malaysia Alent OMG Consideration Cash, net $ (1.3 ) $ 1,507.0 $ 239.1 Equity instruments — 231.4 — Note receivable settlement 125.0 — — Total consideration $ 123.7 $ 1,738.4 $ 239.1 Acquisition costs $ 0.5 $ 29.2 $ 7.4 Identifiable assets acquired and liabilities assumed Accounts receivable $ 4.3 $ 177.4 $ 33.1 - less uncollectible — (1.8 ) (1.6 ) Accounts receivable - fair value 4.3 175.6 31.5 Inventories 6.4 116.1 13.2 Other current assets 0.2 29.3 1.6 Property, plant and equipment 4.7 192.2 35.1 Identifiable intangible assets 38.3 682.9 77.9 Other assets — 38.3 0.2 Current liabilities (3.5 ) (181.8 ) (21.5 ) Non-current deferred tax liability (10.0 ) (139.6 ) (13.6 ) Other long term liabilities — (345.2 ) (2.9 ) Total identifiable net assets 40.4 567.8 121.5 Goodwill 83.3 1,170.6 117.6 Total purchase price $ 123.7 $ 1,738.4 $ 239.1
Identifiable intangible assets recorded in conjunction with acquisitions (finite-lived)	Identifiable intangible assets recorded in conjunction with the OMG Malaysia, Alent and OMG Acquisitions were as follows: OMG Malaysia Alent OMG Total (amounts in millions) Fair Value Weighted average useful life (years) Fair Value Weighted average useful life (years) Fair Value Weighted average useful life (years) Fair Value Weighted average useful life (years) Customer lists $ 35.0 25.0 $ 391.4 14.7 $ 49.0 24.3 $ 475.4 16.5 Developed technology 3.3 5.0 203.3 10.0 28.0 10.0 234.6 9.9 Tradenames — — 85.8 (1) 20.0 0.9 10.0 86.7 18.3 In process - R&D — — 2.4 (2) — — — 2.4 — Total $ 38.3 23.3 $ 682.9 13.2 $ 77.9 19.0 $ 799.1 14.3 (1) Includes $81.4 million of indefinite-lived tradenames which have been excluded from the calculation of weighted average useful life. (2) Excluded from the calculation of weighted average useful life.
Identifiable intangible assets recorded in conjunction with acquisitions (indefinite-lived)	Identifiable intangible assets recorded in conjunction with the OMG Malaysia, Alent and OMG Acquisitions were as follows: OMG Malaysia Alent OMG Total (amounts in millions) Fair Value Weighted average useful life (years) Fair Value Weighted average useful life (years) Fair Value Weighted average useful life (years) Fair Value Weighted average useful life (years) Customer lists $ 35.0 25.0 $ 391.4 14.7 $ 49.0 24.3 $ 475.4 16.5 Developed technology 3.3 5.0 203.3 10.0 28.0 10.0 234.6 9.9 Tradenames — — 85.8 (1) 20.0 0.9 10.0 86.7 18.3 In process - R&D — — 2.4 (2) — — — 2.4 — Total $ 38.3 23.3 $ 682.9 13.2 $ 77.9 19.0 $ 799.1 14.3 (1) Includes $81.4 million of indefinite-lived tradenames which have been excluded from the calculation of weighted average useful life. (2) Excluded from the calculation of weighted average useful life.
Pro forma revenue and earnings	The following unaudited pro forma summary presents consolidated information of the Company for the three and nine months ended September 30, 2016 and 2015 as if the OMG Malaysia, Alent and OMG Acquisitions had each occurred on January 1, 2015, and as if the Arysta Acquisition had occurred on January 1, 2014: Three Months Ended September 30, Nine Months Ended September 30, (amounts in millions) 2016 2015 2016 2015 Pro forma revenue $ 890.5 $ 865.5 $ 2,638.8 $ 2,713.9 Pro forma net income (loss) attributable to stockholders 105.5 (151.8 ) (21.8 ) (198.5 )

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Sep. 30, 2016
Inventory Disclosure [Abstract]
Major components of inventory	The major components of inventory were as follows: (amounts in millions) September 30, December 31, 2015 Finished goods $ 355.9 $ 340.1 Work in process 44.2 28.5 Raw materials and supplies 164.2 148.9 Total inventory, net $ 564.3 $ 517.5

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	9 Months Ended
	Sep. 30, 2016
Property, Plant and Equipment [Abstract]
Major components of property, plant, and equipment	The major components of property, plant and equipment, including equipment under capital leases, were as follows: (amounts in millions) September 30, December 31, 2015 Land and leasehold improvements $ 109.2 $ 107.9 Buildings and improvements 138.1 143.8 Machinery, equipment, fixtures and software 302.4 276.8 Construction in process 27.4 21.4 Assets under capital lease: Land and buildings 8.2 6.4 Machinery and equipment 5.3 5.1 Total property, plant and equipment 590.6 561.4 Accumulated depreciation (111.1 ) (64.3 ) Accumulated amortization of capital leases (6.8 ) (5.5 ) Property, plant and equipment, net $ 472.7 $ 491.6

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Changes in the carrying amount of goodwill by segment	The changes in the carrying amount of goodwill by segment were as follows: (amounts in millions) Performance Solutions Agricultural Solutions Total December 31, 2015 $ 2,147.2 $ 1,874.7 $ 4,021.9 Addition from acquisitions 66.9 — 66.9 Purchase accounting adjustments 46.3 — 46.3 Foreign currency translation and other 4.6 226.6 231.2 September 30, 2016 $ 2,265.0 $ 2,101.3 $ 4,366.3
Schedule of finite-lived intangible assets subject to amortization	Intangible assets subject to amortization were as follows: September 30, 2016 December 31, 2015 (amounts in millions) Weighted Average Useful Life (years) Gross Carrying Amount and Foreign Exchange Accumulated Amortization and Foreign Exchange Net Book Value Gross Carrying Amount and Foreign Exchange Accumulated Amortization and Foreign Exchange Net Book Value Customer lists 18.3 $ 1,240.5 $ (117.9 ) $ 1,122.6 $ 1,297.2 $ (184.0 ) $ 1,113.2 Developed technology 11.7 2,009.4 (146.7 ) 1,862.7 2,260.9 (440.4 ) 1,820.5 Tradenames 8.0 22.2 (5.9 ) 16.3 24.2 (5.4 ) 18.8 Non-compete agreements 5.0 1.9 (0.9 ) 1.0 1.9 (0.5 ) 1.4 Total 14.1 $ 3,274.0 $ (271.4 ) $ 3,002.6 $ 3,584.2 $ (630.3 ) $ 2,953.9

Long-term Compensation Plans (T

Long-term Compensation Plans (Tables)	9 Months Ended
	Sep. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Restricted stock unit award activity in payment awards	Nine Months Ended September 30, 2016 Total RSUs Stock Options Equity Classified Liability Classified Outstanding at December 31, 2015 1,006,436 501,634 329,802 175,000 Granted 2,110,173 1,719,975 — 390,198 Exercised/Issued (7,642 ) (7,642 ) — — Forfeited (109,803 ) (100,313 ) (9,490 ) — Outstanding at September 30, 2016 2,999,164 2,113,654 320,312 565,198
Issuance of restricted stock units	During the nine months ended September 30, 2016 , the Company issued the following RSU grants following their approval by the Board: RSUs Weighted average grant date fair value Weighted average vesting period (months) RSUs issued 1,719,975 $ 10.86 34.1
Schedule of RSUs outstanding	As of September 30, 2016 , the following equity classified RSUs were outstanding: September 30, 2016 Vesting Conditions: Outstanding Weighted average service period (years) Potential additional awards Service-based 772,835 2.8 — Performance-based 713,830 3.3 433,780 Market-based 626,989 3.5 1,202,067 Total 2,113,654 3.2 1,635,847
Non-qualified stock options granted under the 2013 Plan	During the nine months ended September 30, 2016 , the Company granted non-qualified stock options under the 2013 Plan as follows: Stock Options Weighted average strike price per share Weighted average grant date fair value per share Stock options granted 390,198 $ 8.05 $ 4.35
Valuation assumptions for option grants	The following table provides the range of assumptions used in valuing the option grants using the Black-Scholes option pricing method: Black-Scholes Input Assumptions Weighted average expected term (years) 6.0 Expected volatility 53.0% Risk-free rate 1.52% to 1.56% Expected dividend rate —% Fair value price per share $4.32 to $4.81

Pension and Post-Retirement P34

Pension and Post-Retirement Plans (Tables)	9 Months Ended
	Sep. 30, 2016
Compensation and Retirement Disclosure [Abstract]
Components of net periodic pension and post-retirement benefit costs	The components of net periodic pension and post-retirement benefit costs for the three and nine months ended September 30, 2016 and 2015 were as follows: Three Months Ended September 30, Nine Months Ended September 30, (amounts in millions) 2016 2015 2016 2015 Pension & SERP Benefits Domestic Foreign Domestic Foreign Domestic Foreign Domestic Foreign Net periodic (benefit) cost Service cost $ — $ 0.4 $ — $ 0.2 $ — $ 1.3 $ — $ 0.6 Interest cost on the projected benefit obligation 2.5 0.8 1.6 0.5 7.6 2.3 4.8 1.5 Expected return on plan assets (2.9 ) (0.6 ) (2.4 ) (0.5 ) (8.7 ) (1.9 ) (7.2 ) (1.5 ) Amortization of prior service cost — 0.1 — — — 0.4 — — Net periodic (benefit) cost $ (0.4 ) $ 0.7 $ (0.8 ) $ 0.2 $ (1.1 ) $ 2.1 $ (2.4 ) $ 0.6 Three Months Ended September 30, Nine Months Ended September 30, (amounts in millions) 2016 2015 2016 2015 Post-retirement Benefits Domestic Foreign Domestic Foreign Domestic Foreign Domestic Foreign Net periodic cost Interest cost on the projected benefit obligation $ 0.1 $ 0.1 $ 0.1 $ — $ 0.3 $ 0.2 $ 0.3 $ — Net periodic cost $ 0.1 $ 0.1 $ 0.1 $ — $ 0.3 $ 0.2 $ 0.3 $ —

Debt, Capital Leases, Financi35

Debt, Capital Leases, Financial Guarantees and Factoring Arrangements (Tables)	9 Months Ended
	Sep. 30, 2016
Debt Disclosure [Abstract]
Debt and capital lease obligations	Excluding the "Preferred stock redemption liability," the Company’s debt and capital lease obligations consisted of the following: (amounts in millions) September 30, December 31, 2015 Debt and Capital Lease Obligations USD Senior Notes due 2022, $ 1,082.5 $ 1,081.1 EUR Senior Notes due 2023, 387.6 374.0 USD Senior Notes due 2021, 488.5 487.5 First Lien Credit Facility - U.S. Dollar Term Loans due 2020, 2,620.0 2,631.3 First Lien Credit Facility - Euro Term Loans due 2020, 638.0 619.2 Borrowings under the Revolving Credit Facility, — — Borrowings under lines of credit, 42.8 16.7 Other 18.9 18.5 Total debt and capital lease obligations 5,278.3 5,228.3 Less: current portion debt and capital lease obligations (81.4 ) (54.7 ) Total long-term debt and capital lease obligations $ 5,196.9 $ 5,173.6
Minimum principal payments on long-term debt and capital leases	Minimum principal payments on long-term debt and capital leases were as follows: (amounts in millions) Principal Payments Year ending December 31, 2016 - remaining $ 8.9 2017 34.9 2018 34.8 2019 34.6 2020 3,218.8 2021 500.7 Thereafter 1,494.4 Total $ 5,327.1

Derivative Instruments (Tables)

Derivative Instruments (Tables)	9 Months Ended
	Sep. 30, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Summary of significant outstanding foreign exchange derivative contracts	The following table details the Company's significant outstanding foreign exchange derivative contracts as of September 30, 2016 : (in millions) Traded against USD Traded against EUR (USD equivalent) Currency Purchasing Selling Purchasing Selling Euro (EUR) $ 41.4 $ 36.9 $ — $ — Brazilian Real (BRL) 13.8 66.1 — — Japanese Yen (JPY) 12.3 18.7 9.5 1.6 South African Rand (ZAR) — 22.3 — 1.4 Taiwan Dollar (TWD) 10.6 — — — Other 15.4 2.9 9.1 0.3 Total $ 93.5 $ 146.9 $ 18.6 $ 3.3
Summary of the fair value of derivative instruments	The following table summarizes the fair value of derivative instruments reported in the Condensed Consolidated Balance Sheets: (amounts in millions) September 30, December 31, 2015 Derivatives designated as hedging instruments Liabilities Balance Sheet location Interest rate swaps Accrued expenses and other current liabilities $ (10.5 ) $ — Interest rate swaps Other long-term liabilities (17.5 ) (12.5 ) Derivatives not designated as hedging instruments: Assets Balance Sheet location Foreign exchange and metals contracts Prepaid expenses and other current assets 2.6 1.1 Foreign exchange contracts Other assets — 1.0 Liabilities Balance Sheet location Foreign exchange and metals contracts Accrued expenses and other current liabilities (5.5 ) (1.0 ) Net derivative contract liability $ (30.9 ) $ (11.4 )
Offsetting assets	The following table presents recognized foreign currency exchange forward and metal future derivative contracts that are subject to master netting arrangements but not offset, as of September 30, 2016 and December 31, 2015 , and shows in the "Net" column what the net impact would be on the Company's Condensed Consolidated Balance Sheets if all set-off rights were exercised: September 30, 2016 (amounts in millions) Amounts offset Amounts not offset Net Financial assets Gross assets Gross liabilities offset Net amounts presented Financial instruments Cash collateral paid Derivative assets $ 2.1 $ — $ 2.1 $ (0.4 ) $ — $ 1.7 September 30, 2016 Amounts offset Amounts not offset Net Financial liabilities Gross liabilities Gross assets offset Net amounts presented Financial instruments Cash collateral paid Derivative liabilities $ 4.8 $ — $ 4.8 $ (1.0 ) $ (1.0 ) $ 2.8 December 31, 2015 (amounts in millions) Amounts offset Amounts not offset Net Financial assets Gross assets Gross liabilities offset Net amounts presented Financial instruments Cash collateral paid Derivative assets $ 3.1 $ — $ 3.1 $ (0.3 ) $ — $ 2.8 December 31, 2015 Amounts offset Amounts not offset Net Financial liabilities Gross liabilities Gross assets offset Net amounts presented Financial instruments Cash collateral paid Derivative liabilities $ 1.7 $ — $ 1.7 $ (1.2 ) $ (0.9 ) $ (0.4 )
Offsetting liabilities	The following table presents recognized foreign currency exchange forward and metal future derivative contracts that are subject to master netting arrangements but not offset, as of September 30, 2016 and December 31, 2015 , and shows in the "Net" column what the net impact would be on the Company's Condensed Consolidated Balance Sheets if all set-off rights were exercised: September 30, 2016 (amounts in millions) Amounts offset Amounts not offset Net Financial assets Gross assets Gross liabilities offset Net amounts presented Financial instruments Cash collateral paid Derivative assets $ 2.1 $ — $ 2.1 $ (0.4 ) $ — $ 1.7 September 30, 2016 Amounts offset Amounts not offset Net Financial liabilities Gross liabilities Gross assets offset Net amounts presented Financial instruments Cash collateral paid Derivative liabilities $ 4.8 $ — $ 4.8 $ (1.0 ) $ (1.0 ) $ 2.8 December 31, 2015 (amounts in millions) Amounts offset Amounts not offset Net Financial assets Gross assets Gross liabilities offset Net amounts presented Financial instruments Cash collateral paid Derivative assets $ 3.1 $ — $ 3.1 $ (0.3 ) $ — $ 2.8 December 31, 2015 Amounts offset Amounts not offset Net Financial liabilities Gross liabilities Gross assets offset Net amounts presented Financial instruments Cash collateral paid Derivative liabilities $ 1.7 $ — $ 1.7 $ (1.2 ) $ (0.9 ) $ (0.4 )

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2016
Fair Value Disclosures [Abstract]
Summary of financial instruments, assets, and liabilities measured on a recurring basis	The following tables present the Company’s financial instruments, assets and liabilities that are measured at fair value on a recurring basis: Fair Value Measurement Using (amounts in millions) September 30, Quoted prices in active markets (Level 1) Significant other observable inputs (Level 2) Significant unobservable inputs (Level 3) Asset Category Cash equivalents $ 23.2 $ — $ 23.2 $ — Available for sale equity securities 2.5 1.9 0.6 — Derivatives 2.6 — 2.6 — Total $ 28.3 $ 1.9 $ 26.4 $ — Liability Category Derivatives $ 33.5 $ — $ 33.5 $ — Long-term contingent consideration 75.0 — — 75.0 Preferred stock redemption liability 504.0 — — 504.0 Total $ 612.5 $ — $ 33.5 $ 579.0 Fair Value Measurement Using (amounts in millions) December 31, 2015 Quoted prices in active markets (Level 1) Significant other observable inputs (Level 2) Significant unobservable inputs (Level 3) Asset Category Cash equivalents $ 59.4 $ 2.9 $ 56.5 $ — Available for sale equity securities 6.6 5.8 0.8 — Derivatives 2.1 — 2.1 — Total $ 68.1 $ 8.7 $ 59.4 $ — Liability Category Derivatives $ 13.5 $ — $ 13.5 $ — Long-term contingent consideration 70.7 — — 70.7 Total $ 84.2 $ — $ 13.5 $ 70.7
Reconciliation of financial instruments measured on a recurring basis using significant unobservable inputs (Level 3)	The following table provides a reconciliation of the beginning and ending balances for the nine months ended September 30, 2016 for instruments measured at fair value on a recurring basis using significant unobservable inputs (Level 3): (amounts in millions) September 30, 2016 Fair value measurements using significant unobservable inputs (Level 3) Balance at December 31, 2015 $ 70.7 Changes in fair value (1.7 ) Purchases, sales and settlements (1) — Additions 510.0 Transfers into Level 3 — Transfers out of Level 3 — Balance at September 30, 2016 $ 579.0 (1) There were no purchases, sales or settlements during the nine months ended September 30, 2016 .
Summary of nonrecurring fair value measurements	The following table presents the carrying value and estimated fair value of the Company’s long-term debt and capital lease obligations: (amounts in millions) September 30, 2016 December 31, 2015 Carrying Value Fair Value Carrying Value Fair Value USD Senior Notes due 2022 $ 1,082.5 $ 1,071.6 $ 1,081.1 $ 946.3 EUR Senior Notes due 2023 387.6 371.6 374.0 326.7 USD Senior Notes due 2021 488.5 539.9 487.5 500.0 First Lien Credit Facility - U.S. Dollar Term Loans 2,620.0 2,685.7 2,631.3 2,603.6 First Lien Credit Facility - Euro Term Loans 638.0 657.8 619.2 624.3 Capital lease obligations 5.1 5.2 5.5 5.3 Total $ 5,221.7 $ 5,331.8 $ 5,198.6 $ 5,006.2

Accumulated Other Comprehensi38

Accumulated Other Comprehensive (Loss) Income (Tables)	9 Months Ended
	Sep. 30, 2016
Equity [Abstract]
Summary of accumulated other comprehensive (loss) income, net of tax	Changes in each component of accumulated other comprehensive (loss) income, net of tax, for the three and nine months ended September 30, 2016 and 2015 were as follows: Three Months Ended September 30, 2016 (amounts in millions) Foreign Currency Translation Adjustments Pension and Post-retirement Plans Unrealized Loss on Available for Sale Securities Derivative Financial Instrument Revaluation Non-Controlling Interests Accumulated Other Comprehensive (Loss) Income Balance at June 30, 2016 $ (446.8 ) $ (26.3 ) $ (0.4 ) $ (24.9 ) $ 24.7 $ (473.7 ) Other comprehensive (loss) income before reclassifications, net (0.7 ) — (0.1 ) (1.6 ) 9.0 6.6 Reclassifications, pretax — — — 3.0 — 3.0 Balance at September 30, 2016 $ (447.5 ) $ (26.3 ) $ (0.5 ) $ (23.5 ) $ 33.7 $ (464.1 ) Nine Months Ended September 30, 2016 (amounts in millions) Foreign Currency Translation Adjustments Pension and Post-retirement Plans Unrealized Gain on Available for Sale Securities Derivative Financial Instrument Revaluation Non-Controlling Interests Accumulated Other Comprehensive (loss) Income Balance at December 31, 2015 $ (899.3 ) $ (26.3 ) $ 1.2 $ (8.1 ) $ 46.4 $ (886.1 ) Other comprehensive income (loss) before reclassifications, net 451.8 — (1.7 ) (24.3 ) (12.7 ) 413.1 Reclassifications, pretax — — — 8.9 — 8.9 Balance at September 30, 2016 $ (447.5 ) $ (26.3 ) $ (0.5 ) $ (23.5 ) $ 33.7 $ (464.1 ) Three Months Ended September 30, 2015 (amounts in millions) Foreign Currency Translation Adjustments Pension and Post-retirement Plans Unrealized Gain on Available for Sale Securities Derivative Financial Instrument Revaluation Non-Controlling Interests Accumulated Other Comprehensive Loss Balance at June 30, 2015 $ (386.0 ) $ (15.4 ) $ 0.3 $ — $ 13.5 $ (387.6 ) Other comprehensive (loss) income before reclassifications, net (350.2 ) — 1.0 (11.8 ) 7.2 (353.8 ) Balance at September 30, 2015 $ (736.2 ) $ (15.4 ) $ 1.3 $ (11.8 ) $ 20.7 $ (741.4 ) Nine Months Ended September 30, 2015 (amounts in millions) Foreign Currency Translation Adjustments Pension and Post-retirement Plans Unrealized Gain on Available for Sale Securities Derivative Financial Instrument Revaluation Non-Controlling Interests Accumulated Other Comprehensive Loss Balance at December 31, 2014 $ (122.2 ) $ (14.9 ) $ 0.1 $ — $ 6.4 $ (130.6 ) Other comprehensive (loss) income before reclassifications, net (614.0 ) — 1.2 (11.8 ) 14.3 (610.3 ) Tax expense reclassified — (0.5 ) — — — (0.5 ) Balance at September 30, 2015 $ (736.2 ) $ (15.4 ) $ 1.3 $ (11.8 ) $ 20.7 $ (741.4 )

Earnings (Loss) Per Share (Tabl

Earnings (Loss) Per Share (Tables)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Earnings Per Share [Abstract]
Earnings per share		A computation of earnings (loss) per share and weighted average shares of common stock outstanding for the three and nine months ended September 30, 2016 and 2015 follows: Three Months Ended September 30, Nine Months Ended September 30, (amounts in millions, except per share amounts) 2016 2015 2016 2015 (as restated) (as restated) Net income (loss) attributable to common stockholders for basic EPS $ 104.7 $ (140.1 ) $ (39.0 ) $ (178.9 ) Adjustments to the numerator for diluted earnings per share: Gain on settlement agreement related to Series B Convertible Preferred Stock (103.0 ) — (103.0 ) — Gain on amendment of Series B Convertible Preferred Stock (32.9 ) — (32.9 ) — Remeasurement adjustment associated with the Preferred Series B redemption liability (6.0 ) — (6.0 ) — Income allocated to PDH non-controlling interest (1.5 ) — — — Net loss attributable to common stockholders for diluted EPS $ (38.7 ) $ (140.1 ) $ (180.9 ) $ (178.9 ) Basic weighted average common stock outstanding 234.4 210.9 231.2 198.6 Assumed conversion related to the amendment of Series B preferred shares 17.1 — 20.4 — Assumed settlement of preferred stock redemption liability 5.0 — 1.7 — Issuable upon conversion of the PDH non-controlling interest 8.0 — — — Share adjustments (1) 30.1 — 22.1 — Dilutive weighted average common stock outstanding 264.5 210.9 253.3 198.6 Income (loss) per share attributable to common stockholders: Basic $ 0.45 $ (0.66 ) $ (0.17 ) $ (0.89 ) Diluted $ (0.15 ) $ (0.66 ) $ (0.71 ) $ (0.89 ) Dividends per share paid to common stockholders $ — $ — $ — $ — (1) For the three and nine months ended September 30, 2015, no share adjustments are included in the dilutive weighted average shares outstanding computation as their effect would have been anti-dilutive. For more information about such dilutive shares outstanding, refer to the table below.
Summary of securities excluded from computation of earnings per share	For the three and nine months ended September 30, 2016 and 2015 , the following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive or because performance targets were not yet achieved for awards contingent upon performance. These securities may become dilutive in future periods. Three Months Ended September 30, Nine Months Ended September 30, (amounts in thousands) 2016 2015 2016 2015 Shares contingently issuable to Founder Entities as stock dividend on Series A Preferred Stock — — — 1,652 Shares issuable upon conversion of PDH Common Stock — 8,207 8,023 8,207 Shares issuable upon conversion of Series A Preferred Stock 2,000 2,000 2,000 2,000 Shares issuable upon conversion of Series B Convertible Preferred Stock — 22,108 — 18,544 Shares contingently issuable for the contingent consideration 9,262 2,496 8,820 1,719 Stock options — 55 — 70 RSUs 186 60 110 94 Shares issuable under the ESPP 1 2 3 1 11,449 34,928 18,956 32,287

Operating Lease Commitments (Ta

Operating Lease Commitments (Tables)	9 Months Ended
	Sep. 30, 2016
Leases [Abstract]
Rent expense for operating leases	Total rent expense for operating leases was as follows: Three Months Ended September 30, Nine Months Ended September 30, (amounts in millions) 2016 2015 2016 2015 Rent expense $ 8.9 $ 6.0 $ 28.0 $ 16.4
Summary of minimum non-cancelable operating lease commitments	Minimum non-cancelable operating lease commitments were as follows: (amounts in millions) Operating Lease Payment As of September 30, 2016 2016, remaining $ 10.2 2017 26.0 2018 17.7 2019 12.0 2020 9.8 2021 8.7 Thereafter 26.8 Total minimum non-cancelable operating lease commitments $ 111.2

Contingencies, Environmental 41

Contingencies, Environmental and Legal Matters (Tables)	9 Months Ended
	Sep. 30, 2016
Commitments and Contingencies Disclosure [Abstract]
Summary of changes in AROs	Changes in the Company’s AROs were as follows: Three Months Ended September 30, Nine Months Ended September 30, (amounts in millions) 2016 2015 2016 2015 AROs, beginning of period $ 20.9 $ 17.7 $ 17.5 $ 18.5 Acquisitions — — 2.8 0.4 Accretion expense 0.3 0.2 0.9 0.7 Remeasurements — 0.5 0.1 (0.2 ) Payments — (0.4 ) (0.5 ) (0.4 ) Foreign currency adjustments — (0.2 ) 0.4 (1.2 ) AROs, end of period $ 21.2 $ 17.8 $ 21.2 $ 17.8

Restructuring (Tables)

Restructuring (Tables)	9 Months Ended
	Sep. 30, 2016
Restructuring and Related Activities [Abstract]
Restructuring expenses	Restructuring expenses were recorded as follows in each of the Company's segments: Three Months Ended September 30, Nine Months Ended September 30, (amounts in millions) 2016 2015 2016 2015 Performance Solutions $ 6.4 $ 2.9 $ 16.8 $ 5.8 Agricultural Solutions 0.9 1.6 2.7 12.4 Total restructuring $ 7.3 $ 4.5 $ 19.5 $ 18.2 Restructuring expenses were recorded as follows in the Condensed Consolidated Statements of Operations: Three Months Ended September 30, Nine Months Ended September 30, (amounts in millions) 2016 2015 2016 2015 Cost of sales $ — $ 2.4 $ (0.4 ) $ 3.6 Selling, technical, general and administrative 7.3 2.1 19.9 14.6 Total restructuring $ 7.3 $ 4.5 $ 19.5 $ 18.2

Segment Information (Tables)

Segment Information (Tables)	9 Months Ended
	Sep. 30, 2016
Segment Reporting [Abstract]
Summary of segment's results of operations	The following table summarizes financial information regarding each reportable segment’s results of operations for the periods presented. Three Months Ended September 30, Nine Months Ended September 30, (amounts in millions) 2016 2015 2016 2015 Net Sales (from external customers): Performance Solutions $ 454.9 $ 179.7 $ 1,312.9 $ 541.6 Agricultural Solutions 435.6 417.6 1,323.0 1,265.7 Consolidated net sales $ 890.5 $ 597.3 $ 2,635.9 $ 1,807.3 Adjusted EBITDA: Performance Solutions $ 109.9 $ 54.1 $ 290.7 $ 156.9 Agricultural Solutions 80.2 59.5 260.7 256.5 Adjusted EBITDA $ 190.1 $ 113.6 $ 551.4 $ 413.4 The following table reconciles Net income (loss) attributable to common stockholders to Adjusted EBITDA: Three months ended September 30, Nine months ended September 30, (amounts in millions) 2016 2015 2016 2015 Net income (loss) attributable to common stockholders $ 104.7 $ (140.1 ) $ (39.0 ) $ (178.9 ) Gain on amendment of Series B Convertible Preferred Stock (32.9 ) — (32.9 ) — Net (loss) income attributable to the non-controlling interests (5.9 ) 0.5 (4.7 ) 4.0 Income tax expense 20.4 35.4 65.7 59.8 Income (loss) before income taxes and non-controlling interests 86.3 (104.2 ) (10.9 ) (115.1 ) Adjustments to reconcile to Adjusted EBITDA: Interest expense, net 98.5 52.7 289.7 143.2 Depreciation expense 18.9 11.6 55.8 33.7 Amortization expense 68.0 50.4 199.1 142.6 Long-term compensation issued in connection with acquisitions 0.2 (1.5 ) 0.6 0.2 Restructuring expenses 7.3 4.5 19.5 18.2 Manufacturer's profit in inventory purchase accounting adjustments — 1.3 11.7 58.0 Acquisition and integration costs 3.2 15.0 27.4 70.4 Non-cash change in fair value of contingent consideration 0.2 2.7 4.3 6.3 Legal settlements — — (2.8 ) (16.0 ) Foreign exchange loss on foreign denominated external and internal debt 12.0 33.0 58.7 26.8 Fair value loss on foreign exchange forward contract — 48.1 — 48.1 Gain on settlement agreement related to Series B Convertible Preferred Stock (103.0 ) — (103.0 ) — Non-cash change in fair value of preferred stock redemption liability (6.0 ) — (6.0 ) — Other income (expense), net 4.5 — 7.3 (3.0 ) Adjusted EBITDA $ 190.1 $ 113.6 $ 551.4 $ 413.4

Basis of Presentation and Sig44

Basis of Presentation and Significant Accounting Policies (Details) $ / shares in Units, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016USD ($)$ / shares	Sep. 30, 2015USD ($)$ / shares	Sep. 30, 2016USD ($)segment$ / shares	Sep. 30, 2015USD ($)$ / shares	Dec. 31, 2015USD ($)	Jan. 23, 2014$ / shares
Business Acquisition [Line Items]
Number of operating segments | segment			2
Common stock par value (in dollars per share) | $ / shares						$ 0.01
Income tax expense	$ 20.4	$ 35.4	$ 65.7	$ 59.8
Loss per share (in dollars per share) | $ / shares	$ (0.45)	$ 0.66	$ 0.17	$ 0.89
Overstatement of prepaid expenses and other current assets	$ 180.3		$ 180.3		$ 172.5
Understatement of other assets	93.9		93.9		91.9
Understatement of accrued income taxes payable	$ 100.6		100.6		$ 65.1
Error Related to Recording an Unrealized Loss with a Foreign Currency Hedge | Adjustment
Business Acquisition [Line Items]
Income tax expense		$ 17.8		$ 17.8
Loss per share (in dollars per share) | $ / shares		$ 0.08		$ 0.08
Overstatement of prepaid expenses and other current assets		$ (19.6)		$ (19.6)
Understatement of other assets		2.8		2.8
Understatement of accrued income taxes payable		$ 1		$ 1
Incorrect Allocation of Expenses to Non-controlling Interest
Business Acquisition [Line Items]
Correction of prior year error in current period			$ 6.1

Acquisitions of Businesses - Na

Acquisitions of Businesses - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	Jan. 31, 2016	Dec. 01, 2015	Oct. 28, 2015	Feb. 13, 2015	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Business Acquisition [Line Items]
Decrease in goodwill							$ (46.3)
Goodwill acquired							66.9
Acquisition costs					$ 3.2	$ 15	27.4	$ 70.4
OMG Malaysia
Business Acquisition [Line Items]
Total consideration	$ 123.7
Preferred stock redemption liability	0
Decrease in deferred tax liabilities noncurrent							5.1
Decrease in inventories							0.8
Decrease in identifiable intangible assets							20.7
Acquisition costs	$ 0.5
Alent
Business Acquisition [Line Items]
Total consideration		$ 1,738.4
Business acquisition, shares of common stock issued (in shares)		18,419,738
Business acquisition, price per share of common stock acquired (in dollars per share)		$ 12.56
Preferred stock redemption liability		$ 231.4
Increase in environmental reserves							25.6
Increase in non-current other liabilities							2.8
Increase in non-current deferred tax asset							0.7
Acquisition costs		$ 29.2
OMG
Business Acquisition [Line Items]
Total consideration			$ 239.1
Preferred stock redemption liability			0
Increase in environmental reserves							1.5
Decrease in deferred tax liabilities noncurrent							2.6
Decrease in goodwill							1.1
Acquisition costs			$ 7.4
Arysta
Business Acquisition [Line Items]
Total consideration				$ 3,500
Business acquisition, shares of common stock issued (in shares)				600,000
Cash, net				$ 2,860
Preferred stock redemption liability				600
Fair value of equity instruments				$ 646
Acquisition costs						$ 4.4		$ 32.2
OMG Malaysia, Alent and OMG
Business Acquisition [Line Items]
Goodwill acquired							1,370
OMG Malaysia and OMG
Business Acquisition [Line Items]
Goodwill, expected to be tax deductible					113		113
OMG Malaysia, Alent, OMG and Arysta
Business Acquisition [Line Items]
Acquisition costs					$ 1.3		$ 14.3

Acquisitions of Businesses - Re

Acquisitions of Businesses - Revenues and Losses Contributed by Acquisitions (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Business Acquisition [Line Items]
Revenues	$ 643.9	$ 318.2	$ 1,808.7	$ 837.6
Net loss attributable to stockholders	20.2	(34.8)	(128.5)	(100.6)
OMG Malaysia
Business Acquisition [Line Items]
Revenues	8.5	0	21.4	0
Net loss attributable to stockholders	1.2	0	2.3	0
Alent
Business Acquisition [Line Items]
Revenues	243.9	0	693	0
Net loss attributable to stockholders	23.7	0	38.8	0
OMG
Business Acquisition [Line Items]
Revenues	27.8	0	80.9	0
Net loss attributable to stockholders	4.2	0	4.5	0
Arysta
Business Acquisition [Line Items]
Revenues	363.7	318.2	1,013.4	837.6
Net loss attributable to stockholders	$ (8.9)	$ (34.8)	$ (174.1)	$ (100.6)

Acquisitions of Businesses - Pu

Acquisitions of Businesses - Purchase Price Allocation (Details) - USD ($) $ in Millions	Jan. 31, 2016	Dec. 01, 2015	Oct. 28, 2015	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Consideration
Note receivable settlement						$ 125	$ 0
Acquisition costs				$ 3.2	$ 15	27.4	$ 70.4
Identifiable assets acquired and liabilities assumed
Goodwill				$ 4,366.3		$ 4,366.3		$ 4,021.9
OMG Malaysia
Consideration
Cash, net	$ (1.3)
Equity instruments	0
Note receivable settlement	125
Total consideration	123.7
Acquisition costs	0.5
Identifiable assets acquired and liabilities assumed
Accounts receivable	4.3
- less uncollectible	0
Accounts receivable - fair value	4.3
Inventories	6.4
Other current assets	0.2
Property, plant and equipment	4.7
Identifiable intangible assets	38.3
Other assets	0
Current liabilities	(3.5)
Non-current deferred tax liability	(10)
Other long term liabilities	0
Total identifiable net assets	40.4
Goodwill	83.3
Total purchase price	$ 123.7
Alent
Consideration
Cash, net		$ 1,507
Equity instruments		231.4
Note receivable settlement		0
Total consideration		1,738.4
Acquisition costs		29.2
Identifiable assets acquired and liabilities assumed
Accounts receivable		177.4
- less uncollectible		(1.8)
Accounts receivable - fair value		175.6
Inventories		116.1
Other current assets		29.3
Property, plant and equipment		192.2
Identifiable intangible assets		682.9
Other assets		38.3
Current liabilities		(181.8)
Non-current deferred tax liability		(139.6)
Other long term liabilities		(345.2)
Total identifiable net assets		567.8
Goodwill		1,170.6
Total purchase price		$ 1,738.4
OMG
Consideration
Cash, net			$ 239.1
Equity instruments			0
Note receivable settlement			0
Total consideration			239.1
Acquisition costs			7.4
Identifiable assets acquired and liabilities assumed
Accounts receivable			33.1
- less uncollectible			(1.6)
Accounts receivable - fair value			31.5
Inventories			13.2
Other current assets			1.6
Property, plant and equipment			35.1
Identifiable intangible assets			77.9
Other assets			0.2
Current liabilities			(21.5)
Non-current deferred tax liability			(13.6)
Other long term liabilities			(2.9)
Total identifiable net assets			121.5
Goodwill			117.6
Total purchase price			$ 239.1

Acquisitions of Businesses - Id

Acquisitions of Businesses - Identifiable Intangible Assets Acquired (Details) - USD ($) $ in Millions	Jan. 31, 2016	Dec. 01, 2015	Oct. 28, 2015	Jun. 30, 2016	Sep. 30, 2016	Dec. 31, 2015
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Fair Value				$ 799.1
Weighted average useful life				14 years 3 months 18 days
Indefinite-lived tradenames					$ 391	$ 360
Customer lists
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Fair Value				$ 475.4
Weighted average useful life				16 years 6 months
Developed technology
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Fair Value				$ 234.6
Weighted average useful life				9 years 10 months 24 days
Tradenames
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Fair Value				$ 86.7
Weighted average useful life				18 years 3 months 18 days
In process - R&D
Acquired Finite-Lived Intangible Assets [Line Items]
Indefinite-lived intangible assets, Fair Value				$ 2.4
OMG Malaysia
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Fair Value	$ 38.3
Weighted average useful life	23 years 3 months 18 days
OMG Malaysia | Customer lists
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Fair Value	$ 35
Weighted average useful life	25 years
OMG Malaysia | Developed technology
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Fair Value	$ 3.3
Weighted average useful life	5 years
OMG Malaysia | Tradenames
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Fair Value	$ 0
Weighted average useful life	0 years
OMG Malaysia | In process - R&D
Acquired Finite-Lived Intangible Assets [Line Items]
Indefinite-lived intangible assets, Fair Value	$ 0
Alent
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Fair Value		$ 682.9
Weighted average useful life		13 years 2 months 12 days
Indefinite-lived tradenames		$ 81.4
Alent | Customer lists
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Fair Value		$ 391.4
Weighted average useful life		14 years 8 months 12 days
Alent | Developed technology
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Fair Value		$ 203.3
Weighted average useful life		10 years
Alent | Tradenames
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Fair Value		$ 85.8
Weighted average useful life		20 years
Alent | In process - R&D
Acquired Finite-Lived Intangible Assets [Line Items]
Indefinite-lived intangible assets, Fair Value		$ 2.4
OMG
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Fair Value			$ 77.9
Weighted average useful life			19 years
OMG | Customer lists
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Fair Value			$ 49
Weighted average useful life			24 years 3 months 18 days
OMG | Developed technology
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Fair Value			$ 28
Weighted average useful life			10 years
OMG | Tradenames
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, Fair Value			$ 0.9
Weighted average useful life			10 years
OMG | In process - R&D
Acquired Finite-Lived Intangible Assets [Line Items]
Indefinite-lived intangible assets, Fair Value			$ 0

Acquisitions of Businesses - Pr

Acquisitions of Businesses - Pro Forma Revenue and Earnings (Details) - OMG Malaysia, Alent, OMG and Arysta - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Business Acquisition [Line Items]
Pro forma revenue	$ 890.5	$ 865.5	$ 2,638.8	$ 2,713.9
Pro forma net income (loss) attributable to stockholders	$ 105.5	$ (151.8)	$ (21.8)	$ (198.5)

Inventories - Major Components

Inventories - Major Components of Inventory (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Inventory Disclosure [Abstract]
Finished goods	$ 355.9	$ 340.1
Work in process	44.2	28.5
Raw materials and supplies	164.2	148.9
Total inventory, net	$ 564.3	$ 517.5

Inventories - Narrative (Detail

Inventories - Narrative (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Cost of sales | Fair Value Adjustment to Inventory
Inventory [Line Items]
Fair value of assets	$ 0	$ 1,300,000	$ 11,700,000	$ 58,000,000

Property, Plant and Equipment -

Property, Plant and Equipment - Major Components of Property, Plant, and Equipment (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Property, Plant and Equipment [Line Items]
Total property, plant and equipment	$ 590.6	$ 561.4
Accumulated depreciation	(111.1)	(64.3)
Accumulated amortization of capital leases	(6.8)	(5.5)
Property, plant and equipment, net	472.7	491.6
Land and leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment excluding assets under capital lease	109.2	107.9
Buildings and improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment excluding assets under capital lease	138.1	143.8
Machinery, equipment, fixtures and software
Property, Plant and Equipment [Line Items]
Property, plant and equipment excluding assets under capital lease	302.4	276.8
Construction in process
Property, Plant and Equipment [Line Items]
Property, plant and equipment excluding assets under capital lease	27.4	21.4
Land and buildings
Property, Plant and Equipment [Line Items]
Assets under capital lease:	8.2	6.4
Machinery and equipment
Property, Plant and Equipment [Line Items]
Assets under capital lease:	$ 5.3	$ 5.1

Property, Plant and Equipment53

Property, Plant and Equipment - Narrative (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended		9 Months Ended
	Mar. 31, 2016	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Property, Plant and Equipment [Line Items]
Depreciation expense		$ 18.9	$ 11.6	$ 55.8	$ 33.7
Property, plant and equipment, net		$ 472.7		$ 472.7		$ 491.6
Sale Agreement for Long-lived Asset
Property, Plant and Equipment [Line Items]
Property, plant and equipment, net	$ 12.1
Long lived asset held for sale, fair value	9.3
Estimated selling expense	0.2
Selling, General and Administrative Expenses | Sale Agreement for Long-lived Asset
Property, Plant and Equipment [Line Items]
Reduction in net book value of the asset	$ 2.8

Goodwill and Intangible Asset54

Goodwill and Intangible Assets - Changes in Carrying Amount of Goodwill by Segment (Details) $ in Millions	9 Months Ended
	Sep. 30, 2016USD ($)
Goodwill [Roll Forward]
Beginning balance	$ 4,021.9
Addition from acquisitions	66.9
Purchase accounting adjustments	46.3
Foreign currency translation and other	231.2
Ending balance	4,366.3
Performance Solutions
Goodwill [Roll Forward]
Beginning balance	2,147.2
Addition from acquisitions	66.9
Purchase accounting adjustments	46.3
Foreign currency translation and other	4.6
Ending balance	2,265
Agricultural Solutions
Goodwill [Roll Forward]
Beginning balance	1,874.7
Addition from acquisitions	0
Purchase accounting adjustments	0
Foreign currency translation and other	226.6
Ending balance	$ 2,101.3

Goodwill and Intangible Asset55

Goodwill and Intangible Assets - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Carrying value of indefinite-lived intangible assets other than goodwill	$ 391		$ 391		$ 360
Amortization of expense of intangible assets	$ 68	$ 50.4	$ 199	$ 143

Goodwill and Intangible Asset56

Goodwill and Intangible Assets - Intangible Assets Subject to Amortization (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Finite-Lived Intangible Assets [Line Items]
Weighted Average Useful Life (years)	14 years 1 month 6 days
Gross Carrying Amount and Foreign Exchange	$ 3,274	$ 3,584.2
Accumulated Amortization and Foreign Exchange	(271.4)	(630.3)
Net Book Value	$ 3,002.6	2,953.9
Customer lists
Finite-Lived Intangible Assets [Line Items]
Weighted Average Useful Life (years)	18 years 3 months 18 days
Gross Carrying Amount and Foreign Exchange	$ 1,240.5	1,297.2
Accumulated Amortization and Foreign Exchange	(117.9)	(184)
Net Book Value	$ 1,122.6	1,113.2
Developed technology
Finite-Lived Intangible Assets [Line Items]
Weighted Average Useful Life (years)	11 years 8 months 18 days
Gross Carrying Amount and Foreign Exchange	$ 2,009.4	2,260.9
Accumulated Amortization and Foreign Exchange	(146.7)	(440.4)
Net Book Value	$ 1,862.7	1,820.5
Tradenames
Finite-Lived Intangible Assets [Line Items]
Weighted Average Useful Life (years)	8 years
Gross Carrying Amount and Foreign Exchange	$ 22.2	24.2
Accumulated Amortization and Foreign Exchange	(5.9)	(5.4)
Net Book Value	$ 16.3	18.8
Non-compete agreements
Finite-Lived Intangible Assets [Line Items]
Weighted Average Useful Life (years)	5 years
Gross Carrying Amount and Foreign Exchange	$ 1.9	1.9
Accumulated Amortization and Foreign Exchange	(0.9)	(0.5)
Net Book Value	$ 1	$ 1.4

Long-term Compensation Plans -

Long-term Compensation Plans - Narrative (Details) - shares	9 Months Ended
	Sep. 30, 2016	Dec. 31, 2015	Jun. 30, 2014
The 2013 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total number of shares of common stock that may be subject to grant awards (in shares)			15,500,000
Awards granted (in shares)	373,434
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted (in shares)	1,719,975
Awards outstanding (in shares)	2,113,654	501,634
RSUs | The 2013 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards outstanding (in shares)	2,824,164

Long-term Compensation Plans 58

Long-term Compensation Plans - Activity in Payment Awards (Details)	9 Months Ended
	Sep. 30, 2016shares
Total
Beginning balance (in shares)	1,006,436
Granted (in shares)	2,110,173
Exercised (in shares)	(7,642)
Forfeited (in shares)	(109,803)
Ending balance (in shares)	2,999,164
Stock Options
Beginning balance (in shares)	175,000
Granted (in shares)	390,198
Exercised (in shares)	0
Forfeited (in shares)	0
Ending balance (in shares)	565,198
RSUs
Equity Classified
Beginning balance (in shares)	501,634
Granted (in shares)	1,719,975
Exercised (in shares)	(7,642)
Forfeited (in shares)	(100,313)
Ending balance (in shares)	2,113,654
Liability Classified
Outstanding, beginning balance (in shares)	329,802
Forfeited (in shares)	(9,490)
Outstanding, ending balance (in shares)	320,312

Long-term Compensation Plans 59

Long-term Compensation Plans - Equity Classified Share Based Payments (Details) - RSUs	9 Months Ended
	Sep. 30, 2016$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted (in shares) | shares	1,719,975
Weighted average grant date fair value (in dollars per share) | $ / shares	$ 10.86
Weighted average vesting period	34 years 1 month 6 days

Long-term Compensation Plans 60

Long-term Compensation Plans - Schedule Equity Classified Share Based Payment RSUs (Details) - shares	9 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding (in shares)	2,113,654	501,634
Weighted average service period (years)	3 years 2 months 12 days
Potential additional awards	1,635,847
Service-based
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding (in shares)	772,835
Weighted average service period (years)	2 years 9 months 18 days
Potential additional awards	0
Performance-based
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding (in shares)	713,830
Weighted average service period (years)	3 years 3 months 19 days
Potential additional awards	433,780
Market-based
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding (in shares)	626,989
Weighted average service period (years)	3 years 6 months
Potential additional awards	1,202,067

Long-term Compensation Plans 61

Long-term Compensation Plans - Equity Classified Share Based Payments Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Jun. 30, 2014
The 2013 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total number of shares of common stock that may be subject to grant awards (in shares)					15,500,000
Performance Restricted Stock Units (RSUs) | The 2013 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total number of shares of common stock that may be subject to grant awards (in shares)	166,667		166,667
Performance Restricted Stock Units (RSUs) | The 2013 Plan | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share multiplier (as a percent)			0.00%
Performance Restricted Stock Units (RSUs) | The 2013 Plan | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share multiplier (as a percent)			100.00%
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity compensation expense (income)	$ 2	$ 0.2	$ 4.6	$ 0.6

Long-term Compensation Plans 62

Long-term Compensation Plans - Liability Classified Share Based Payments (Details) - The 2013 Plan - USD ($) $ in Millions	1 Months Ended	3 Months Ended		9 Months Ended
	Mar. 31, 2014	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted (in shares)				373,434
Restricted Stock Units Granted 6 March 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted (in shares)	329,823
RSUs, liability classified, outstanding (in shares)		320,312		320,312
Combined undiscounted maximum cash value of all RSUs		$ 6.9		$ 6.9
Equity compensation expense (income)		$ 0	$ (0.6)	$ 0	$ 0.8

Long-term Compensation Plans 63

Long-term Compensation Plans - Stock Options (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options (in shares)		390,198
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity compensation expense (income)	$ 0.1	$ 0.3
The 2013 Plan | Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options (in shares)		390,198
Weighted average strike price (in dollars per share)		$ 8.05
Weighted average grant date fair value (in dollars per share)		$ 4.35
Vesting period		3 years
Award expiration period		10 years

Long-term Compensation Plans 64

Long-term Compensation Plans - Stock Options Valuation Assumptions (Details)	9 Months Ended
	Sep. 30, 2016$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value price (in dollars per share)	$ 8.11
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average expected term	6 years
Expected volatility	53.00%
Expected dividend rate	0.00%
Employee Stock Option | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free rate (as a percent)	1.52%
Fair value price (in dollars per share)	$ 4.32
Employee Stock Option | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free rate (as a percent)	1.56%
Fair value price (in dollars per share)	$ 4.81

Long-term Compensation Plans 65

Long-term Compensation Plans - Long Term Cash Bonus Plan (Details) - Deferred Bonus - Long Term Cash Bonus Plan (LTCB) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allotted bonus total amount	$ 10.5		$ 10.5
Decrease in long-term cash bonus			4.8
Equity compensation (benefit) expense	$ 0.1	$ (0.6)	$ 0.2	$ 0.2
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period			36 months
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period			62 months 15 days

Long-term Compensation Plans 66

Long-term Compensation Plans - Employee Stock Purchase Plan (Details) - Employee Stock Purchase Plan	Mar. 06, 2014shares	Sep. 30, 2016USD ($)	Sep. 30, 2015USD ($)	Sep. 30, 2016USD ($)personshares	Sep. 30, 2015USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum approved shares of common stock for ESPP (in shares)	5,178,815
Total number of shares issued under ESPP (in shares)				152,665
Persons eligible to participate | person				1,200
Equity compensation expense (income) | $		$ 200,000	$ 0	$ 300,000	$ 100,000

Pension and Post-Retirement P67

Pension and Post-Retirement Plans - Components of Net Periodic Costs (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Domestic
Defined Benefit Plan Disclosure [Line Items]
Amortization of prior service cost			$ 0	$ 0
Post-retirement Benefits | Domestic
Defined Benefit Plan Disclosure [Line Items]
Interest cost on the projected benefit obligation	$ 0.1	$ 0.1	0.3	0.3
Net periodic (benefit) cost	0.1	0.1	0.3	0.3
Post-retirement Benefits | Foreign
Defined Benefit Plan Disclosure [Line Items]
Interest cost on the projected benefit obligation	0.1	0	0.2	0
Net periodic (benefit) cost	0.1	0	0.2	0
Pension & SERP Benefits | Domestic
Defined Benefit Plan Disclosure [Line Items]
Service cost	0	0	0	0
Interest cost on the projected benefit obligation	2.5	1.6	7.6	4.8
Expected return on plan assets	(2.9)	(2.4)	(8.7)	(7.2)
Amortization of prior service cost	0	0
Net periodic (benefit) cost	(0.4)	(0.8)	(1.1)	(2.4)
Pension & SERP Benefits | Foreign
Defined Benefit Plan Disclosure [Line Items]
Service cost	0.4	0.2	1.3	0.6
Interest cost on the projected benefit obligation	0.8	0.5	2.3	1.5
Expected return on plan assets	(0.6)	(0.5)	(1.9)	(1.5)
Amortization of prior service cost	0.1	0	0.4	0
Net periodic (benefit) cost	$ 0.7	$ 0.2	$ 2.1	$ 0.6

Pension and Post-Retirement P68

Pension and Post-Retirement Plans - Narrative (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Contributions by employer			$ 6,600,000
Expected contributions in current year			6,900,000
Domestic | Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Service cost	$ 0	$ 0	$ 0	$ 0

Debt, Capital Leases, Financi69

Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Summary of Debt and Capital Leases Outstanding (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Debt Instrument [Line Items]
Total debt and capital lease obligations	$ 5,278.3	$ 5,228.3
Less: current portion debt and capital lease obligations	(81.4)	(54.7)
Total long-term debt and capital lease obligations	5,196.9	5,173.6
Senior Notes | USD Senior Notes, due 2022
Debt Instrument [Line Items]
Total debt and capital lease obligations	$ 1,082.5	1,081.1
Stated interest rate	6.50%
Unamortized discount (premium) and debt issuance costs, net	$ 17.5	18.9
Senior Notes | EUR Senior Notes, due 2023
Debt Instrument [Line Items]
Total debt and capital lease obligations	$ 387.6	374
Stated interest rate	6.00%
Unamortized discount (premium) and debt issuance costs, net	$ 5.8	6.1
Senior Notes | USD Senior Notes, due 2021
Debt Instrument [Line Items]
Total debt and capital lease obligations	$ 488.5	487.5
Stated interest rate	10.375%
Unamortized discount (premium) and debt issuance costs, net	$ 11.5	12.5
Domestic Line of Credit | First Lien Credit Facility - U.S. Dollar Term Loans, due 2020
Debt Instrument [Line Items]
Total debt and capital lease obligations	$ 2,620	2,631.3
Stated interest rate	5.50%
Unamortized discount (premium) and debt issuance costs, net	$ 57.4	66.8
Domestic Line of Credit | First Lien Credit Facility - U.S. Dollar Term Loans, due 2020 | LIBOR
Debt Instrument [Line Items]
Spread on variable rate (as a percent)	4.50%
Foreign Line of Credit | First Lien Credit Facility - EURO Term Loans, due 2020
Debt Instrument [Line Items]
Total debt and capital lease obligations	$ 638	619.2
Stated interest rate	5.50%
Unamortized discount (premium) and debt issuance costs, net	$ 13.2	14.9
Foreign Line of Credit | First Lien Credit Facility - EURO Term Loans, due 2020 | LIBOR
Debt Instrument [Line Items]
Spread on variable rate (as a percent)	4.50%
Line of Credit
Debt Instrument [Line Items]
Total debt and capital lease obligations	$ 42.8	$ 16.7
Weighted average interest rate, short term debt	3.52%	4.28%
Line of Credit | Revolving Credit Facility
Debt Instrument [Line Items]
Total debt and capital lease obligations	$ 0	$ 0
Line of Credit | Revolving Credit Facility | LIBOR
Debt Instrument [Line Items]
Spread on variable rate (as a percent)	3.00%
Other
Debt Instrument [Line Items]
Total debt and capital lease obligations	$ 18.9	$ 18.5

Debt, Capital Leases, Financi70

Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Additional Information (Details) $ / shares in Units, € in Millions	Sep. 21, 2016USD ($)shares	Sep. 30, 2016USD ($)$ / sharesshares	Jun. 30, 2015USD ($)	Sep. 30, 2016USD ($)$ / sharesshares	Sep. 30, 2015USD ($)	Sep. 09, 2016shares	Dec. 31, 2015USD ($)	Aug. 31, 2015USD ($)	Aug. 31, 2015EUR (€)
Debt Instrument [Line Items]
Effective interest rate		6.99%		6.99%
Preferred stock redemption liability		$ 504,000,000		$ 504,000,000			$ 0
Debt and capital lease obligations		5,278,300,000		5,278,300,000			$ 5,228,300,000
Periodic interest payments (in excess of)				300,000,000
First significant payment due in 2020		$ 3,218,800,000		$ 3,218,800,000
Share price (in dollars per share) | $ / shares		$ 8.11		$ 8.11
Issuance of common stock in equity offering (in shares) | shares	48,787,878
Issuance of common stock in equity offering	$ 402,500,000	$ 402,500,000	$ 483,000,000
Proceeds from issuance of common stock				$ 391,500,000	$ 469,500,000
Arysta
Debt Instrument [Line Items]
Volume weighted average price period				10 days
Redeemable Series B Preferred Stock | Arysta
Debt Instrument [Line Items]
Conversion price (in dollars per share) | $ / shares		$ 27.14		$ 27.14
Redeemable Series B Preferred Stock | Arysta | October 20, 2016 to December 15, 2016
Debt Instrument [Line Items]
Make-whole payment		$ 460,000,000		$ 460,000,000
Cash payment for convertible preferred stock				$ 1
Number of shares issued upon conversion (in shares) | shares		5,500,000		5,500,000
Redeemable Series B Preferred Stock | Arysta | After December 15, 2016 to April 20, 2017
Debt Instrument [Line Items]
Volume weighted average price period				10 days
Conversion price (in dollars per share) | $ / shares		$ 27.14		$ 27.14
Make-whole payment		$ 421,000,000		$ 421,000,000
Number of shares issued upon conversion (in shares) | shares		22,107,590		22,107,590		22,107,590
Revolving Credit Facility
Debt Instrument [Line Items]
Maximum capacity		$ 500,000,000		$ 500,000,000
Current borrowing capacity		500,000,000		500,000,000
Bank Overdrafts
Debt Instrument [Line Items]
Current borrowing capacity		$ 118,000,000		$ 118,000,000
Notes Payable to Banks | USD Denominated Debt | Interest rate swaps
Debt Instrument [Line Items]
Derivative notional amount								$ 1,150,000,000
Interest rate swap rate (as a percent)								1.96%	1.96%
Notes Payable to Banks | Euro Denominated Debt | Interest rate swaps
Debt Instrument [Line Items]
Derivative notional amount | €									€ 282
Interest rate swap rate (as a percent)								1.20%	1.20%

Debt, Capital Leases, Financi71

Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Minimum Principal Payments on Long-term Debt and Capital Leases (Details) $ in Millions	Sep. 30, 2016USD ($)
Debt Disclosure [Abstract]
2016 - remaining	$ 8.9
2,017	34.9
2,018	34.8
2,019	34.6
2,020	3,218.8
2,021	500.7
Thereafter	1,494.4
Total debt and capital lease obligations	$ 5,327.1

Debt, Capital Leases, Financi72

Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Amended and Restated Credit Agreement (Details)	9 Months Ended
	Sep. 30, 2016USD ($)
First Lien Credit Facility - U.S. Dollar Term Loans, due 2020 | Eurodollar
Line of Credit Facility [Line Items]
Spread on variable rate (as a percent)	5.50%
First Lien Credit Facility - U.S. Dollar Term Loans, due 2020 | Base Rate
Line of Credit Facility [Line Items]
Spread on variable rate (as a percent)	4.50%
First Lien Credit Facility - EURO Term Loans, due 2020 | Eurodollar
Line of Credit Facility [Line Items]
Spread on variable rate (as a percent)	5.50%
First Lien Credit Facility - EURO Term Loans, due 2020 | Base Rate
Line of Credit Facility [Line Items]
Spread on variable rate (as a percent)	4.50%
Letter of Credit
Line of Credit Facility [Line Items]
Maximum capacity	$ 30,000,000
Revolving Credit Facility
Line of Credit Facility [Line Items]
Maximum capacity	$ 500,000,000
Revolving Credit Facility | Eurodollar
Line of Credit Facility [Line Items]
Spread on variable rate (as a percent)	3.00%
Revolving Credit Facility | Base Rate
Line of Credit Facility [Line Items]
Spread on variable rate (as a percent)	2.00%
Revolving Credit Facility, U.S. Dollars
Line of Credit Facility [Line Items]
Maximum capacity	$ 250,000,000
Revolving Credit Facility, Multi-Currency
Line of Credit Facility [Line Items]
Maximum capacity	$ 250,000,000

Debt, Capital Leases, Financi73

Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Covenants and Events of Default (Details)	9 Months Ended
	Sep. 30, 2016USD ($)
Debt Instrument [Line Items]
Protection provision, indebtedness yield increase (as a percent)	0.50%
Protection provision, additional loan yield minimum (as a percent)	0.50%
Minimum
Debt Instrument [Line Items]
Ratio of debt to EBITDA	6.25
Revolving Credit Facility
Debt Instrument [Line Items]
Debt covenant period	12 months
Current borrowing capacity	$ 500,000,000

Debt, Capital Leases, Financi74

Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Subsequent Event (Details)	Oct. 14, 2016USD ($)	Oct. 14, 2016EUR (€)	Sep. 30, 2016USD ($)	Sep. 30, 2016	Sep. 30, 2016MXN / $	Sep. 30, 2016BRL / $
Debt Instrument [Line Items]
Exchange rate					0.0516	0.3065
Subsequent Event
Debt Instrument [Line Items]
Ratio of debt to EBITDA	6
Prepayment percentage	75.00%	75.00%
Prepayment percentage, step-down one	50.00%	50.00%
Prepayment percentage, step-down two	25.00%	25.00%
Prepayment percentage, step-down three	0.00%	0.00%
Revolving Credit Facility, U.S. Dollars
Debt Instrument [Line Items]
Maximum capacity			$ 250,000,000
Revolving Credit Facility, Multi-Currency
Debt Instrument [Line Items]
Maximum capacity			$ 250,000,000
Term Loans | USD Denominated Debt | Subsequent Event
Debt Instrument [Line Items]
Original issue discount, as a percentage	0.50%	0.50%
Debt face amount	$ 1,480,000,000
Decrease in interest rate	0.50%
Term Loans | Euro Denominated Debt | Subsequent Event
Debt Instrument [Line Items]
Original issue discount, as a percentage	0.25%	0.25%
Debt face amount	$ 487,000,000	€ 433,000,000
Decrease in interest rate	0.75%
Exchange rate	1.124	1.124
Senior Notes | USD Senior Notes, due 2022
Debt Instrument [Line Items]
Stated interest rate				6.50%
Eurodollar | Term Loans | USD Denominated Debt | Subsequent Event
Debt Instrument [Line Items]
Spread on variable rate (as a percent)	4.00%
Eurodollar | Term Loans | Euro Denominated Debt | Subsequent Event
Debt Instrument [Line Items]
Spread on variable rate (as a percent)	3.75%

Debt, Capital Leases, Financi75

Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Guarantees, Lines of Credit and Other Debt Facilities (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Debt Instrument [Line Items]
Voting capital stock pledged of domestic subsidiaries (as a percent)	100.00%
Voting capital stock pledged of non-domestic subsidiaries (as a percent)	65.00%
Debt and capital lease obligations	$ 5,278.3	$ 5,228.3
Overdraft facility capacity	618
Line of Credit
Debt Instrument [Line Items]
Debt and capital lease obligations	42.8	16.7
Outstanding letters of credit	32.9	40
Reduction in borrowings	$ 11.2	$ 11

Debt, Capital Leases, Financi76

Debt, Capital Leases, Financial Guarantees and Factoring Arrangements - Financial Guarantees and Factoring Arrangements (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Debt Instrument [Line Items]
Factoring agreements total current capacity	$ 287,000,000		$ 287,000,000
Factoring agreements qualifying for sales treatment	33,100,000		33,100,000		$ 189,000,000
Factoring agreements recorded in accounts receivable	31,000,000		31,000,000		24,800,000
Factoring agreements, additional capacity	96,800,000		96,800,000
Overdraft facility capacity			618,000,000
United States
Debt Instrument [Line Items]
Overdraft facility capacity			18,000,000
Other Operating Income (Expense)
Debt Instrument [Line Items]
Factoring agreement program expense	100,000	$ (500,000)	300,000	$ (1,500,000)
Factoring fees	700,000	$ 100,000	1,400,000	$ 100,000
Financial Guarantee
Debt Instrument [Line Items]
Financial guarantees	$ 6,700,000		$ 6,700,000		$ 46,300,000

Derivative Instruments - Narrat

Derivative Instruments - Narrative (Details) € in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016USD ($)	Sep. 30, 2015USD ($)	Sep. 30, 2016USD ($)	Sep. 30, 2015USD ($)	Dec. 31, 2015USD ($)	Aug. 31, 2015USD ($)	Aug. 31, 2015EUR (€)
Derivative Instruments, Gain (Loss) [Line Items]
Reclassification from AOCI	$ 3,000,000		$ 8,900,000
Loss on derivative contracts	(1,400,000)	$ (47,300,000)	(12,100,000)	$ (49,900,000)
Foreign Exchange Forward
Derivative Instruments, Gain (Loss) [Line Items]
Derivative notional amount	38,700,000		$ 38,700,000		$ 16,500,000
Derivative remaining maturity			12 months
Foreign Exchange Forward | Not Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Derivative notional amount	264,000,000		$ 264,000,000
Derivative remaining maturity			1 year
Embedded Derivative Financial Instruments
Derivative Instruments, Gain (Loss) [Line Items]
Derivative notional amount	13,700,000		$ 13,700,000		13,000,000
Interest rate swaps | Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized losses recorded to other comprehensive income related to foreign currency hedges	1,600,000	18,100,000	24,300,000	0
Reclassification from AOCI	3,000,000		8,900,000
Gain (loss) to be reclassified during next 12 months	(10,500,000)		(10,500,000)
Interest rate swaps | Notes Payable to Banks | USD Denominated Debt
Derivative Instruments, Gain (Loss) [Line Items]
Derivative notional amount						$ 1,150,000,000
Interest rate swap rate (as a percent)						1.96%	1.96%
Interest rate swaps | Notes Payable to Banks | Euro Denominated Debt
Derivative Instruments, Gain (Loss) [Line Items]
Derivative notional amount | €							€ 282
Interest rate swap rate (as a percent)						1.20%	1.20%
Commodity Contract
Derivative Instruments, Gain (Loss) [Line Items]
Derivative liability, current	(400,000)		(400,000)		$ 0
Foreign exchange contracts
Derivative Instruments, Gain (Loss) [Line Items]
Loss on derivative contracts	$ (1,400,000)	$ (47,300,000)	$ (12,100,000)	$ (49,900,000)

Derivative Instruments - Signif

Derivative Instruments - Significant Outstanding Foreign Exchange Derivative Contracts (Details) - Foreign Exchange Forward - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Derivative [Line Items]
Derivative notional amount	$ 38.7	$ 16.5
Not Designated as Hedging Instrument
Derivative [Line Items]
Derivative notional amount	264
Not Designated as Hedging Instrument | Purchasing | Traded against USD
Derivative [Line Items]
Derivative notional amount	93.5
Not Designated as Hedging Instrument | Purchasing | Traded against USD | Euro (EUR)
Derivative [Line Items]
Derivative notional amount	41.4
Not Designated as Hedging Instrument | Purchasing | Traded against USD | Brazilian Real (BRL)
Derivative [Line Items]
Derivative notional amount	13.8
Not Designated as Hedging Instrument | Purchasing | Traded against USD | South African Rand (ZAR)
Derivative [Line Items]
Derivative notional amount	12.3
Not Designated as Hedging Instrument | Purchasing | Traded against USD | South African Rand (ZAR)
Derivative [Line Items]
Derivative notional amount	0
Not Designated as Hedging Instrument | Purchasing | Traded against USD | Taiwan Dollar (TWD)
Derivative [Line Items]
Derivative notional amount	10.6
Not Designated as Hedging Instrument | Purchasing | Traded against USD | Other
Derivative [Line Items]
Derivative notional amount	15.4
Not Designated as Hedging Instrument | Purchasing | Traded against EUR (USD equivalent)
Derivative [Line Items]
Derivative notional amount	18.6
Not Designated as Hedging Instrument | Purchasing | Traded against EUR (USD equivalent) | Euro (EUR)
Derivative [Line Items]
Derivative notional amount	0
Not Designated as Hedging Instrument | Purchasing | Traded against EUR (USD equivalent) | Brazilian Real (BRL)
Derivative [Line Items]
Derivative notional amount	0
Not Designated as Hedging Instrument | Purchasing | Traded against EUR (USD equivalent) | South African Rand (ZAR)
Derivative [Line Items]
Derivative notional amount	9.5
Not Designated as Hedging Instrument | Purchasing | Traded against EUR (USD equivalent) | South African Rand (ZAR)
Derivative [Line Items]
Derivative notional amount	0
Not Designated as Hedging Instrument | Purchasing | Traded against EUR (USD equivalent) | Taiwan Dollar (TWD)
Derivative [Line Items]
Derivative notional amount	0
Not Designated as Hedging Instrument | Purchasing | Traded against EUR (USD equivalent) | Other
Derivative [Line Items]
Derivative notional amount	9.1
Not Designated as Hedging Instrument | Selling | Traded against USD
Derivative [Line Items]
Derivative notional amount	146.9
Not Designated as Hedging Instrument | Selling | Traded against USD | Euro (EUR)
Derivative [Line Items]
Derivative notional amount	36.9
Not Designated as Hedging Instrument | Selling | Traded against USD | Brazilian Real (BRL)
Derivative [Line Items]
Derivative notional amount	66.1
Not Designated as Hedging Instrument | Selling | Traded against USD | South African Rand (ZAR)
Derivative [Line Items]
Derivative notional amount	18.7
Not Designated as Hedging Instrument | Selling | Traded against USD | South African Rand (ZAR)
Derivative [Line Items]
Derivative notional amount	22.3
Not Designated as Hedging Instrument | Selling | Traded against USD | Taiwan Dollar (TWD)
Derivative [Line Items]
Derivative notional amount	0
Not Designated as Hedging Instrument | Selling | Traded against USD | Other
Derivative [Line Items]
Derivative notional amount	2.9
Not Designated as Hedging Instrument | Selling | Traded against EUR (USD equivalent)
Derivative [Line Items]
Derivative notional amount	3.3
Not Designated as Hedging Instrument | Selling | Traded against EUR (USD equivalent) | Euro (EUR)
Derivative [Line Items]
Derivative notional amount	0
Not Designated as Hedging Instrument | Selling | Traded against EUR (USD equivalent) | Brazilian Real (BRL)
Derivative [Line Items]
Derivative notional amount	0
Not Designated as Hedging Instrument | Selling | Traded against EUR (USD equivalent) | South African Rand (ZAR)
Derivative [Line Items]
Derivative notional amount	1.6
Not Designated as Hedging Instrument | Selling | Traded against EUR (USD equivalent) | South African Rand (ZAR)
Derivative [Line Items]
Derivative notional amount	1.4
Not Designated as Hedging Instrument | Selling | Traded against EUR (USD equivalent) | Taiwan Dollar (TWD)
Derivative [Line Items]
Derivative notional amount	0
Not Designated as Hedging Instrument | Selling | Traded against EUR (USD equivalent) | Other
Derivative [Line Items]
Derivative notional amount	$ 0.3

Derivative Instruments - Fair V

Derivative Instruments - Fair Value of Derivative Instruments (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Derivative Instruments, Gain (Loss) [Line Items]
Total derivative contracts	$ (30.9)	$ (11.4)
Accrued expenses and other current liabilities | Interest rate swaps | Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Derivative liability, current	(10.5)	0
Accrued expenses and other current liabilities | Foreign exchange and metals contracts | Not Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Derivative liability, current	(5.5)	(1)
Other long-term liabilities | Interest rate swaps | Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Derivative liability, noncurrent	(17.5)	(12.5)
Prepaid expenses and other current assets | Foreign exchange and metals contracts | Not Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Derivative assets, current	2.6	1.1
Other assets | Foreign exchange contracts | Not Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Derivative assets, noncurrent	$ 0	$ 1

Derivative Instruments - Master

Derivative Instruments - Master Netting Arrangements (Details) - Foreign Exchange Forward and Commodity Contracts - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Financial assets
Gross assets	$ 2.1	$ 3.1
Gross liabilities offset	0	0
Net amounts presented	2.1	3.1
Financial instruments	(0.4)	(0.3)
Cash collateral paid	0	0
Net	1.7	2.8
Financial liabilities
Gross liabilities	4.8	1.7
Gross assets offset	0	0
Net amounts presented	4.8	1.7
Financial instruments	(1)	(1.2)
Cash collateral paid	(1)	(0.9)
Net	$ 2.8	$ (0.4)

Fair Value Measurements - Asset

Fair Value Measurements - Assets and Liabilities Measured at Fair Value (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Liability Category
Preferred stock redemption liability	$ 504	$ 0
Fair Value, Measurements, Recurring
Asset Category
Cash equivalents	23.2	59.4
Available for sale equity securities	2.5	6.6
Derivatives	2.6	2.1
Total	28.3	68.1
Liability Category
Derivatives	33.5	13.5
Long-term contingent consideration	75	70.7
Preferred stock redemption liability	504
Total	612.5	84.2
Fair Value, Measurements, Recurring | Quoted prices in active markets (Level 1)
Asset Category
Cash equivalents	0	2.9
Available for sale equity securities	1.9	5.8
Derivatives	0	0
Total	1.9	8.7
Liability Category
Derivatives	0	0
Long-term contingent consideration	0	0
Preferred stock redemption liability	0
Total	0	0
Fair Value, Measurements, Recurring | Significant other observable inputs (Level 2)
Asset Category
Cash equivalents	23.2	56.5
Available for sale equity securities	0.6	0.8
Derivatives	2.6	2.1
Total	26.4	59.4
Liability Category
Derivatives	33.5	13.5
Long-term contingent consideration	0	0
Preferred stock redemption liability	0
Total	33.5	13.5
Fair Value, Measurements, Recurring | Significant unobservable inputs (Level 3)
Asset Category
Cash equivalents	0	0
Available for sale equity securities	0	0
Derivatives	0	0
Total	0	0
Liability Category
Derivatives	0	0
Long-term contingent consideration	75	70.7
Preferred stock redemption liability	504
Total	$ 579	$ 70.7

Fair Value Measurements - Narra

Fair Value Measurements - Narrative (Details) - USD ($)	Feb. 13, 2015	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Percentage change in rate affecting component measurement (as a percent)				1.00%
Measurement component change affected by change in discount rate				$ 1,700,000
EBITDA metric, measurement component change affected by change in discount rate				3,000,000
Non-cash change in fair value of preferred stock redemption liability		$ 6,000,000	$ 0	$ 6,000,000	$ 0
Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
EBITDA probability range (as a percent)				80.00%
Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
EBITDA probability range (as a percent)				100.00%
Mac Dermid
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term contingent consideration (up to)		100,000,000		$ 100,000,000
Price performance metrics period				7 years
EBITDA related earnout include a discount rate (as a percent)				1.06%
Business acquisition expected future value payments				$ 60,000,000
Arysta
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Preferred stock redemption liability	$ 600,000,000
Business acquisition, shares of common stock issued (in shares)	600,000
Arysta | Redeemable Series B Preferred Stock
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Preferred stock redemption liability				600,000,000
Non-cash change in fair value of preferred stock redemption liability		6,000,000
Arysta | October 20, 2016 to December 15, 2016 | Redeemable Series B Preferred Stock
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Make-whole payment		$ 460,000,000		$ 460,000,000
Number of shares issued upon conversion (in shares)		5,500,000		5,500,000

Fair Value Measurements - Level

Fair Value Measurements - Level 3 Reconciliation (Details)	9 Months Ended
	Sep. 30, 2016USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance	$ 70,700,000
Changes in fair value	(1,700,000)
Purchases, sales and settlements	0
Additions	510,000,000
Transfers into Level 3	0
Transfers out of Level 3	0
Balance	$ 579,000,000

Fair Value Measurements - Nonre

Fair Value Measurements - Nonrecurring Fair Value Measurements (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	$ 5,221.7	$ 5,198.6
Carrying Value | Senior Notes | USD Senior Notes due 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	1,082.5	1,081.1
Carrying Value | Senior Notes | EUR Senior Notes due 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	387.6	374
Carrying Value | Senior Notes | USD Senior Notes due 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	488.5	487.5
Carrying Value | Domestic Line of Credit | First Lien Credit Facility - U.S. Dollar Term Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	2,620	2,631.3
Carrying Value | Foreign Line of Credit | First Lien Credit Facility - Euro Term Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	638	619.2
Carrying Value | Capital Lease Obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	5.1	5.5
Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	5,331.8	5,006.2
Fair Value | Senior Notes | USD Senior Notes due 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	1,071.6	946.3
Fair Value | Senior Notes | EUR Senior Notes due 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	371.6	326.7
Fair Value | Senior Notes | USD Senior Notes due 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	539.9	500
Fair Value | Domestic Line of Credit | First Lien Credit Facility - U.S. Dollar Term Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	2,685.7	2,603.6
Fair Value | Foreign Line of Credit | First Lien Credit Facility - Euro Term Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	657.8	624.3
Fair Value | Capital Lease Obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	$ 5.2	$ 5.3

Stockholders' Equity (Details)

Stockholders' Equity (Details)	Sep. 21, 2016USD ($)$ / sharesshares	Feb. 13, 2015USD ($)$ / sharesshares	Sep. 30, 2016USD ($)$ / sharesshares	Sep. 30, 2015USD ($)	Jun. 30, 2015USD ($)	Sep. 30, 2016USD ($)$ / sharesshares	Sep. 30, 2015USD ($)	Sep. 09, 2016shares	Dec. 31, 2015shares
Class of Stock [Line Items]
Common shares issued (in shares) | shares	48,787,878
Share price (in dollars per share) | $ / shares	$ 8.25
Issuance of common stock in equity offering | $	$ 402,500,000		$ 402,500,000		$ 483,000,000
Underwriting discounts, commissions and offering expenses | $	$ 11,600,000		$ 11,600,000		$ 14,800,000
Number of preferred shares authorized in amendment (in shares) | shares			5,000,000			5,000,000
Share price (in dollars per share) | $ / shares			$ 8.11			$ 8.11
Gain on amendment of Series B Convertible Preferred Stock | $			$ 32,900,000	$ 0		$ 32,900,000	$ 0
Gain on settlement | $			103,000,000	0		103,000,000	0
Non-cash change in fair value of preferred stock redemption liability | $			6,000,000	0		$ 6,000,000	0
Total number of shares of common stock originally issuable upon the exchange of PDH common stock pursuant to the RHSA (in shares) | shares						8,800,000
Arysta
Class of Stock [Line Items]
Business acquisition, shares of common stock issued (in shares) | shares		600,000
Equity instruments | $		$ 646,000,000
Volume weighted average price period						10 days
Mac Dermid
Class of Stock [Line Items]
Equity instruments | $			97,500,000			$ 97,500,000
Net income (loss) allocated to Retaining Holders | $			$ (1,500,000)	$ (1,100,000)		$ (4,200,000)	$ 100,000
Noncontrolling interest percentage (as a percent)			6.20%	6.35%		6.20%	6.35%		6.25%
PDH
Class of Stock [Line Items]
Rate PDH Common stock that may be exchanged for shares of common stock						25.00%
Period during which PDH Common stock that may be exchanged for shares of common stock						4 years
Common stock issued in connection with exchange of PDH common stock (in shares) | shares			776,862			776,862
Series A Preferred Stock
Class of Stock [Line Items]
Number of preferred shares authorized in amendment (in shares) | shares			2,000,000			2,000,000
Preferred shares, shares issued (in shares) | shares			2,000,000			2,000,000			2,000,000
Preferred shares, shares outstanding (in shares) | shares			2,000,000			2,000,000			2,000,000
Dividend price (in dollars per share) | $ / shares						$ 22.85
Series A Preferred Stock | Founders Entities
Class of Stock [Line Items]
Preferred shares, shares outstanding (in shares) | shares			2,000,000			2,000,000
Convertible preferred stock conversion ratio			1			1
Automatic conversion period						7 years
Extension period for conversion						3 years
Redeemable Series B Preferred Stock
Class of Stock [Line Items]
Temporary equity designated (in shares) | shares			600,000			600,000
Temporary equity issued (in shares) | shares			600,000			600,000			600,000
Temporary equity outstanding (in shares) | shares			600,000			600,000			600,000
Redeemable Series B Preferred Stock | Arysta
Class of Stock [Line Items]
Liquidation preference per share (in dollars per share) | $ / shares		$ 1,000	$ 1,000			$ 1,000
Conversion price (in dollars per share) | $ / shares			$ 27.14			$ 27.14
Incremental distribution to holders per month | $			$ 4,000,000			$ 4,000,000
Gain on amendment of Series B Convertible Preferred Stock | $			32,900,000
Gain on settlement | $			103,000,000
Non-cash change in fair value of preferred stock redemption liability | $			$ 6,000,000
Redeemable Series B Preferred Stock | October 20, 2016 to December 15, 2016 | Arysta
Class of Stock [Line Items]
Cash payment for convertible preferred stock | $						$ 1
Number of shares issued upon conversion (in shares) | shares			5,500,000			5,500,000
Make-whole payment | $			$ 460,000,000			$ 460,000,000
Redeemable Series B Preferred Stock | After December 15, 2016 to April 20, 2017 | Arysta
Class of Stock [Line Items]
Number of shares issued upon conversion (in shares) | shares			22,107,590			22,107,590		22,107,590
Make-whole payment | $			$ 421,000,000			$ 421,000,000
Conversion price (in dollars per share) | $ / shares			$ 27.14			$ 27.14
Volume weighted average price period						10 days
Over-Allotment Option
Class of Stock [Line Items]
Common shares issued (in shares) | shares	6,363,636

Accumulated Other Comprehensi86

Accumulated Other Comprehensive (Loss) Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Balance	$ 2,567.9	$ 2,748.5	$ 2,273.3	$ 2,552.6
Other comprehensive (loss) income before reclassifications, net	6.6	(353.8)	413.1	(610.3)
Reclassifications, pretax	3		8.9
Tax expense reclassified				(0.5)
Balance	3,060.3	2,250.4	3,060.3	2,250.4
Foreign Currency Translation Adjustments
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Balance	(446.8)	(386)	(899.3)	(122.2)
Other comprehensive (loss) income before reclassifications, net	(0.7)	(350.2)	451.8	(614)
Reclassifications, pretax	0		0
Tax expense reclassified				0
Balance	(447.5)	(736.2)	(447.5)	(736.2)
Pension and Post-retirement Plans
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Balance	(26.3)	(15.4)	(26.3)	(14.9)
Other comprehensive (loss) income before reclassifications, net	0	0	0	0
Reclassifications, pretax	0		0
Tax expense reclassified				(0.5)
Balance	(26.3)	(15.4)	(26.3)	(15.4)
Unrealized (Loss) Gain on Available for Sale Securities
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Balance	(0.4)	0.3	1.2	0.1
Other comprehensive (loss) income before reclassifications, net	(0.1)	1	(1.7)	1.2
Reclassifications, pretax	0		0
Tax expense reclassified				0
Balance	(0.5)	1.3	(0.5)	1.3
Derivative Financial Instrument Revaluation
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Balance	(24.9)	0	(8.1)	0
Other comprehensive (loss) income before reclassifications, net	(1.6)	(11.8)	(24.3)	(11.8)
Reclassifications, pretax	3		8.9
Tax expense reclassified				0
Balance	(23.5)	(11.8)	(23.5)	(11.8)
Non-Controlling Interests
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Balance	191.4	109.1	169.4	93
Other comprehensive (loss) income before reclassifications, net	9	7.2	(12.7)	14.3
Reclassifications, pretax	0		0
Tax expense reclassified				0
Balance	172.1	105.5	172.1	105.5
Non-Controlling Interests
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Balance	24.7	13.5	46.4	6.4
Balance	33.7	20.7	33.7	20.7
Accumulated Other Comprehensive (Loss) Income
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Balance	(473.7)	(387.6)	(886.1)	(130.6)
Balance	$ (464.1)	$ (741.4)	$ (464.1)	$ (741.4)

Earnings (Loss) Per Share - Com

Earnings (Loss) Per Share - Computation of Weighted Average Shares Outstanding (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Schedule of Earnings Per Share [Line Items]
Net income (loss) attributable to common stockholders for basic EPS	$ 104.7	$ (140.1)	$ (39)	$ (178.9)
Adjustments to the numerator for diluted earnings per share:
Gain on settlement agreement related to Series B Convertible Preferred Stock	(103)	0	(103)	0
Gain on amendment of Series B Convertible Preferred Stock	(32.9)	0	(32.9)	0
Remeasurement adjustment associated with the Preferred Series B redemption liability	(6)	0	(6)	0
Income allocated to PDH non-controlling interest	(1.5)	0	0	0
Net loss attributable to common stockholders for diluted EPS	$ (38.7)	$ (140.1)	$ (180.9)	$ (178.9)
Basic weighted average common stock outstanding (in shares)	234,400,000	210,900,000	231,200,000	198,600,000
Issuable upon conversion of the PDH non-controlling interest (in shares)	8,000,000	0	0	0
Share adjustments (in shares)	30,100,000	0	22,100,000	0
Dilutive weighted average common stock outstanding (in shares)	264,500,000	210,900,000	253,300,000	198,600,000
Income (loss) per share attributable to common stockholders:
Basic (in dollars per share)	$ 0.45	$ (0.66)	$ (0.17)	$ (0.89)
Diluted (in dollars per share)	(0.15)	(0.66)	(0.71)	(0.89)
Dividends per share paid to common stockholders (in dollars per share)	$ 0	$ 0	$ 0	$ 0
Redeemable Series B Preferred Stock
Adjustments to the numerator for diluted earnings per share:
Assumed conversion related to the amendment of Series B preferred shares (in shares)	17,100,000	0	20,400,000	0
Assumed settlement of preferred stock redemption liability (in shares)	5,000,000	0	1,700,000	0

Earnings (Loss) Per Share - Ant

Earnings (Loss) Per Share - Anti-dilutive Securities (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted-average securities not included in computation of diluted shares outstanding (in shares)	11,449	34,928	18,956	32,287
Shares contingently issuable to Founder Entities as stock dividend on Series A Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted-average securities not included in computation of diluted shares outstanding (in shares)	0	0	0	1,652
Shares issuable upon conversion of PDH Common Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted-average securities not included in computation of diluted shares outstanding (in shares)	0	8,207	8,023	8,207
Shares issuable upon conversion of Series A Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted-average securities not included in computation of diluted shares outstanding (in shares)	2,000	2,000	2,000	2,000
Shares issuable upon conversion of Series B Convertible Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted-average securities not included in computation of diluted shares outstanding (in shares)	0	22,108	0	18,544
Shares contingently issuable for the contingent consideration
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted-average securities not included in computation of diluted shares outstanding (in shares)	9,262	2,496	8,820	1,719
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted-average securities not included in computation of diluted shares outstanding (in shares)	0	55	0	70
RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted-average securities not included in computation of diluted shares outstanding (in shares)	186	60	110	94
Shares issuable under the ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Weighted-average securities not included in computation of diluted shares outstanding (in shares)	1	2	3	1

Operating Lease Commitments - R

Operating Lease Commitments - Rent Expense for Operating Leases (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Leases [Abstract]
Rent expense	$ 8.9	$ 6	$ 28	$ 16.4

Operating Lease Commitments - M

Operating Lease Commitments - Minimum Non-cancelable Operating Lease Commitments (Details) $ in Millions	Sep. 30, 2016USD ($)
Leases [Abstract]
2016, remaining	$ 10.2
2,017	26
2,018	17.7
2,019	12
2,020	9.8
2,021	8.7
Thereafter	26.8
Total minimum non-cancelable operating lease commitments	$ 111.2

Contingencies, Environmental 91

Contingencies, Environmental and Legal Matters - Changes in AROs (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Loss Contingency Accrual [Roll Forward]
AROs, beginning of period	$ 20.9	$ 17.7	$ 17.5	$ 18.5
Acquisitions	0	0	2.8	0.4
Accretion expense	0.3	0.2	0.9	0.7
Remeasurements	0	0.5	0.1	(0.2)
Payments	0	(0.4)	(0.5)	(0.4)
Foreign currency adjustments	0	(0.2)	0.4	(1.2)
AROs, end of period	$ 21.2	$ 17.8	$ 21.2	$ 17.8

Contingencies, Environmental 92

Contingencies, Environmental and Legal Matters - Narrative (Details) MXN in Millions, BRL in Millions

Apr. 03, 2015USD ($)

Feb. 13, 2015USD ($)

Jun. 30, 2016USD ($)

Apr. 30, 2016USD ($)

Feb. 28, 2015USD ($)

Jul. 31, 2014USD ($)

Nov. 30, 2011defendant

Jun. 30, 2009defendant

Sep. 30, 2016USD ($)

Sep. 30, 2015USD ($)

Sep. 30, 2016USD ($)employeedefendant

Sep. 30, 2016BRLemployeedefendant

Sep. 30, 2016MXNemployeedefendant

Sep. 30, 2015USD ($)

Sep. 30, 2016shares

Sep. 30, 2016MXN / $

Sep. 30, 2016BRL / $

Sep. 30, 2016BRL

Sep. 09, 2016shares

Dec. 31, 2015USD ($)

Jun. 30, 2015USD ($)

Dec. 31, 2014USD ($)

Loss Contingencies [Line Items]

Asset retirement obligations

$ 20,900,000

$ 21,200,000

$ 17,800,000

$ 21,200,000

$ 17,800,000

$ 17,500,000

$ 17,700,000

$ 18,500,000

Reserves for environmental matters

47,900,000

47,900,000

25,700,000

Estimate of possible loss in legal proceedings

8,800,000

8,800,000

$ 6,500,000

Potential litigation loss exchange rate (in MXN per USD)

0.0516

0.3065

Contest of tax assessment

24,900,000

24,900,000

BRL 81.1

Legal settlement

0

$ 0

2,800,000

$ 16,000,000

Settled Litigation

Loss Contingencies [Line Items]

Amount awarded

$ 16,000,000

Legal settlement

$ 25,000,000

Arysta

Loss Contingencies [Line Items]

Equity instruments

$ 600,000,000

Maximum share conversion amount

$ 600,000,000

Volume weighted average price period

10 days

10 days

10 days

Arysta | Redeemable Series B Preferred Stock

Loss Contingencies [Line Items]

Equity instruments

$ 600,000,000

Agricola Colonet, SA de CV | Pending Litigation

Loss Contingencies [Line Items]

Compensation sought (more than $6.0 million)

$ 6,000,000

9,800,000

MXN 191

Arysta | Pending Litigation

Loss Contingencies [Line Items]

Compensation sought (more than $6.0 million)

15,300,000

BRL 50

Number of defendants | defendant

5

25

Remediation amount sought

21,700,000

70.9

Arysta | Pending Litigation | Health Problems From Employment Site

Loss Contingencies [Line Items]

Compensation sought (more than $6.0 million)

$ 118,000,000

BRL 387

Number of defendants | defendant

80

80

80

Number of former employees | employee

29

29

29

Alent

Loss Contingencies [Line Items]

Accrual for environmental loss contingencies

$ 44,700,000

$ 44,700,000

Alent | Minimum

Loss Contingencies [Line Items]

Estimated period to resolve contingency

5 years

5 years

5 years

Alent | Maximum

Loss Contingencies [Line Items]

Estimated period to resolve contingency

10 years

10 years

10 years

Arysta LifeScience Corporation

Loss Contingencies [Line Items]

Amount awarded

$ 100,000

Litigation expense

$ 600,000

Litigation expense (as a percent)

50.00%

Mac Dermid | Pending Litigation

Loss Contingencies [Line Items]

Legal settlement

$ 64,700,000

After December 15, 2016 to April 20, 2017 | Arysta | Redeemable Series B Preferred Stock

Loss Contingencies [Line Items]

Maximum share conversion (in shares) | shares

22,107,590

22,107,590

Volume weighted average price period

10 days

10 days

10 days

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	Dec. 01, 2015	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Income Taxes
Income tax expense		$ (20.4)	$ (35.4)	$ (65.7)	$ (59.8)
Effective income tax rate (as a percent)		23.60%	(34.00%)	(602.80%)	(52.00%)
Net income (loss) before income taxes and non-controlling interests		$ 86.3	$ (104.2)	$ (10.9)	$ (115.1)
Change in tax reserves		26		27.9
Tax benefit for nontaxable gain on sale		38.2		38.2
Benefit for deductions associated with acquisition		25.6		25.6
Benefit related to recognition of tax deductible goodwill		15.3		15.3
Benefit related to tax on foreign operations		14.7		10
Unrecognized tax benefit		188		188		$ 112
Reduction in effective tax rate		94		94		92
Uncertain tax liability	$ 44.5			25.6
Accrued interest and penalties related to unrecognized tax benefits		19.7		19.7		$ 17.5
Interest and penalties recognized				3.5	$ 0.4
Possible reduction in tax benefits from lapse of applicable statute of limitations		7.8		7.8
Net Operating Loss
Income Taxes
Change in valuation allowance		$ 21.9		$ 103

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Mariposa Capital
Related Party Transaction [Line Items]
Automatic renewal period			1 year
Agreement renewal period			90 days
Advisory fees	$ 500,000	$ 500,000	$ 1,500,000	$ 1,500,000
Annual Fees | Mariposa Capital
Related Party Transaction [Line Items]
Annual fee			$ 2,000,000
Mac Dermid
Related Party Transaction [Line Items]
Price exchange rate (in dollars per share)	$ 11		$ 11
Contingent purchase payable (up to)	$ 100,000,000		$ 100,000,000
Price performance metrics period			7 years
Noncontrolling interest percentage (as a percent)	6.20%	6.35%	6.20%	6.35%	6.25%

Restructuring (Details)

Restructuring (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Restructuring Cost and Reserve [Line Items]
Restructuring expenses	$ 7.3	$ 4.5	$ 19.5	$ 18.2
Cost of sales
Restructuring Cost and Reserve [Line Items]
Restructuring expenses	0	2.4	(0.4)	3.6
Selling, technical, general and administrative
Restructuring Cost and Reserve [Line Items]
Restructuring expenses	7.3	2.1	19.9	14.6
Performance Solutions
Restructuring Cost and Reserve [Line Items]
Restructuring expenses	6.4	2.9	16.8	5.8
Agricultural Solutions
Restructuring Cost and Reserve [Line Items]
Restructuring expenses	0.9	$ 1.6	2.7	$ 12.4
Accrued expenses and other current liabilities
Restructuring Cost and Reserve [Line Items]
Restructuring liabilities	$ 0.4		$ 0.4		$ 1.1

Segment Information - Financial

Segment Information - Financial Information by Reportable Segment (Details) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016USD ($)	Sep. 30, 2015USD ($)	Sep. 30, 2016USD ($)segment	Sep. 30, 2015USD ($)
Segment Reporting Information [Line Items]
Number of reportable segments | segment			2
Net Sales (from external customers):
Net Sales	$ 890.5	$ 597.3	$ 2,635.9	$ 1,807.3
Adjusted EBITDA:
Adjusted EBITDA	190.1	113.6	551.4	413.4
Performance Solutions
Net Sales (from external customers):
Net Sales	454.9	179.7	1,312.9	541.6
Adjusted EBITDA:
Adjusted EBITDA	109.9	54.1	290.7	156.9
Agricultural Solutions
Net Sales (from external customers):
Net Sales	435.6	417.6	1,323	1,265.7
Adjusted EBITDA:
Adjusted EBITDA	$ 80.2	$ 59.5	$ 260.7	$ 256.5

Segment Information - Reconcili

Segment Information - Reconciliation of Adjusted EBITDA to Net Loss (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Segment Reporting [Abstract]
Net income (loss) attributable to common stockholders	$ 104.7	$ (140.1)	$ (39)	$ (178.9)
Gain on amendment of Series B Convertible Preferred Stock	(32.9)	0	(32.9)	0
Net (loss) income attributable to the non-controlling interests	(5.9)	0.5	(4.7)	4
Income tax expense	20.4	35.4	65.7	59.8
Income (loss) before income taxes and non-controlling interests	86.3	(104.2)	(10.9)	(115.1)
Adjustments to reconcile to Adjusted EBITDA:
Interest expense, net	98.5	52.7	289.7	143.2
Depreciation expense	18.9	11.6	55.8	33.7
Amortization expense	68	50.4	199.1	142.6
Long-term compensation issued in connection with acquisitions	0.2	(1.5)	0.6	0.2
Restructuring expenses	7.3	4.5	19.5	18.2
Manufacturer's profit in inventory purchase accounting adjustments	0	1.3	11.7	58
Acquisition and integration costs	3.2	15	27.4	70.4
Non-cash change in fair value of contingent consideration	0.2	2.7	4.3	6.3
Legal settlements	0	0	(2.8)	(16)
Foreign exchange loss on foreign denominated external and internal debt	12	33	58.7	26.8
Fair value loss on foreign exchange forward contract	0	48.1	0	48.1
Gain on settlement agreement related to Series B Convertible Preferred Stock	(103)	0	(103)	0
Non-cash change in fair value of preferred stock redemption liability	(6)	0	(6)	0
Other income (expense), net	4.5	0	7.3	(3)
Adjusted EBITDA	$ 190.1	$ 113.6	$ 551.4	$ 413.4